<html lang="en" class="js"><head><link rel="preload" href="/static/fonts/HardingText-Regular-Web-cecd90984f.woff2" as="font" type="font/woff2" crossorigin="">
    <title>Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer | Nature Communications</title>
    
        
<link rel="alternate" type="application/rss+xml" href="https://www.nature.com/ncomms.rss">


    
        

        <script async="" src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2"></script><script type="text/javascript" async="" src="https://pagead2.googlesyndication.com/tag/js/gpt.js"></script><script async="" src="https://sgtm.nature.com/gtm.js?id=GTM-MRVXSHQ"></script><script id="save-data-connection-testing">
            function hasConnection() {
                return navigator.connection || navigator.mozConnection || navigator.webkitConnection || navigator.msConnection;
            }

            function createLink(src) {
                var preloadLink = document.createElement("link");
                preloadLink.rel = "preload";
                preloadLink.href = src;
                preloadLink.as = "font";
                preloadLink.type = "font/woff2";
                preloadLink.crossOrigin = "";
                document.head.insertBefore(preloadLink, document.head.firstChild);
            }

            var connectionDetail = {
                saveDataEnabled: false,
                slowConnection: false
            };

            var connection = hasConnection();
            if (connection) {
                connectionDetail.saveDataEnabled = connection.saveData;
                if (/\slow-2g|2g/.test(connection.effectiveType)) {
                    connectionDetail.slowConnection = true;
                }
            }

            if (!(connectionDetail.saveDataEnabled || connectionDetail.slowConnection)) {
                createLink("/static/fonts/HardingText-Regular-Web-cecd90984f.woff2");
            } else {
                document.documentElement.classList.add('save-data');
            }
        </script><script src="https://cmp.nature.com/production_live/en/consent-bundle-8-87.js" onload="initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')"></script>
    

<link rel="preconnect" href="https://cmp.nature.com" crossorigin="">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="applicable-device" content="pc,mobile">
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<meta name="360-site-verification" content="5a2dc4ab3fcb9b0393241ffbbb490480">

<script data-test="dataLayer">
    window.dataLayer = [{"content":{"category":{"contentType":"article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"cancer-therapeutic-resistance;glycobiology;non-small-cell-lung-cancer","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Nature Communications","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Article","status":null}},"article":{"doi":"10.1038/s41467-024-51831-7"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":true,"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by-nc-nd/4.0/"}}},"contentInfo":{"authors":["Chun-Hua Hung","Shang-Yin Wu","Cheng-I Daniel Yao","Hsuan-Heng Yeh","Chien-Chung Lin","Chang-Yao Chu","Tzu-Yu Huang","Meng-Ru Shen","Chun-Hung Lin","Wu-Chou Su"],"publishedAt":1725840000,"publishedAtString":"2024-09-09","title":"Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer","legacy":null,"publishedAtTime":null,"documentType":"aplusplus","subjects":"Cancer therapeutic resistance,Glycobiology,Non-small-cell lung cancer"},"journal":{"pcode":"ncomms","title":"nature communications","volume":"15","issue":"1","id":41467,"publishingModel":"Open Access"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"nature-onwards-journey","active":false}],"testGroup":null},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true,"country":"US","hasBody":true,"uneditedManuscript":false,"twitterId":["o3xnx","o43y9","o3ef7"],"baiduId":"d38bce82bcb44717ccc29a90c4b781ea","japan":false}];
    window.dataLayer.push({
        ga4MeasurementId: 'G-ERRNTNZ807',
        ga360TrackingId: 'UA-71668177-1',
        twitterId: ['3xnx', 'o43y9', 'o3ef7'],
        baiduId: 'd38bce82bcb44717ccc29a90c4b781ea',
        ga4ServerUrl: 'https://collect.nature.com',
        imprint: 'nature'
    });
</script>

<script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
            d.classList.remove('no-js');
        }
    })(window, document.documentElement);
</script>
 



     
    
    
        
    
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  .c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card--major .c-card__title,.c-card__title,.u-h2,.u-h3,h2,h3{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,.u-h3,h3{font-size:1.25rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}html{line-height:1.15;text-size-adjust:100%;box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}body{background:#eee;color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;line-height:1.76;margin:0;min-height:100%}details,main{display:block}h1{font-size:2em;margin:.67em 0}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}button,input,select{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=checkbox]{box-sizing:border-box;padding:0}summary{display:list-item}[hidden]{display:none}button{border-radius:0;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;font-size:2rem;letter-spacing:-.0390625rem;line-height:2.25rem}.c-card--major .c-card__title,.u-h2,.u-h3,h2{font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-card--major .c-card__title,.u-h2,h2{font-weight:700;-webkit-font-smoothing:antialiased;font-size:1.5rem;line-height:1.6rem}.u-h3{font-size:1.25rem}.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h4,h5,h6{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,h3{font-family:Harding,Palatino,serif;font-size:1.25rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,h3{font-weight:700;-webkit-font-smoothing:antialiased;letter-spacing:-.0117156rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;letter-spacing:-.0117156rem}input+label{padding-left:.5em}nav ol,nav ul{list-style:none none}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;padding:0}.c-article-identifiers__item{list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin:0 0 16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#069;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:16px 0}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Harding,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-body p{margin-bottom:24px;margin-top:0}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-code-block{border:1px solid #fff;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#069;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-editorial-summary__container{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child{margin-bottom:0}.c-article-editorial-summary__container .c-article-editorial-summary__content--less{max-height:9.5rem;overflow:hidden}.c-article-editorial-summary__container .c-article-editorial-summary__button{background-color:#fff;border:0;color:#069;font-size:.875rem;margin-bottom:16px}.c-article-editorial-summary__container .c-article-editorial-summary__button.active,.c-article-editorial-summary__container .c-article-editorial-summary__button.hover,.c-article-editorial-summary__container .c-article-editorial-summary__button:active,.c-article-editorial-summary__container .c-article-editorial-summary__button:hover{text-decoration:underline;text-decoration-skip-ink:auto}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-cod,.c-reading-companion__panel--active{display:block}.c-cod{font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-basis:75%;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#069;border:1px solid #069;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#069}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-context-bar--sticky .c-pdf-download{display:block;margin-bottom:0;white-space:nowrap}@media only screen and (max-width:539px){.c-pdf-download .u-sticky-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:16px}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}.c-article-extras .c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:0}@media only screen and (min-width:540px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:none}@media only screen and (max-width:1023px){.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:block}}.c-recommendations-column-switch .c-meta{margin-top:auto}.app-researcher-popup__link.hover,.app-researcher-popup__link.visited,.app-researcher-popup__link:hover,.app-researcher-popup__link:visited,.c-article-metrics__heading a,.c-article-metrics__posts .c-card__title a{color:inherit}.c-article-authors-search__list{align-items:center;display:flex;flex-wrap:wrap;gap:16px 16px;justify-content:center}@media only screen and (min-width:320px){.c-article-authors-search__list{justify-content:normal}}.c-article-authors-search__text{align-items:center;display:flex;flex-flow:column wrap;font-size:14px;justify-content:center}@media only screen and (min-width:320px){.c-article-authors-search__text{flex-direction:row;font-size:16px}}.c-article-authors-search__links-text{font-weight:700;margin-right:8px;text-align:center}@media only screen and (min-width:320px){.c-article-authors-search__links-text{text-align:left}}.c-article-authors-search__list-item--left{flex:1 1 100%}@media only screen and (min-width:320px){.c-article-authors-search__list-item--left{flex-basis:auto}}.c-article-authors-search__list-item--right{flex:1 1 auto}.c-article-identifiers{margin:0}.c-article-identifiers__item{border-right:2px solid #cedbe0;color:#222;font-size:14px}@media only screen and (min-width:320px){.c-article-identifiers__item{font-size:16px}}.c-article-identifiers__item:last-child{border-right:none}.c-article-metrics__posts .c-card__title{font-size:1.05rem}.c-article-metrics__posts .c-card__title+span{color:#6f6f6f;font-size:1rem}p{overflow-wrap:break-word;word-break:break-word}.app-author-list{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;line-height:1.4;list-style:none;margin:0;padding:0}.app-author-list>li,.c-breadcrumbs>li,.c-footer__links>li,.js .app-author-list,.u-list-comma-separated>li,.u-list-inline>li{display:inline}.app-author-list>li:not(:first-child):not(:last-child):before{content:", "}.app-author-list>li:not(:only-child):last-child:before{content:" & "}.app-author-list--compact{font-size:.875rem;line-height:1.4}.app-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.js .app-author-list__hide{display:none;visibility:hidden}.js .app-author-list__hide:first-child+*{margin-block-start:0}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-meta{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-meta{color:inherit;line-height:1.4;list-style:none;margin:0;padding:0}.c-meta--large{font-size:1rem}.c-meta--large .c-meta__item{margin-bottom:8px}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;margin-right:4px;padding-right:4px}@media only screen and (max-width:539px){.c-meta__item--block-sm-max{display:block}.c-meta__item--block-sm-max:not(:last-child){border-right:none;margin-right:0;padding-right:0}}@media only screen and (min-width:1024px){.c-meta__item--block-at-lg{display:block}.c-meta__item--block-at-lg:not(:last-child){border-right:none;margin-right:0;padding-right:0}}.c-meta__type{font-weight:700;text-transform:none}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#fff}.c-status-message{align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-card__summary>p:last-child,.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #eee;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}svg.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888;height:10px;width:10px}@media only screen and (max-width:539px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-card{background-color:transparent;border:0;box-shadow:none;display:flex;flex-direction:column;font-size:14px;min-width:0;overflow:hidden;padding:0;position:relative}.c-card--no-shape{background:0 0;border:0;box-shadow:none}.c-card__image{display:flex;justify-content:center;overflow:hidden;padding-bottom:56.25%;position:relative}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0}}.c-card__image img{left:0;min-height:100%;min-width:100%;position:absolute}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{height:100%;object-fit:cover;width:100%}}.c-card__body{flex:1 1 auto;padding:16px}.c-card--no-shape .c-card__body{padding:0}.c-card--no-shape .c-card__body:not(:first-child){padding-top:16px}.c-card__title{letter-spacing:-.01875rem;margin-bottom:8px;margin-top:0}[lang=de] .c-card__title{hyphens:auto}.c-card__summary{line-height:1.4}.c-card__summary>p{margin-bottom:5px}.c-card__summary a{text-decoration:underline}.c-card__link:not(.c-card__link--no-block-link):before{bottom:0;content:"";left:0;position:absolute;right:0;top:0}.c-card--flush .c-card__body{padding:0}.c-card--major{font-size:1rem}.c-card--dark{background-color:#29303c;border-width:0;color:#e3e4e5}.c-card--dark .c-card__title{color:#fff}.c-card--dark .c-card__link,.c-card--dark .c-card__summary a{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin:8px 24px 8px 0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;gap:8px 8px;line-height:1.4;list-style:none;margin:0 -8px;padding:0}@media print{.c-header__menu{display:none}}@media only screen and (max-width:1023px){.c-header__menu--hide-lg-max{display:none;visibility:hidden}}.c-header__menu--global{font-weight:400;justify-content:flex-end}.c-header__menu--global svg{display:none;visibility:hidden}.c-header__menu--global svg:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__menu--global svg{display:block;visibility:visible}}.c-header__menu--journal{font-size:.875rem;margin:8px 0 8px -8px}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}.c-header__item{padding-bottom:0;padding-top:0;position:static}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}.c-header__item--padding{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}@media only screen and (min-width:1024px){.c-header__item--hide-lg{display:none;visibility:hidden}}@media only screen and (max-width:767px){.c-header__item--hide-md-max{display:none;visibility:hidden}.c-header__item--hide-md-max:first-child+*{margin-block-start:0}}.c-header__link{align-items:center;color:inherit;display:inline-flex;gap:4px 4px;padding:8px;white-space:nowrap}.c-header__link svg{transition-duration:.2s}.c-header__show-text{display:none;visibility:hidden}.has-tethered .c-header__heading--js-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__show-text{display:inline;visibility:visible}}.c-header__dropdown{background-color:#000;border-bottom:1px solid #2f2f2f;color:#eee;font-size:.875rem;line-height:1.2;padding:16px 0}@media print{.c-header__dropdown{display:none}}.c-header__heading{display:inline-block;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.4;margin-bottom:8px}.c-header__heading--keyline{border-top:1px solid;border-color:#2f2f2f;margin-top:16px;padding-top:16px;width:100%}.c-header__list{display:flex;flex-wrap:wrap;gap:0 16px;list-style:none;margin:0 -8px}.c-header__flush{margin:0 -8px}.c-header__visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.c-header__search-form{margin-bottom:8px}.c-header__search-layout{display:flex;flex-wrap:wrap;gap:16px 16px}.c-header__search-layout>:first-child{flex:999 1 auto}.c-header__search-layout>*{flex:1 1 auto}.c-header__search-layout--max-width{max-width:720px}.c-header__search-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #fff;border-radius:2px;color:#fff;cursor:pointer;display:flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.15;margin:0;padding:8px 16px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:100%}.u-button svg,.u-button--primary svg{fill:currentcolor}.c-header__input,.c-header__select{border:1px solid;border-radius:3px;box-sizing:border-box;font-size:1rem;padding:8px 16px;width:100%}.c-header__select{-webkit-appearance:none;background-image:url("data:image/svg+xml,%3Csvg height='16' viewBox='0 0 16 16' width='16' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z' fill='%23333' fill-rule='evenodd' transform='matrix(0 1 -1 0 11 3)'/%3E%3C/svg%3E");background-position:right .7em top 50%;background-repeat:no-repeat;background-size:1em;box-shadow:0 1px 0 1px rgba(0,0,0,.04);display:block;margin:0;max-width:100%;min-width:150px}@media only screen and (min-width:540px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:auto;right:0}}@media only screen and (min-width:768px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:0;right:auto}}.c-header__dropdown.has-tethered{border-bottom:0;border-radius:0 0 2px 2px;left:0;position:absolute;top:100%;transform:translateY(5px);width:100%;z-index:1}@media only screen and (min-width:540px){.c-header__dropdown.has-tethered{transform:translateY(8px);width:auto}}@media only screen and (min-width:768px){.c-header__dropdown.has-tethered{min-width:225px}}.c-header__dropdown--full-width.has-tethered{padding:32px 0 24px;transform:none;width:100%}.has-tethered .c-header__heading--js-hide{display:none;visibility:hidden}.has-tethered .c-header__list--js-stack{flex-direction:column}.has-tethered .c-header__item--keyline,.has-tethered .c-header__list~.c-header__list .c-header__item:first-child{border-top:1px solid #d5d5d5;margin-top:8px;padding-top:8px}.c-header__item--snid-account-widget{display:flex}.c-header__container{padding:0 4px}.c-header__list{padding:0 12px}.c-header__menu .c-header__link{font-size:14px}.c-header__item--snid-account-widget .c-header__link{padding:8px}.c-header__menu--journal{margin-left:0}@media only screen and (min-width:540px){.c-header__container{padding:0 16px}.c-header__menu--journal{margin-left:-8px}.c-header__menu .c-header__link{font-size:16px}.c-header__link--search{gap:13px 13px}}.u-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #069;border-radius:2px;color:#069;cursor:pointer;display:inline-flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}.u-hide-at-lg:first-child+*{margin-block-start:0}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-full-height{height:100%}.u-list-reset{list-style:none;margin:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.c-nature-box svg+.c-article__button-text,.u-ml-8{margin-left:8px}.u-pa-16{padding:16px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-card__title{line-height:1.4em}.c-article__button{background-color:#069;border:1px solid #069;border-radius:2px;color:#fff;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;margin-bottom:16px;padding:13px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-article__button,.c-article__button:hover{text-decoration:none}.c-article__button--inverted,.c-article__button:hover{background-color:#fff;color:#069}.c-article__button--inverted:hover{background-color:#069;color:#fff}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.c-nature-box{background-color:#fff;border:1px solid #d5d5d5;border-radius:2px;box-shadow:0 0 5px 0 rgba(51,51,51,.1);line-height:1.3;margin-bottom:24px;padding:16px 16px 3px}.c-nature-box__text{font-size:1rem;margin-bottom:16px}.c-nature-box--access-to-pdf{display:none}@media only screen and (min-width:1024px){.c-nature-box--mobile{display:none}}.c-nature-box .c-pdf-download{margin-bottom:16px!important}.c-nature-box--version{background-color:#eee}.c-nature-box__wrapper{transform:translateZ(0)}.c-nature-box__wrapper--placeholder{min-height:165px}.c-pdf-download__link{padding:13px 24px} } </style>




    
        <link data-test="critical-css-handler" data-inline-css-source="critical-css" rel="stylesheet" href="/static/css/enhanced-article-nature-branded-3ad80c7544.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null">
    
    <noscript>
        <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-nature-branded-3ad80c7544.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
    </noscript>

<link rel="stylesheet" type="text/css" href="/static/css/article-print-c9121fecab.css" media="print">
    



<link rel="apple-touch-icon" sizes="180x180" href="/static/images/favicons/nature/apple-touch-icon-f39cb19454.png">
<link rel="icon" type="image/png" sizes="48x48" href="/static/images/favicons/nature/favicon-48x48-b52890008c.png">
<link rel="icon" type="image/png" sizes="32x32" href="/static/images/favicons/nature/favicon-32x32-3fe59ece92.png">
<link rel="icon" type="image/png" sizes="16x16" href="/static/images/favicons/nature/favicon-16x16-951651ab72.png">
<link rel="manifest" href="/static/manifest.json" crossorigin="use-credentials">
<link rel="mask-icon" href="/static/images/favicons/nature/safari-pinned-tab-69bff48fe6.svg" color="#000000">
<link rel="shortcut icon" href="/static/images/favicons/nature/favicon.ico">
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content="/static/browserconfig.xml">
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">


<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>



<!-- Google Tag Manager -->
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                j.src = 'https://sgtm.nature.com/gtm.js?id=' + i + dl;
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>
<!-- End Google Tag Manager -->

    <script>
    (function(w,d,t) {
        function cc() {
            var h = w.location.hostname;
            if (h.indexOf('preview-www.nature.com') > -1) return;

            var e = d.createElement(t),
                    s = d.getElementsByTagName(t)[0];

            if (h.indexOf('nature.com') > -1) {
                if (h.indexOf('test-www.nature.com') > -1) {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-87.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                } else {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-87.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                }
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window,document,'script');
</script>


<script id="js-position0">
    (function(w, d) {
        w.idpVerifyPrefix = 'https://verify.nature.com';
        w.ra21Host = 'https://wayf.springernature.com';
        var moduleSupport = (function() {
            return 'noModule' in d.createElement('script');
        })();

        if (w.config.mustardcut === true) {
            w.loader = {
                index: 0,
                registered: [],
                scripts: [
                    
                        {src: '/static/js/global-article-es6-bundle-19e70d4396.js', test: 'global-article-js', module: true},
                        {src: '/static/js/global-article-es5-bundle-f7c78bebb9.js', test: 'global-article-js', nomodule: true},
                        {src: '/static/js/shared-es6-bundle-a5ef08dc2f.js', test: 'shared-js', module: true},
                        {src: '/static/js/shared-es5-bundle-c0cee661dc.js', test: 'shared-js', nomodule: true},
                        {src: '/static/js/header-150-es6-bundle-5bb959eaa1.js', test: 'header-150-js', module: true},
                        {src: '/static/js/header-150-es5-bundle-994fde5b1d.js', test: 'header-150-js', nomodule: true}
                    
                ].filter(function (s) {
                    if (s.src === null) return false;
                    if (moduleSupport && s.nomodule) return false;
                    return !(!moduleSupport && s.module);
                }),

                register: function (value) {
                    this.registered.push(value);
                },

                ready: function () {
                    if (this.registered.length === this.scripts.length) {
                        this.registered.forEach(function (fn) {
                            if (typeof fn === 'function') {
                                setTimeout(fn, 0); 
                            }
                        });
                        this.ready = function () {};
                    }
                },

                insert: function (s) {
                    var t = d.getElementById('js-position' + this.index);
                    if (t && t.insertAdjacentElement) {
                        t.insertAdjacentElement('afterend', s);
                    } else {
                        d.head.appendChild(s);
                    }
                    ++this.index;
                },

                createScript: function (script, beforeLoad) {
                    var s = d.createElement('script');
                    s.id = 'js-position' + (this.index + 1);
                    s.setAttribute('data-test', script.test);
                    if (beforeLoad) {
                        s.defer = 'defer';
                        s.onload = function () {
                            if (script.noinit) {
                                loader.register(true);
                            }
                            if (d.readyState === 'interactive' || d.readyState === 'complete') {
                                loader.ready();
                            }
                        };
                    } else {
                        s.async = 'async';
                    }
                    s.src = script.src;
                    return s;
                },

                init: function () {
                    this.scripts.forEach(function (s) {
                        loader.insert(loader.createScript(s, true));
                    });

                    d.addEventListener('DOMContentLoaded', function () {
                        loader.ready();
                        var conditionalScripts;
                        
                            conditionalScripts = [
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es6-bundle-464a2af269.js', test: 'pan-zoom-js',  module: true },
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es5-bundle-98fb9b653b.js', test: 'pan-zoom-js',  nomodule: true },
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es6-bundle-23597ae350.js', test: 'math-js', module: true},
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es5-bundle-6532c6f78b.js', test: 'math-js', nomodule: true}
                            ];
                        

                        if (conditionalScripts) {
                            conditionalScripts.filter(function (script) {
                                return !!document.querySelector(script.match) && !((moduleSupport && script.nomodule) || (!moduleSupport && script.module));
                            }).forEach(function (script) {
                                loader.insert(loader.createScript(script));
                            });
                        }
                    }, false);
                }
            };
            loader.init();
        }
    })(window, document);
</script><script id="js-position1" data-test="global-article-js" defer="" src="/static/js/global-article-es6-bundle-19e70d4396.js"></script><script id="js-position2" data-test="shared-js" defer="" src="/static/js/shared-es6-bundle-a5ef08dc2f.js"></script><script id="js-position3" data-test="header-150-js" defer="" src="/static/js/header-150-es6-bundle-5bb959eaa1.js"></script>










<meta name="robots" content="noarchive">
<meta name="access" content="Yes">


<link rel="search" href="https://www.nature.com/search">
<link rel="search" href="https://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="https://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">





    
    <script type="application/ld+json">{"mainEntity":{"headline":"Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer","description":"The IL6-GP130-STAT3 pathway facilitates lung cancer progression and resistance to tyrosine kinase inhibitors. Although glycosylation alters the stability of GP130, its effect on the ligand IL6 remains unclear. We herein find that N-glycosylated IL6, especially at Asn73, primarily stimulates JAK-STAT3 signaling and prolongs STAT3 phosphorylation, whereas N-glycosylation-defective IL6 (deNG-IL6) induces shortened STAT3 activation and alters the downstream signaling preference for the SRC-YAP-SOX2 axis. This signaling shift induces epithelial-mesenchymal transition (EMT) and migration in vitro and metastasis in vivo, which are suppressed by targeted inhibitors and shRNAs against SRC, YAP, and SOX2. Osimertinib-resistant lung cancer cells secrete a large amount of deNG-IL6 through reduced N-glycosyltransferase gene expression, leading to clear SRC-YAP activation. deNG-IL6 contributes to drug resistance, as confirmed by in silico analysis of cellular and clinical transcriptomes and signal expression in patient specimens. Therefore, the N-glycosylation status of IL6 not only affects cell behaviors but also shows promise in monitoring the dynamics of lung cancer evolution. Post-translational modifications regulate tumorigenesis and cancer therapy sensitivity. Here, the authors show that N-glycosylation defective Interleukin-6 (deNG-IL6) switches downstream signalling pathway from JAK-STAT3 to SRC-YAP axis and lung cancer cells secrete deNG-IL6 to promote metastasis and tyrosine kinase inhibitor resistance.","datePublished":"2024-09-09T00:00:00Z","dateModified":"2024-09-09T00:00:00Z","pageStart":"1","pageEnd":"24","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","sameAs":"https://doi.org/10.1038/s41467-024-51831-7","keywords":["Cancer therapeutic resistance","Glycobiology","Non-small-cell lung cancer","Science","Humanities and Social Sciences","multidisciplinary"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig1_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig2_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig3_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig4_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig5_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig6_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig7_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig8_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig9_HTML.png"],"isPartOf":{"name":"Nature Communications","issn":["2041-1723"],"volumeNumber":"15","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group UK","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Chun-Hua Hung","url":"http://orcid.org/0000-0002-8580-8759","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Department of Biomedical Engineering, College of Engineering, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Shang-Yin Wu","url":"http://orcid.org/0000-0003-2914-510X","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Cheng-I Daniel Yao","url":"http://orcid.org/0000-0002-0902-045X","affiliation":[{"name":"Academia Sinica","address":{"name":"Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Hsuan-Heng Yeh","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Chien-Chung Lin","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Chang-Yao Chu","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Tzu-Yu Huang","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Meng-Ru Shen","url":"http://orcid.org/0000-0003-0506-3505","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Chun-Hung Lin","url":"http://orcid.org/0000-0002-6795-8825","affiliation":[{"name":"Academia Sinica","address":{"name":"Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Taiwan University","address":{"name":"Department of Chemistry and Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Wu-Chou Su","url":"http://orcid.org/0000-0003-2953-4105","affiliation":[{"name":"National Cheng Kung University","address":{"name":"Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"},{"name":"National Cheng Kung University","address":{"name":"Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan","@type":"PostalAddress"},"@type":"Organization"}],"email":"sunnysu@mail.ncku.edu.tw","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>




    
    
    


    
    <link rel="canonical" href="https://www.nature.com/articles/s41467-024-51831-7">
    
    
    <meta name="journal_id" content="41467">
    <meta name="dc.title" content="Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer">
    <meta name="dc.source" content="Nature Communications 2024 15:1">
    <meta name="dc.format" content="text/html">
    <meta name="dc.publisher" content="Nature Publishing Group">
    <meta name="dc.date" content="2024-09-09">
    <meta name="dc.type" content="OriginalPaper">
    <meta name="dc.language" content="En">
    <meta name="dc.copyright" content="2024 The Author(s)">
    <meta name="dc.rights" content="2024 The Author(s)">
    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="dc.description" content="The IL6-GP130-STAT3 pathway facilitates lung cancer progression and resistance to tyrosine kinase inhibitors. Although glycosylation alters the stability of GP130, its effect on the ligand IL6 remains unclear. We herein find that N-glycosylated IL6, especially at Asn73, primarily stimulates JAK-STAT3 signaling and prolongs STAT3 phosphorylation, whereas N-glycosylation-defective IL6 (deNG-IL6) induces shortened STAT3 activation and alters the downstream signaling preference for the SRC-YAP-SOX2 axis. This signaling shift induces epithelial-mesenchymal transition (EMT) and migration in vitro and metastasis in vivo, which are suppressed by targeted inhibitors and shRNAs against SRC, YAP, and SOX2. Osimertinib-resistant lung cancer cells secrete a large amount of deNG-IL6 through reduced N-glycosyltransferase gene expression, leading to clear SRC-YAP activation. deNG-IL6 contributes to drug resistance, as confirmed by in silico analysis of cellular and clinical transcriptomes and signal expression in patient specimens. Therefore, the N-glycosylation status of IL6 not only affects cell behaviors but also shows promise in monitoring the dynamics of lung cancer evolution. Post-translational modifications regulate tumorigenesis and cancer therapy sensitivity. Here, the authors show that N-glycosylation defective Interleukin-6 (deNG-IL6) switches downstream signalling pathway from JAK-STAT3 to SRC-YAP axis and lung cancer cells secrete deNG-IL6 to promote metastasis and tyrosine kinase inhibitor resistance.">
    <meta name="prism.issn" content="2041-1723">
    <meta name="prism.publicationName" content="Nature Communications">
    <meta name="prism.publicationDate" content="2024-09-09">
    <meta name="prism.volume" content="15">
    <meta name="prism.number" content="1">
    <meta name="prism.section" content="OriginalPaper">
    <meta name="prism.startingPage" content="1">
    <meta name="prism.endingPage" content="24">
    <meta name="prism.copyright" content="2024 The Author(s)">
    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="prism.url" content="https://www.nature.com/articles/s41467-024-51831-7">
    <meta name="prism.doi" content="doi:10.1038/s41467-024-51831-7">
    <meta name="citation_pdf_url" content="https://www.nature.com/articles/s41467-024-51831-7.pdf">
    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/s41467-024-51831-7">
    <meta name="citation_journal_title" content="Nature Communications">
    <meta name="citation_journal_abbrev" content="Nat Commun">
    <meta name="citation_publisher" content="Nature Publishing Group">
    <meta name="citation_issn" content="2041-1723">
    <meta name="citation_title" content="Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer">
    <meta name="citation_volume" content="15">
    <meta name="citation_issue" content="1">
    <meta name="citation_online_date" content="2024/09/09">
    <meta name="citation_firstpage" content="1">
    <meta name="citation_lastpage" content="24">
    <meta name="citation_article_type" content="Article">
    <meta name="citation_fulltext_world_readable" content="">
    <meta name="citation_language" content="en">
    <meta name="dc.identifier" content="doi:10.1038/s41467-024-51831-7">
    <meta name="DOI" content="10.1038/s41467-024-51831-7">
    <meta name="size" content="307181">
    <meta name="citation_doi" content="10.1038/s41467-024-51831-7">
    <meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41467-024-51831-7&amp;api_key=">
    <meta name="description" content="The IL6-GP130-STAT3 pathway facilitates lung cancer progression and resistance to tyrosine kinase inhibitors. Although glycosylation alters the stability of GP130, its effect on the ligand IL6 remains unclear. We herein find that N-glycosylated IL6, especially at Asn73, primarily stimulates JAK-STAT3 signaling and prolongs STAT3 phosphorylation, whereas N-glycosylation-defective IL6 (deNG-IL6) induces shortened STAT3 activation and alters the downstream signaling preference for the SRC-YAP-SOX2 axis. This signaling shift induces epithelial-mesenchymal transition (EMT) and migration in vitro and metastasis in vivo, which are suppressed by targeted inhibitors and shRNAs against SRC, YAP, and SOX2. Osimertinib-resistant lung cancer cells secrete a large amount of deNG-IL6 through reduced N-glycosyltransferase gene expression, leading to clear SRC-YAP activation. deNG-IL6 contributes to drug resistance, as confirmed by in silico analysis of cellular and clinical transcriptomes and signal expression in patient specimens. Therefore, the N-glycosylation status of IL6 not only affects cell behaviors but also shows promise in monitoring the dynamics of lung cancer evolution. Post-translational modifications regulate tumorigenesis and cancer therapy sensitivity. Here, the authors show that N-glycosylation defective Interleukin-6 (deNG-IL6) switches downstream signalling pathway from JAK-STAT3 to SRC-YAP axis and lung cancer cells secrete deNG-IL6 to promote metastasis and tyrosine kinase inhibitor resistance.">
    <meta name="dc.creator" content="Hung, Chun-Hua">
    <meta name="dc.creator" content="Wu, Shang-Yin">
    <meta name="dc.creator" content="Yao, Cheng-I Daniel">
    <meta name="dc.creator" content="Yeh, Hsuan-Heng">
    <meta name="dc.creator" content="Lin, Chien-Chung">
    <meta name="dc.creator" content="Chu, Chang-Yao">
    <meta name="dc.creator" content="Huang, Tzu-Yu">
    <meta name="dc.creator" content="Shen, Meng-Ru">
    <meta name="dc.creator" content="Lin, Chun-Hung">
    <meta name="dc.creator" content="Su, Wu-Chou">
    <meta name="dc.subject" content="Cancer therapeutic resistance">
    <meta name="dc.subject" content="Glycobiology">
    <meta name="dc.subject" content="Non-small-cell lung cancer">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Cancer; citation_title=Revisiting STAT3 signalling in cancer: new and unexpected biological functions; citation_author=H Yu, H Lee, A Herrmann, R Buettner, R Jove; citation_volume=14; citation_publication_date=2014; citation_pages=736-746; citation_doi=10.1038/nrc3818; citation_id=CR1">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Immunol.; citation_title=Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer; citation_author=SA Jones, BJ Jenkins; citation_volume=18; citation_publication_date=2018; citation_pages=773-789; citation_doi=10.1038/s41577-018-0066-7; citation_id=CR2">
    <meta name="citation_reference" content="citation_journal_title=Clin. Pharmacol. Therapeut.; citation_title=The soluble interleukin 6 receptor: advanced therapeutic options in inflammation; citation_author=S Rose-John; citation_volume=102; citation_publication_date=2017; citation_pages=591-598; citation_doi=10.1002/cpt.782; citation_id=CR3">
    <meta name="citation_reference" content="citation_journal_title=Clin. Cancer Res.; citation_title=Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence; citation_author=M Trikha, R Corringham, B Klein, JF Rossi; citation_volume=9; citation_publication_date=2003; citation_pages=4653-4665; citation_id=CR4">
    <meta name="citation_reference" content="citation_journal_title=Nat. Immunol; citation_title=IL-6 as a keystone cytokine in health and disease; citation_author=CA Hunter, SA Jones; citation_volume=16; citation_publication_date=2015; citation_pages=448-457; citation_doi=10.1038/ni.3153; citation_id=CR5">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Drug Discov.; citation_title=Interleukin-6: designing specific therapeutics for a complex cytokine; citation_author=C Garbers, S Heink, T Korn, S Rose-John; citation_volume=17; citation_publication_date=2018; citation_pages=395-412; citation_doi=10.1038/nrd.2018.45; citation_id=CR6">
    <meta name="citation_reference" content="citation_journal_title=Immunity; citation_title=Pleiotropy and specificity: insights from the interleukin 6 family of cytokines; citation_author=M Murakami, D Kamimura, T Hirano; citation_volume=50; citation_publication_date=2019; citation_pages=812-831; citation_doi=10.1016/j.immuni.2019.03.027; citation_id=CR7">
    <meta name="citation_reference" content="citation_journal_title=Clin. Cancer Res.; citation_title=Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer; citation_author=Z Duan; citation_volume=12; citation_publication_date=2006; citation_pages=5055-5063; citation_doi=10.1158/1078-0432.CCR-06-0861; citation_id=CR8">
    <meta name="citation_reference" content="citation_journal_title=Mol. Cancer; citation_title=Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells; citation_author=WL Huang; citation_volume=9; citation_publication_date=2010; citation_doi=10.1186/1476-4598-9-309; citation_id=CR9">
    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells; citation_author=HJ Lee; citation_volume=26; citation_publication_date=2014; citation_pages=207-221; citation_doi=10.1016/j.ccr.2014.05.019; citation_id=CR10">
    <meta name="citation_reference" content="citation_journal_title=J. Clin. Invest.; citation_title=IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis; citation_author=M Rokavec; citation_volume=124; citation_publication_date=2014; citation_pages=1853-1867; citation_doi=10.1172/JCI73531; citation_id=CR11">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A gp130-Src-YAP module links inflammation to epithelial regeneration; citation_author=K Taniguchi; citation_volume=519; citation_publication_date=2015; citation_pages=57-62; citation_doi=10.1038/nature14228; citation_id=CR12">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Clin. Oncol.; citation_title=Lineage plasticity in cancer: a shared pathway of therapeutic resistance; citation_author=A Quintanal-Villalonga; citation_volume=17; citation_publication_date=2020; citation_pages=360-371; citation_doi=10.1038/s41571-020-0340-z; citation_id=CR13">
    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy; citation_author=JG Paez; citation_volume=304; citation_publication_date=2004; citation_pages=1497-1500; citation_doi=10.1126/science.1099314; citation_id=CR14">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC; citation_author=SS Ramalingam; citation_volume=382; citation_publication_date=2020; citation_pages=41-50; citation_doi=10.1056/NEJMoa1913662; citation_id=CR15">
    <meta name="citation_reference" content="citation_journal_title=JAMA Oncol.; citation_title=Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib; citation_author=GR Oxnard; citation_volume=4; citation_publication_date=2018; citation_pages=1527-1534; citation_doi=10.1001/jamaoncol.2018.2969; citation_id=CR16">
    <meta name="citation_reference" content="citation_journal_title=Clin. Cancer Res.; citation_title=Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients; citation_author=Z Yang; citation_volume=24; citation_publication_date=2018; citation_pages=3097-3107; citation_doi=10.1158/1078-0432.CCR-17-2310; citation_id=CR17">
    <meta name="citation_reference" content="citation_journal_title=Sci. Transl. Med.; citation_title=Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors; citation_author=LV Sequist; citation_volume=3; citation_publication_date=2011; citation_pages=75ra26; citation_doi=10.1126/scitranslmed.3002003; citation_id=CR18">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Cancer; citation_title=Linking EMT programmes to normal and neoplastic epithelial stem cells; citation_author=AW Lambert, RA Weinberg; citation_volume=21; citation_publication_date=2021; citation_pages=325-338; citation_doi=10.1038/s41568-021-00332-6; citation_id=CR19">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Cancer; citation_title=Controversies around epithelial-mesenchymal plasticity in cancer metastasis; citation_author=ED Williams, D Gao, A Redfern, EW Thompson; citation_volume=19; citation_publication_date=2019; citation_pages=716-732; citation_doi=10.1038/s41568-019-0213-x; citation_id=CR20">
    <meta name="citation_reference" content="citation_journal_title=Proc. Natl Acad. Sci. USA; citation_title=TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer; citation_author=Z Yao; citation_volume=107; citation_publication_date=2010; citation_pages=15535-15540; citation_doi=10.1073/pnas.1009472107; citation_id=CR21">
    <meta name="citation_reference" content="citation_journal_title=Mol. Cancer Ther.; citation_title=Activation of IL-6R/JAK1/STAT signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation; citation_author=SM Kim; citation_volume=11; citation_publication_date=2012; citation_pages=2254-2264; citation_doi=10.1158/1535-7163.MCT-12-0311; citation_id=CR22">
    <meta name="citation_reference" content="citation_journal_title=Clin. Cancer Res.; citation_title=Regulation of cancer stem cells by cytokine networks: attacking cancers inflammatory roots; citation_author=H Korkaya, S Liu, MS Wicha; citation_volume=17; citation_publication_date=2011; citation_pages=6125-6129; citation_doi=10.1158/1078-0432.CCR-10-2743; citation_id=CR23">
    <meta name="citation_reference" content="citation_journal_title=Front. Mol. Biosci.; citation_title=and tumor cell plasticity; citation_author=VernotJP Senescence-Associated Pro-inflammatory Cytokines; citation_volume=7; citation_publication_date=2020; citation_pages=63; citation_id=CR24">
    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway; citation_author=KJ Kurppa; citation_volume=37; citation_publication_date=2020; citation_pages=104-122.e112; citation_doi=10.1016/j.ccell.2019.12.006; citation_id=CR25">
    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=SOX2 is the determining oncogenic switch in promoting lung squamous cell carcinoma from different cells of origin; citation_author=G Ferone; citation_volume=30; citation_publication_date=2016; citation_pages=519-532; citation_doi=10.1016/j.ccell.2016.09.001; citation_id=CR26">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Drug Discov.; citation_title=The great escape: tumour cell plasticity in resistance to targeted therapy; citation_author=S Boumahdi, FJ Sauvage; citation_volume=19; citation_publication_date=2020; citation_pages=39-56; citation_doi=10.1038/s41573-019-0044-1; citation_id=CR27">
    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Tissue damage and senescence provide critical signals for cellular reprogramming in vivo; citation_author=L Mosteiro; citation_volume=354; citation_publication_date=2016; citation_pages=6315; citation_doi=10.1126/science.aaf4445; citation_id=CR28">
    <meta name="citation_reference" content="citation_journal_title=Stem cells; citation_title=YAP1 regulates OCT4 activity and SOX2 expression to facilitate self-renewal and vascular mimicry of stem-like cells; citation_author=N Bora-Singhal; citation_volume=33; citation_publication_date=2015; citation_pages=1705-1718; citation_doi=10.1002/stem.1993; citation_id=CR29">
    <meta name="citation_reference" content="citation_journal_title=EMBO J; citation_title=B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF); citation_author=P Poupart; citation_volume=6; citation_publication_date=1987; citation_pages=1219-1224; citation_doi=10.1002/j.1460-2075.1987.tb02357.x; citation_id=CR30">
    <meta name="citation_reference" content="citation_journal_title=Biochem. Biophys. Res. Commun.; citation_title=Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6; citation_author=LT May; citation_volume=152; citation_publication_date=1988; citation_pages=1144-1150; citation_doi=10.1016/S0006-291X(88)80404-2; citation_id=CR31">
    <meta name="citation_reference" content="citation_journal_title=Proc. Natl Acad. Sci. USA; citation_title=Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2); citation_author=T Hirano; citation_volume=82; citation_publication_date=1985; citation_pages=5490-5494; citation_doi=10.1073/pnas.82.16.5490; citation_id=CR32">
    <meta name="citation_reference" content="citation_journal_title=J. Biol. Chem.; citation_title=On the multimeric nature of natural human interleukin-6; citation_author=LT May, U Santhanam, PB Sehgal; citation_volume=266; citation_publication_date=1991; citation_pages=9950-9955; citation_doi=10.1016/S0021-9258(18)92911-X; citation_id=CR33">
    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Glycosylation in the era of cancer-targeted therapy: where are we heading?; citation_author=S Mereiter, M Balmana, D Campos, J Gomes, CA Reis; citation_volume=36; citation_publication_date=2019; citation_pages=6-16; citation_doi=10.1016/j.ccell.2019.06.006; citation_id=CR34">
    <meta name="citation_reference" content="citation_journal_title=Eur. J. Biochem.; citation_title=Glycosylation of interleukin-6 purified from normal human blood mononuclear cells; citation_author=RB Parekh, RA Dwek, TW Rademacher, G Opdenakker, J Damme; citation_volume=203; citation_publication_date=1992; citation_pages=135-141; citation_doi=10.1111/j.1432-1033.1992.tb19838.x; citation_id=CR35">
    <meta name="citation_reference" content="citation_journal_title=J. Exp. Med.; citation_title=N-linked glycosylation is required for optimal function of Kaposis sarcoma herpesvirus-encoded, but not cellular, interleukin 6; citation_author=CS Cruz; citation_volume=199; citation_publication_date=2004; citation_pages=503-514; citation_doi=10.1084/jem.20031205; citation_id=CR36">
    <meta name="citation_reference" content="citation_journal_title=Biochimica. et biophysica. Acta Rev. Cancer; citation_title=Altered glycosylation in cancer: a promising target for biomarkers and therapeutics; citation_author=D Thomas, AK Rathinavel, P Radhakrishnan; citation_volume=1875; citation_publication_date=2021; citation_pages=188464; citation_doi=10.1016/j.bbcan.2020.188464; citation_id=CR37">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Cancer; citation_title=Glycosylation in cancer: mechanisms and clinical implications; citation_author=SS Pinho, CA Reis; citation_volume=15; citation_publication_date=2015; citation_pages=540-555; citation_doi=10.1038/nrc3982; citation_id=CR38">
    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion; citation_author=HH Yeh, WW Lai, HH Chen, HS Liu, WC Su; citation_volume=25; citation_publication_date=2006; citation_pages=4300-4309; citation_doi=10.1038/sj.onc.1209464; citation_id=CR39">
    <meta name="citation_reference" content="citation_journal_title=Chem. Rev.; citation_title=Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions; citation_author=J Roth; citation_volume=102; citation_publication_date=2002; citation_pages=285-303; citation_doi=10.1021/cr000423j; citation_id=CR40">
    <meta name="citation_reference" content="citation_journal_title=Trends Cell Biol.; citation_title=Cracking the glycome encoder: signaling, trafficking, and glycosylation; citation_author=F Bard, J Chia; citation_volume=26; citation_publication_date=2016; citation_pages=379-388; citation_doi=10.1016/j.tcb.2015.12.004; citation_id=CR41">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Mol. Cell Biol.; citation_title=Global view of human protein glycosylation pathways and functions; citation_author=KT Schjoldager, Y Narimatsu, HJ Joshi, H Clausen; citation_volume=21; citation_publication_date=2020; citation_pages=729-749; citation_doi=10.1038/s41580-020-00294-x; citation_id=CR42">
    <meta name="citation_reference" content="citation_journal_title=Proc. Natl Acad. Sci. USA; citation_title=Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles; citation_author=A Subramanian; citation_volume=102; citation_publication_date=2005; citation_pages=15545-15550; citation_doi=10.1073/pnas.0506580102; citation_id=CR43">
    <meta name="citation_reference" content="citation_journal_title=Nat. Genet.; citation_title=PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes; citation_author=VK Mootha; citation_volume=34; citation_publication_date=2003; citation_pages=267-273; citation_doi=10.1038/ng1180; citation_id=CR44">
    <meta name="citation_reference" content="citation_journal_title=Cancer Res.; citation_title=Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas; citation_author=H Okayama; citation_volume=72; citation_publication_date=2012; citation_pages=100-111; citation_doi=10.1158/0008-5472.CAN-11-1403; citation_id=CR45">
    <meta name="citation_reference" content="citation_journal_title=Nat. Chem. Biol.; citation_title=Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells; citation_author=C Lopez-Sambrooks; citation_volume=12; citation_publication_date=2016; citation_pages=1023-1030; citation_doi=10.1038/nchembio.2194; citation_id=CR46">
    <meta name="citation_reference" content="citation_journal_title=Proteomics; citation_title=Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence; citation_author=N Blom, T Sicheritz-Ponten, R Gupta, S Gammeltoft, S Brunak; citation_volume=4; citation_publication_date=2004; citation_pages=1633-1649; citation_doi=10.1002/pmic.200300771; citation_id=CR47">
    <meta name="citation_reference" content="citation_journal_title=J. Biol. Chem; citation_title=Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties; citation_author=K Yamaguchi; citation_volume=266; citation_publication_date=1991; citation_pages=20434-20439; citation_doi=10.1016/S0021-9258(18)54942-5; citation_id=CR48">
    <meta name="citation_reference" content="citation_journal_title=FEBS J.; citation_title=Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6; citation_author=R Bobby; citation_volume=281; citation_publication_date=2014; citation_pages=2471-2483; citation_doi=10.1111/febs.12800; citation_id=CR49">
    <meta name="citation_reference" content="citation_journal_title=J. Biol. Chem.; citation_title=Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition; citation_author=H Xiong; citation_volume=287; citation_publication_date=2012; citation_pages=5819-5832; citation_doi=10.1074/jbc.M111.295964; citation_id=CR50">
    <meta name="citation_reference" content="citation_journal_title=Stem cells; citation_title=STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer; citation_author=W Wei; citation_volume=32; citation_publication_date=2014; citation_pages=2571-2582; citation_doi=10.1002/stem.1752; citation_id=CR51">
    <meta name="citation_reference" content="citation_journal_title=Stem Cells; citation_title=IGF/STAT3/NANOG/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer; citation_author=C Yao; citation_volume=34; citation_publication_date=2016; citation_pages=820-831; citation_doi=10.1002/stem.2320; citation_id=CR52">
    <meta name="citation_reference" content="citation_journal_title=Melanoma Res.; citation_title=Interleukin-6-induced twist and N-cadherin enhance melanoma cell metastasis; citation_author=YR Na, JS Lee, SJ Lee, SH Seok; citation_volume=23; citation_publication_date=2013; citation_pages=434-443; citation_doi=10.1097/CMR.0000000000000021; citation_id=CR53">
    <meta name="citation_reference" content="citation_journal_title=J. Invest. Dermatol; citation_title=IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice; citation_author=RM Gallucci, EG Lee, JJ Tomasek; citation_volume=126; citation_publication_date=2006; citation_pages=561-568; citation_doi=10.1038/sj.jid.5700109; citation_id=CR54">
    <meta name="citation_reference" content="citation_journal_title=Cell Rep.; citation_title=Yap1-driven intestinal repair is controlled by group 3 innate lymphoid cells; citation_author=M Romera-Hernandez; citation_volume=30; citation_publication_date=2020; citation_pages=37-45.e33; citation_doi=10.1016/j.celrep.2019.11.115; citation_id=CR55">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation; citation_author=T Tsuji; citation_volume=11; citation_publication_date=2020; citation_doi=10.1038/s41467-019-13771-5; citation_id=CR56">
    <meta name="citation_reference" content="citation_journal_title=Sci. Rep.; citation_title=Ankyrin repeat domain 1 overexpression is associated with common resistance to afatinib and osimertinib in EGFR-mutant lung cancer; citation_author=A Takahashi; citation_volume=8; citation_publication_date=2018; citation_doi=10.1038/s41598-018-33190-8; citation_id=CR57">
    <meta name="citation_reference" content="citation_journal_title=Genom. Proteom. Bioinform.; citation_title=SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets; citation_author=S Zheng; citation_volume=20; citation_publication_date=2022; citation_pages=587-596; citation_doi=10.1016/j.gpb.2022.01.004; citation_id=CR58">
    <meta name="citation_reference" content="citation_journal_title=Cell Rep. Med.; citation_title=Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer; citation_author=N Roper; citation_volume=1; citation_publication_date=2020; citation_pages=10007; citation_id=CR59">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1; citation_author=DA Barbie; citation_volume=462; citation_publication_date=2009; citation_pages=108-112; citation_doi=10.1038/nature08460; citation_id=CR60">
    <meta name="citation_reference" content="citation_journal_title=Cancer Res.; citation_title=Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage; citation_author=MC Heinz; citation_volume=82; citation_publication_date=2022; citation_pages=1953-1968; citation_doi=10.1158/0008-5472.CAN-21-0933; citation_id=CR61">
    <meta name="citation_reference" content="citation_journal_title=Cancer Res.; citation_title=YES1 is a targetable oncogene in cancers harboring YES1 gene amplification; citation_author=N Hamanaka; citation_volume=79; citation_publication_date=2019; citation_pages=5734-5745; citation_doi=10.1158/0008-5472.CAN-18-3376; citation_id=CR62">
    <meta name="citation_reference" content="citation_journal_title=Cancer Res.; citation_title=Oligosaccharyltransferase inhibition overcomes therapeutic resistance to EGFR tyrosine kinase inhibitors; citation_author=C Lopez Sambrooks; citation_volume=78; citation_publication_date=2018; citation_pages=5094-5106; citation_doi=10.1158/0008-5472.CAN-18-0505; citation_id=CR63">
    <meta name="citation_reference" content="citation_journal_title=J. Clin. Invest.; citation_title=IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion; citation_author=LC Chan; citation_volume=129; citation_publication_date=2019; citation_pages=3324-3338; citation_doi=10.1172/JCI126022; citation_id=CR64">
    <meta name="citation_reference" content="citation_journal_title=Mol. Cancer; citation_title=Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma; citation_author=MR Miller; citation_volume=14; citation_publication_date=2015; citation_doi=10.1186/s12943-015-0416-z; citation_id=CR65">
    <meta name="citation_reference" content="citation_journal_title=Br. J. Cancer; citation_title=Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation; citation_author=S Chugh, J Meza, YM Sheinin, MP Ponnusamy, SK Batra; citation_volume=114; citation_publication_date=2016; citation_pages=1376-1386; citation_doi=10.1038/bjc.2016.116; citation_id=CR66">
    <meta name="citation_reference" content="citation_journal_title=Mol. Cell; citation_title=Regulation of the Hippo-YAP pathway by glucose sensor O-GlcNAcylation; citation_author=C Peng; citation_volume=68; citation_publication_date=2017; citation_pages=591-604.e595; citation_doi=10.1016/j.molcel.2017.10.010; citation_id=CR67">
    <meta name="citation_reference" content="citation_journal_title=Clin. Cancer Res.; citation_title=Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis; citation_author=TL Hung; citation_volume=9; citation_publication_date=2003; citation_pages=2605-2612; citation_id=CR68">
    <meta name="citation_reference" content="citation_journal_title=Am. J. Respir. Cell Mol. Biol.; citation_title=Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line; citation_author=YW Chu; citation_volume=17; citation_publication_date=1997; citation_pages=353-360; citation_doi=10.1165/ajrcmb.17.3.2837; citation_id=CR69">
    <meta name="citation_reference" content="citation_journal_title=Nat. Methods; citation_title=Universal sample preparation method for proteome analysis; citation_author=JR Wisniewski, A Zougman, N Nagaraj, M Mann; citation_volume=6; citation_publication_date=2009; citation_pages=359-362; citation_doi=10.1038/nmeth.1322; citation_id=CR70">
    <meta name="citation_reference" content="citation_journal_title=Curr. Protocol. Bioinform.; citation_title=Byonic: advanced peptide and protein identification software; citation_author=M Bern, YJ Kil, C Becker; citation_volume=13; citation_publication_date=2012; citation_pages=13 20 11-13 20 14; citation_id=CR71">
    <meta name="citation_author" content="Hung, Chun-Hua">
    <meta name="citation_author_institution" content="Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Department of Biomedical Engineering, College of Engineering, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author" content="Wu, Shang-Yin">
    <meta name="citation_author_institution" content="Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author" content="Yao, Cheng-I Daniel">
    <meta name="citation_author_institution" content="Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan">
    <meta name="citation_author" content="Yeh, Hsuan-Heng">
    <meta name="citation_author_institution" content="Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author" content="Lin, Chien-Chung">
    <meta name="citation_author_institution" content="Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author" content="Chu, Chang-Yao">
    <meta name="citation_author_institution" content="Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author" content="Huang, Tzu-Yu">
    <meta name="citation_author_institution" content="Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author" content="Shen, Meng-Ru">
    <meta name="citation_author_institution" content="Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author" content="Lin, Chun-Hung">
    <meta name="citation_author_institution" content="Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan">
    <meta name="citation_author_institution" content="Department of Chemistry and Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan">
    <meta name="citation_author" content="Su, Wu-Chou">
    <meta name="citation_author_institution" content="Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="citation_author_institution" content="Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan">
    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access">
    <meta name="twitter:site" content="@NatureComms">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:image:alt" content="Content cover image">
    <meta name="twitter:title" content="Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer">
    <meta name="twitter:description" content="Nature Communications - Post-translational modifications regulate tumorigenesis and cancer therapy sensitivity. Here, the authors show that N-glycosylation defective Interleukin-6 (deNG-IL6)...">
    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig1_HTML.png">
    

    
    
    <meta property="og:url" content="https://www.nature.com/articles/s41467-024-51831-7">
    <meta property="og:type" content="article">
    <meta property="og:site_name" content="Nature">
    <meta property="og:title" content="Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer - Nature Communications">
    <meta property="og:description" content="Post-translational modifications regulate tumorigenesis and cancer therapy sensitivity. Here, the authors show that N-glycosylation defective Interleukin-6 (deNG-IL6) switches downstream signalling pathway from JAK-STAT3 to SRC-YAP axis and lung cancer cells secrete deNG-IL6 to promote metastasis and tyrosine kinase inhibitor resistance.">
    <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig1_HTML.png">
    

    <script>
        window.eligibleForRa21 = 'false'; 
    </script>
<script async="" type="text/javascript" src="https://injections.readcube.com/nature/inject.fa744f3f.js"></script><style type="text/css">.cc-banner{background-color:#01324b;border:none!important;bottom:0;box-sizing:border-box;color:#fff!important;left:0;line-height:1.3;margin:auto 0 0;max-width:100%;outline:0;overflow:visible;padding:0;position:fixed;right:0;width:100%;z-index:99999}.cc-banner::backdrop{background-color:#0000004d}.cc-banner *{color:inherit!important}.cc-banner:focus{box-shadow:none;outline:0}.cc-banner a{color:#fff!important;text-decoration:underline}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{color:inherit;text-decoration:none}.cc-banner a:focus{outline:3px solid #08c!important}.cc-banner h2,.cc-banner h3,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-banner .cc-h2,.cc-banner h2{font-size:18px}.cc-banner .cc-h3,.cc-banner h3{font-size:16px}.cc-banner .cc-h4,.cc-banner .cc-h5,.cc-banner .cc-h6,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-size:14px}.cc-banner .cc-button{font-size:16px}.cc-banner__content{background-color:#01324b;display:flex;flex-direction:column;margin:0 auto;max-height:90vh;max-width:100%;padding:16px;position:relative}.cc-banner__content:focus{outline:0}@media (min-width:680px){.cc-banner__content{padding:12px}}@media (min-width:980px){.cc-banner__content{max-height:60vh;padding-bottom:20px;padding-top:20px}}@media (min-width:1320px){.cc-banner__content{padding-bottom:40px;padding-top:40px}}.cc-banner__container{display:flex;flex-direction:column;margin:auto;max-width:1320px;overflow:auto}.cc-banner__title{background:none!important;border:0;flex-shrink:0;font-size:18px!important;font-size:22px!important;font-weight:700!important;letter-spacing:normal;margin:0 0 12px!important;padding:0}@media (min-width:680px){.cc-banner__title{font-size:24px!important;margin:0 0 16px!important}}@media (min-width:1320px){.cc-banner__title{font-size:26px!important;margin:0 0 24px!important}}.cc-banner__body{display:flex;flex-direction:column;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;overflow-x:hidden;overflow-y:auto;padding:3px 3px 16px}@media (min-width:980px){.cc-banner__body{flex-direction:row}}.cc-banner__policy p{font-size:16px!important;margin:0;max-width:none;padding:0}.cc-banner__policy p:not(:last-child){margin:0 0 16px}@media (min-width:980px){.cc-banner__policy p:not(:last-child){margin:0 0 24px}}.cc-banner__policy p a{font-size:16px!important;font-weight:700}.cc-banner__footer{box-shadow:none;flex-shrink:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif !important!important;margin:0;padding:12px 0 3px 3px;position:relative}@media (min-width:380px){.cc-banner__footer{align-items:stretch;display:flex;flex-wrap:wrap}}@media (min-width:680px){.cc-banner__footer{box-shadow:none;flex-wrap:nowrap;width:40%}}.cc-banner__footer .cc-banner__button{flex:1 1 auto;font-weight:700;overflow:hidden;padding:.5em 1em;width:100%}@media (min-width:680px){.cc-banner__footer .cc-banner__button{max-width:275px}}.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:12px}@media (min-width:680px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:0;margin-right:16px}}@media (min-width:980px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-right:24px}}@media (min-width:680px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:16px!important;margin-right:0!important}}@media (min-width:980px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:24px!important;margin-right:0!important}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-break{display:block}}@media (min-width:680px){.cc-banner--is-tcf .cc-banner__footer{width:auto}}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__footer{padding-right:48px;width:66%}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px!important}.cc-banner--is-tcf .cc-banner__stacks{margin:16px 0 0}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__stacks{display:flex;flex:0 0 33%;flex-direction:column;margin:0 0 0 48px;overflow:auto}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px;margin:0 0 12px}.cc-banner--is-tcf .cc-banner__stacks-details{padding:0 3px}.cc-banner--is-tcf .cc-banner .cc-details{border-color:#fff3!important}.cc-box{border-radius:10px;padding:12px}.cc-box--info{background-color:#eff6fb}.cc-box--light{background-color:#faf9f6}.cc-button{border:2px solid #0000;border-radius:32px!important;color:inherit;cursor:pointer;font-size:14px;font-weight:700!important;left:auto;line-height:1.2;margin:0;padding:.5em 1em;right:auto;text-transform:none!important;transition:all .2s}@media (min-width:680px){.cc-button{font-size:14px;padding:.75em 1em}}.cc-button--sm{font-size:12px;padding:2px 8px!important}.cc-button--primary{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--primary:focus{outline:3px solid #08c}.cc-button--primary:focus,.cc-button--primary:hover,.cc-button--secondary{background-color:#fff!important;border-color:#025e8d!important;color:#025e8d!important}.cc-button--secondary:focus{background-color:#025e8d!important;border-color:#fff!important;color:#fff!important;outline:3px solid #08c!important}.cc-button--secondary:hover{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--secondary:active{border:2px solid #01324b!important}.cc-button--secondary.cc-button--contrast{border-color:#fff!important}.cc-button--secondary.cc-button--contrast:hover{background-color:initial!important;color:#fff!important}.cc-button--tertiary{background-color:#f0f7fc!important;background-image:none;border:2px solid #f0f7fc;color:#025e8d!important;text-decoration:underline!important;text-underline-offset:.25em}.cc-button--tertiary:focus{outline:3px solid #08c!important}.cc-button--tertiary:hover{text-decoration-thickness:.25em}.cc-button--tertiary:active{color:#013c5b}.cc-button--link{background-color:initial!important;border-color:#0000!important;border-radius:0!important;color:inherit!important;padding:0!important;text-decoration:underline!important;width:inherit!important}.cc-button--link:focus{outline:3px solid #08c}.cc-button--link:hover{background-color:initial!important;box-shadow:none;text-decoration:none}.cc-button--text{border-radius:0;padding:0}.cc-button--details{padding-right:24px!important;position:relative;width:auto}.cc-button--details:after,.cc-button--details:before{background-color:currentColor;content:"";position:absolute;transition:transform .25s ease-out}.cc-button--details:before{height:10px;margin-top:-5px;right:12px;top:50%;width:2px}.cc-button--details:after{height:2px;margin-top:-1px;right:8px;top:50%;width:10px}.cc-button--details.cc-active:before{transform:rotate(90deg);transform-origin:center}.cc-button--details.cc-active:after{display:none}.cc-details{border-bottom:1px solid #0000001a;padding:12px 0;position:relative;width:100%}.cc-details__summary{align-items:center;display:flex;font-size:14px;font-weight:700;list-style-type:none}.cc-details__summary:focus,.cc-details__summary:focus-visible{outline:3px solid #08c!important;will-change:auto}.cc-details__title{align-items:baseline;display:flex}.cc-details__title h2,.cc-details__title h3,.cc-details__title h4,.cc-details__title h5{line-height:1.4;margin:0!important;padding:0!important}.cc-details__title svg{flex-shrink:0;height:auto;margin-right:8px;position:relative;top:-1px;transition:all .2s;width:auto}.cc-details[open] .cc-details__title svg{top:2px;transform:rotate(90deg)}.cc-details__switch{margin-left:auto}.cc-details__section{padding:16px 0 0 18px}.cc-details__section p{margin:0}.cc-details__section p:not(:last-child){margin-bottom:12px}details summary::-webkit-details-marker{display:none}.cc-radio{align-items:center;display:flex;position:relative}.cc-radio *{cursor:pointer}.cc-radio__input{height:22px;left:0;position:absolute;top:0;width:22px}.cc-radio__input:focus{outline:none}.cc-radio__label{color:inherit;font-size:14px;font-weight:700;line-height:23px;margin:0;padding-left:28px}.cc-radio__label:after,.cc-radio__label:before{background-color:#fff;content:"";display:block;position:absolute;transition:transform .25s ease-out}.cc-radio__label:before{border:1px solid #777;border-radius:50%;height:22px;left:0;top:0;width:22px}.cc-radio__label:after{border:7px solid #025e8d;border-radius:50%;height:0;left:4px;opacity:0;top:4px;width:0}.cc-radio__input:focus+.cc-radio__label:before{box-shadow:0 0 0 2px #08c;outline:none}.cc-radio__label--hidden{display:none}.cc-radio__input:checked+.cc-radio__label:after{opacity:1}.cc-radio__input:disabled{cursor:default}.cc-radio__input:disabled+.cc-radio__label{cursor:default;opacity:.5}.cc-switch *{cursor:pointer}.cc-switch{align-items:center;display:flex;line-height:1;position:relative}.cc-switch__input[type=checkbox]{-webkit-appearance:none;appearance:none;border-radius:9px!important;height:18px!important;left:0;margin:0!important;position:absolute;width:32px!important}.cc-switch__input[type=checkbox]:hover{cursor:pointer;outline:none}.cc-switch__input[type=checkbox]:focus,.cc-switch__input[type=checkbox]:focus-visible{cursor:pointer;outline:3px solid #08c!important;outline-offset:0}.cc-switch__label{align-items:center;cursor:pointer;display:flex;font-size:14px;font-weight:700;margin:0;padding:0;position:relative;-webkit-user-select:none;user-select:none}.cc-switch__label:after,.cc-switch__label:before{content:"";display:block;transition:transform .2s ease-in-out!important}.cc-switch__label:before{background-color:#999!important;border-radius:9px!important;height:18px!important;margin-right:8px;width:32px!important}.cc-switch__label:after{background-color:#fff!important;border-radius:50%;height:14px;left:0;position:absolute;top:2px;transform:translateX(2px);width:14px}.cc-switch__input[type=checkbox]:checked+.cc-switch__label:before{background-color:#025e8d!important}.cc-switch__input[type=checkbox]:checked+.cc-switch__label:after{transform:translateX(16px)}.cc-switch__input[type=checkbox]:checked+.cc-switch__label>.cc-switch__text-off,.cc-switch__input[type=checkbox]:not(:checked)+.cc-switch__label>.cc-switch__text-on{display:none}html[dir=rtl] .cc-switch__input[type=checkbox]{left:auto;right:0}html[dir=rtl] .cc-switch__label:before{margin-left:8px;margin-right:0}html[dir=rtl] .cc-switch__label:after{left:auto;right:0;transform:translateX(-2px)}html[dir=rtl] .cc-switch__input[type=checkbox]:checked+.cc-switch__label:after{transform:translateX(-16px)}.cc-list>ul,ul.cc-list{list-style-type:disc;margin-left:0;padding-left:0}.cc-list>ul>li,ul.cc-list>li{margin-left:1em}.cc-list>ul>li:not(:last-child),ul.cc-list>li:not(:last-child){margin-bottom:4px}.cc-list__title{margin-bottom:8px!important}.cc-list--inline>ul,ul.cc-list--inline{display:flex;flex-wrap:wrap;list-style-type:none}.cc-list--inline>ul>li,ul.cc-list--inline>li{margin:0 .5em .5em 0}.cc-overlay{background-color:#0000004d;z-index:99998}.cc-overlay,.cc-preferences{bottom:0;left:0;position:fixed;right:0;top:0}.cc-preferences{background-color:#050a14f2!important;border:0;box-sizing:border-box;color:#111;font-family:sans-serif!important;line-height:1.4;margin:auto;max-height:100vh;overflow:auto;padding:0;z-index:100000}.cc-preferences:focus{outline:none}.cc-preferences *,.cc-preferences :after,.cc-preferences :before{box-sizing:inherit!important}.cc-preferences h2,.cc-preferences h3,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-preferences .cc-h2,.cc-preferences h2{font-size:18px}.cc-preferences .cc-h3,.cc-preferences h3{font-size:16px}.cc-preferences .cc-h4,.cc-preferences .cc-h5,.cc-preferences .cc-h6,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-size:14px}.cc-preferences a{color:#025e8d;text-decoration:underline}.cc-preferences a:hover{color:inherit;text-decoration:none}.cc-preferences h3{background:none;color:#111;padding:0;text-transform:none}dialog.cc-preferences{background-color:initial}dialog.cc-preferences::backdrop{background-color:#000000e6}.cc-preferences__dialog{display:flex;flex-direction:column;margin:auto;max-height:100vh;max-width:860px;padding:12px;position:relative}.cc-preferences__dialog>:last-child{border-bottom-left-radius:10px;border-bottom-right-radius:10px}@media (min-width:980px){.cc-preferences__dialog{padding:16px}}.cc-preferences__close{background:#0000!important;border:1px solid #ececec;border-radius:50%;color:#111!important;cursor:pointer;font-family:Times New Roman,serif;font-size:40px;height:40px;left:auto;line-height:1;margin-top:-20px;padding:0!important;position:absolute;right:20px;top:50%;width:40px}.cc-preferences__close:focus{outline:3px solid #08c}.cc-preferences__close-label{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__header{background:#fff!important;border-bottom:1px solid #0000001a;border-top-left-radius:10px;border-top-right-radius:10px;padding:16px;position:relative;text-align:center}.cc-preferences__title{background:none!important;color:#111!important;font-family:sans-serif!important;font-size:18px!important;font-weight:700!important;margin:0!important;padding:0 16px 0 0!important}@media (min-width:480px){.cc-preferences__title{padding-right:0!important}}@media (min-width:980px){.cc-preferences__title{font-size:22px!important}}.cc-preferences__body{background:#fff!important;flex:1 1 auto;min-height:200px;overflow-x:hidden;overflow-y:auto;padding:16px}.cc-preferences__footer{background:#fff!important;border-top:1px solid #d0d0d0;box-shadow:0 0 5px 0 #0003;margin-bottom:0;padding:12px;position:relative}@media (min-width:480px){.cc-preferences__footer{align-items:stretch;display:flex}}.cc-preferences__footer>.cc-button{display:block;width:100%}@media (min-width:480px){.cc-preferences__footer>.cc-button{flex:1 1 auto}}@media (min-width:980px){.cc-preferences__footer>.cc-button{flex-basis:auto}}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:first-child){margin-left:12px}}.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:8px}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:0}}.cc-preferences__categories{list-style:none;margin:0;padding:0}.cc-preferences__category:not(:last-child){border-bottom:1px solid #0000001a;margin-bottom:12px;padding-bottom:12px}.cc-preferences__category-description{font-size:14px;margin:0 0 8px;padding:0}.cc-preferences__category-footer{align-items:center;display:flex;justify-content:space-between}.cc-preferences__status{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__controls{display:flex;margin:0}.cc-preferences__controls>:not(:last-child){margin-right:12px}.cc-preferences__always-on{font-size:14px;font-weight:700;padding-left:26px;position:relative}.cc-preferences__always-on:before{background:#0000!important;border:solid;border-top-color:#0000;border-width:0 0 4px 4px;content:"";display:block;height:10px;left:0;position:absolute;top:2px;transform:rotate(-45deg);width:18px}.cc-preferences__details{font-size:14px;margin:12px 0 0}.cc-preferences__cookie-list,.cc-preferences__provider-list{list-style:none;margin:0;padding:0}.cc-preferences__provider-list{columns:170px}.cc-preferences__cookie-title{display:flex;font-size:1em;font-style:normal;font-weight:400;line-height:1;margin:0 0 4px}.cc-preferences__cookie-description{font-size:1em;margin:0}.cc-preferences__cookie-description:not(:last-child){border-bottom:1px solid #dbebf6;margin:0 0 8px;padding:0 0 8px}.cc-preferences__cookie-name{font-weight:700}.cc-preferences__cookie-domain,.cc-preferences__cookie-lifespan{border-left:1px solid #999;color:#666;margin-left:8px;padding-left:8px}html[dir=rtl] .cc-preferences__cookie-title .cc-preferences__cookie-domain,html[dir=rtl] .cc-preferences__cookie-title .cc-preferences__cookie-lifespan,html[dir=rtl] .cc-preferences__cookie-title .cc-preferences__cookie-name{direction:ltr;unicode-bidi:isolate}html[dir=rtl] .cc-preferences__cookie-title .cc-preferences__cookie-domain,html[dir=rtl] .cc-preferences__cookie-title .cc-preferences__cookie-lifespan{border-left:0;border-right:1px solid #999;margin-left:0;margin-right:8px;padding-left:0;padding-right:8px}body.cc-has-preferences-open{overflow:hidden;position:relative}.cc-table{border-collapse:collapse;width:100%}.cc-table tbody tr{border-top:1px solid #0000001a}.cc-table td,.cc-table th{font-size:14px;padding:4px 8px;vertical-align:top}.cc-table+.cc-table{margin-top:8px}.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:70%}@media (min-width:680px){.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:80%}}.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{padding-left:8px;width:40%}@media (min-width:680px){.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{width:30%}}.cc-tabs,.cc-tabs>ul{background-color:#faf9f6;display:flex;list-style:none;margin:0;padding:0}.cc-tabs__panel{border-top:1px solid #ececec;margin-top:-1px}.cc-tabs__button{background-color:initial;border:0;border-left:1px solid #0000;border-right:1px solid #0000;color:#111;font-size:16px;font-weight:700;margin:0;padding:15px 16px 12px;position:relative}.cc-tabs__button:before{background-color:initial;content:"";display:block;height:3px;left:0;position:absolute;top:0;width:100%}.cc-tabs__button.cc-active{background-color:#fff;border-color:#025e8d #ececec #ececec;color:#111}.cc-tabs__button.cc-active:before{background-color:#025e8d}.cc-tabs__content{background-color:#fff;display:none;font-size:14px;padding:16px}.cc-tabs__section:not(:first-child){padding-top:24px}.cc-tcf{font-size:14px;margin-top:16px}.cc-tcf__list{list-style:none;margin:0;padding:0}.cc-vendor-count{color:#666;font-size:16px;margin:0 0 8px}.cc-hide{display:none!important}.cc-show{display:block!important}.cc-external-link{background-color:#ececec;background-image:url("data:image/svg+xml;base64,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");background-position:right 8px center;background-repeat:no-repeat;background-size:10px auto;border-radius:3px;box-shadow:0 1px 0 #0003;color:#111!important;display:inline-block;font-size:12px;padding:4px 26px 4px 8px;text-decoration:none!important}.cc-external-link:hover{text-decoration:underline!important}.cc-m-0{margin:0!important}.cc-grey{color:#666}</style><meta http-equiv="origin-trial" content="AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="A9wSqI5i0iwGdf6L1CERNdmsTPgVu44ewj8QxTBYgsv1LCPUVF7YmWOvTappqB1139jAymxUW/RO8zmMqo4zlAAAAACNeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><meta http-equiv="origin-trial" content="A+d7vJfYtay4OUbdtRPZA3y7bKQLsxaMEPmxgfhBGqKXNrdkCQeJlUwqa6EBbSfjwFtJWTrWIioXeMW+y8bWAgQAAACTeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><script src="https://pagead2.googlesyndication.com/pagead/managed/js/gpt/m202506260101/pubads_impl.js" async=""></script></head>
<body class="article-page"><dialog class="cc-banner" data-cc-banner="" data-nosnippet="" aria-labelledby="cc-banner-label" open="">
		<div class="cc-banner__content" autofocus="" tabindex="-1">
			<div class="cc-banner__container">
				<div class="cc-banner__header">
					<h2 class="cc-banner__title" id="cc-banner-label">Your privacy, your choice</h2>
				</div>
				<div class="cc-banner__body">
					<div class="cc-banner__policy">
						<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href="https://www.nature.com/info/privacy" data-cc-action="privacy">privacy policy</a> for more information on the use of your personal data.</p><p><button type="button" data-cc-action="preferences" class="cc-button cc-button--link cc-button--text">Manage preferences</button> for further information and to change your choices.</p>
					</div>
					
				</div>
				<div class="cc-banner__footer">
					
			<button data-cc-action="accept" class="cc-button cc-button--secondary cc-button--contrast cc-banner__button cc-banner__button-accept">Accept all cookies</button>
			
		
				</div>
			</div>
		</div>
	</dialog>

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="position-relative cleared z-index-50 background-white" data-test="top-containers">
    <a class="c-skip-link" href="#content">Skip to main content</a>



<div class="c-grade-c-banner u-hide">
    <div class="c-grade-c-banner__container">
        
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>

    </div>
</div>

    

    

    
    
        <div class="u-hide u-show-following-ad"></div>

    <aside class="c-ad c-ad--728x90">
        <div class="c-ad__inner" data-container-type="banner-advert">
            <p class="c-ad__label">Advertisement</p>
            
        
            
    <div id="div-gpt-ad-top-1" class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide" data-ad-type="top" data-test="top-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/nature_communications/article" data-gpt-sizes="728x90" data-gpt-targeting="type=article;pos=top;artid=s41467-024-51831-7;doi=10.1038/s41467-024-51831-7;techmeta=1,13,14,19,21,34,38,42,49,5,51,58,59,60,61,64,70,77,82,83,88,89,95,96;subjmeta=1059,1350,1612,221,2326,631,67,80;kwrd=Cancer+therapeutic+resistance,Glycobiology,Non-small-cell+lung+cancer" data-google-query-id="CK3B7aDQq44DFdcADAId7Y0lpA">
        
        
        
    <div id="google_ads_iframe_/270604982/nature/ncomms/articles_0__container__" style="border: 0pt;"><iframe id="google_ads_iframe_/270604982/nature/ncomms/articles_0" name="google_ads_iframe_/270604982/nature/ncomms/articles_0" title="3rd party ad content" width="728" height="90" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" style="border: 0px; vertical-align: bottom;" aria-label="Advertisement" tabindex="0" sandbox="allow-forms allow-pointer-lock allow-popups allow-popups-to-escape-sandbox allow-same-origin allow-scripts allow-top-navigation-by-user-activation" data-google-container-id="1" data-load-complete="true"></iframe></div></div>

        
    
        </div>
    </aside>


    <header class="c-header" id="header" data-header="" data-track-component="nature-150-split-header" style="border-color:#e63323">
        <div class="c-header__row">
            <div class="c-header__container">
                <div class="c-header__split">
                    
                    
                    <div class="c-header__logo-container">
                        
                        <a href="/ncomms" data-track="click" data-track-action="home" data-track-label="image">
                            <picture class="c-header__logo">
                                <source srcset="https://media.springernature.com/full/nature-cms/uploads/product/ncomms/header-03d2e325c0a02f6df509e5730e9be304.svg" media="(min-width: 875px)">
                                <img src="https://media.springernature.com/full/nature-cms/uploads/product/ncomms/header-7001f06bc3fe2437048388e9f2f44215.svg" height="32" alt="Nature Communications">
                            </picture>
                        </a>
                    
                    </div>
                    
                    <ul class="c-header__menu c-header__menu--global">
                        <li class="c-header__item c-header__item--padding c-header__item--hide-md-max">
                            <a class="c-header__link" href="https://www.nature.com/siteindex" data-test="siteindex-link" data-track="click" data-track-action="open nature research index" data-track-label="link">
                                <span>View all journals</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--pipe">
                            <a class="c-header__link c-header__link--search" href="javascript:;" data-header-expander="" data-test="search-link" data-track="click" data-track-action="open search tray" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                <svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"></path></svg><span>Search</span>
                            </a><div id="search-menu" class="c-header__dropdown c-header__dropdown--full-width has-tethered u-js-hide" data-track-component="nature-150-split-header" hidden="">
    <div class="c-header__container">
        <h2 class="c-header__visually-hidden">Search</h2>
        <form class="c-header__search-form" action="/search" method="get" role="search" autocomplete="off" data-test="inline-search">
            <label class="c-header__heading" for="keywords">Search articles by subject, keyword or author</label>
            <div class="c-header__search-layout c-header__search-layout--max-width">
                <div>
                    <input type="text" required="" class="c-header__input" id="keywords" name="q" value="">
                </div>
                <div class="c-header__search-layout">
                    <div>
                        <label for="results-from" class="c-header__visually-hidden">Show results from</label>
                        <select id="results-from" name="journal" class="c-header__select">
                            
                                
                                    <option value="" selected="">All journals</option>
                                    <option value="ncomms">This journal</option>
                                
                            
                        </select>
                    </div>
                    <div>
                        <button type="submit" class="c-header__search-button">Search</button>
                    </div>
                </div>

            </div>
        </form>

        <div class="c-header__flush">
            <a class="c-header__link" href="/search/advanced" data-track="click" data-track-action="advanced search" data-track-label="link">
                Advanced search
            </a>
        </div>

        <h3 class="c-header__heading c-header__heading--keyline">Quick links</h3>
        <ul class="c-header__list">
            <li><a class="c-header__link" href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
            <li><a class="c-header__link" href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
            <li><a class="c-header__link" href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
            <li><a class="c-header__link" href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
        </ul>
    </div>
</div>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--snid-account-widget c-header__item--pipe">
                            
                                <a class="c-header__link eds-c-header__link" id="identity-account-widget" data-track="click_login" data-track-context="header" href="https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41467-024-51831-7"><span class="eds-c-header__widget-fragment-title">Log in</span></a>
                            
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
            <div class="c-header__row">
                <div class="c-header__container" data-test="navigation-row">
                    <div class="c-header__split">
                        <ul class="c-header__menu c-header__menu--journal">
                            
                                <li class="c-header__item c-header__item--dropdown-menu" data-test="explore-content-button">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--explore" data-track="click" data-track-action="open explore expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span><span class="c-header__show-text">Explore</span> content</span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Explore-content" data-test="Explore-content" id="explore" data-track-component="nature-150-split-header" hidden="">
            <div class="c-header__container">
                <h2 id="Explore-content" class="c-header__heading c-header__heading--js-hide">Explore content</h2>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/research-articles" data-track="click" data-track-action="research articles" data-track-label="link" data-test="explore-nav-item">
                                    Research articles
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/reviews-and-analysis" data-track="click" data-track-action="reviews &amp; analysis" data-track-label="link" data-test="explore-nav-item">
                                    Reviews &amp; Analysis
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/news-and-comment" data-track="click" data-track-action="news &amp; comment" data-track-label="link" data-test="explore-nav-item">
                                    News &amp; Comment
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/video" data-track="click" data-track-action="videos" data-track-label="link" data-test="explore-nav-item">
                                    Videos
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/collections" data-track="click" data-track-action="collections" data-track-label="link" data-test="explore-nav-item">
                                    Collections
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/browse-subjects" data-track="click" data-track-action="subjects" data-track-label="link" data-test="explore-nav-item">
                                    Subjects
                                </a>
                            </li>
                        
                    
                </ul>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://www.facebook.com/NatureCommunications" data-track="click" data-track-action="facebook" data-track-label="link">Follow us on Facebook
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://twitter.com/NatureComms" data-track="click" data-track-action="twitter" data-track-label="link">Follow us on Twitter
                            </a>
                        </li>
                    
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id=264" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-external="" data-track-label="link (mobile dropdown)">Sign up for alerts<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#fff"></path></svg>
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/ncomms.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                <span>RSS feed</span>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--dropdown-menu">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--about-the-journal" data-track="click" data-track-action="open about the journal expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span>About <span class="c-header__show-text">the journal</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="About-the-journal" id="about-the-journal" data-test="about-the-journal" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="About-the-journal" class="c-header__heading c-header__heading--js-hide">About the journal</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/aims" data-track="click" data-track-action="aims &amp; scope" data-track-label="link">
                                    Aims &amp; Scope
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/editors" data-track="click" data-track-action="editors" data-track-label="link">
                                    Editors
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/journal-information" data-track="click" data-track-action="journal information" data-track-label="link">
                                    Journal Information
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/open-access" data-track="click" data-track-action="open access fees and funding" data-track-label="link">
                                    Open Access Fees and Funding
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/calls-for-papers" data-track="click" data-track-action="calls for papers" data-track-label="link">
                                    Calls for Papers
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/editorial-values-statement" data-track="click" data-track-action="editorial values statement" data-track-label="link">
                                    Editorial Values Statement
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/journal-impact" data-track="click" data-track-action="journal metrics" data-track-label="link">
                                    Journal Metrics
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/editorshighlights" data-track="click" data-track-action="editors' highlights" data-track-label="link">
                                    Editors' Highlights
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/contact" data-track="click" data-track-action="contact" data-track-label="link">
                                    Contact
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/editorial-policies" data-track="click" data-track-action="editorial policies" data-track-label="link">
                                    Editorial policies
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/top-articles" data-track="click" data-track-action="top articles" data-track-label="link">
                                    Top Articles
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                </li>
                                
                                    <li class="c-header__item c-header__item--dropdown-menu" data-test="publish-with-us-button">
                                        <a href="javascript:;" class="c-header__link c-header__link--dropdown-menu" data-header-expander="" data-test="menu-button--publish" data-track="click" data-track-action="open publish with us expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                            <span>Publish <span class="c-header__show-text">with us</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                        </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Publish-with-us-label" id="publish-with-us" data-test="publish-with-us" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="Publish-with-us-label" class="c-header__heading c-header__heading--js-hide">Publish with us</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/submit" data-track="click" data-track-action="for authors" data-track-label="link">
                                    For authors
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/for-reviewers" data-track="click" data-track-action="for reviewers" data-track-label="link">
                                    For Reviewers
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" data-test="nature-author-services" data-track="nav_language_services" data-track-context="header publish with us dropdown menu" data-track-action="manuscript author services" data-track-label="link manuscript author services" href="https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&amp;utm_medium=Website_Nature&amp;utm_campaign=Platform+Experimentation+2022&amp;utm_id=PE2022">
                                    Language editing services
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/ncomms/open-access-funding" data-test="funding-eligibility-link" data-track="click_explore_funding" data-track-context="header publish with us" data-track-action="funding eligibility">Open access funding</a>
                            </li>
                        
                        
                            <li class="c-header__item c-header__item--keyline">
                                <a class="c-header__link" href="https://mts-ncomms.nature.com/" data-track="click_submit_manuscript" data-track-context="submit link in Nature header dropdown menu" data-track-action="submit manuscript" data-track-label="link (publish with us dropdown menu)" data-track-external="" data-gtm-criteo="submit-manuscript">Submit manuscript<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill="#fff"></path></svg>
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                    </li>
                                
                            
                            
                        </ul>
                        <ul class="c-header__menu c-header__menu--hide-lg-max">
                            
                                <li class="c-header__item" data-test="alert-link">
                                    <a class="c-header__link" href="https://journal-alerts.springernature.com/subscribe?journal_id=41467" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-label="link (desktop site header)" data-track-external="">
                                        <span>Sign up for alerts</span><svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#222"></path></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--pipe">
                                    <a class="c-header__link" href="https://www.nature.com/ncomms.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                            <span>RSS feed</span>
                                    </a>
                                </li>
                            
                        </ul>
                    </div>
                </div>
            </div>
        
    </header>


    
    
        <nav class="u-mb-16" aria-label="breadcrumbs">
            <div class="u-container">
                <ol class="c-breadcrumbs" itemscope="" itemtype="https://schema.org/BreadcrumbList">
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="name">nature</span></a><meta itemprop="position" content="1">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/ncomms" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature communications"><span itemprop="name">nature communications</span></a><meta itemprop="position" content="2">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/ncomms/articles?type=article" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:articles"><span itemprop="name">articles</span></a><meta itemprop="position" content="3">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb3" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                                    <span itemprop="name">article</span><meta itemprop="position" content="4"></li>
                </ol>
            </div>
        </nav>
    



    

</div>


<div class="u-container u-mt-32 u-mb-32 u-clearfix" id="content" data-component="article-container" data-container-type="article">
    <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
        
            
                <div class="c-context-bar c-context-bar--sticky" id="js-enable-context-bar" data-test="context-bar" data-context-bar="" aria-hidden="false">
                    <div class="c-context-bar__container u-container" data-track-context="sticky banner">
                        <div class="c-context-bar__title">
                            Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer
                        </div>
                        
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41467-024-51831-7.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="button sticky" data-track-external="" download="" tabindex="-1">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                    </div>
                </div>
            
        
        <article lang="en">
            
                <div class="c-pdf-button__container u-mb-16 u-hide-at-lg js-context-bar-sticky-point-mobile">
                    <div class="c-pdf-container" data-track-context="article body">
                        
                            
                                
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41467-024-51831-7.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                            
                        
                    </div>
                </div>
            
            <div class="c-article-header">
                <header>
                    <ul class="c-article-identifiers" data-test="article-identifier">
                        
        <li class="c-article-identifiers__item" data-test="article-category">Article</li>
    
        <li class="c-article-identifiers__item">
            <a href="https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access">Open access</a>
        </li>
    
    

                        <li class="c-article-identifiers__item">Published: <time datetime="2024-09-09">09 September 2024</time></li>
                    </ul>

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer</h1>
                    <ul class="c-article-author-list c-article-author-list--short js-no-scroll" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="1_10" data-track-context="researcher popup with no profile" href="#auth-Chun_Hua-Hung-Aff1-Aff2-Aff3-Aff4" data-author-popup="auth-Chun_Hua-Hung-Aff1-Aff2-Aff3-Aff4" data-author-search="Hung, Chun-Hua">Chun-Hua Hung</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="https://orcid.org/0000-0002-8580-8759"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-8580-8759</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a>,<a href="#Aff3" tabindex="-1">3</a>,<a href="#Aff4" tabindex="-1">4</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="2_10" data-track-context="researcher popup with no profile" href="#auth-Shang_Yin-Wu-Aff1-Aff5" data-author-popup="auth-Shang_Yin-Wu-Aff1-Aff5" data-author-search="Wu, Shang-Yin">Shang-Yin Wu</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="https://orcid.org/0000-0003-2914-510X"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-2914-510X</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff5" tabindex="-1">5</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="3_10" data-track-context="researcher popup with no profile" href="#auth-Cheng_I_Daniel-Yao-Aff6" data-author-popup="auth-Cheng_I_Daniel-Yao-Aff6" data-author-search="Yao, Cheng-I Daniel">Cheng-I Daniel Yao</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="https://orcid.org/0000-0002-0902-045X"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-0902-045X</a></span><sup class="u-js-hide"><a href="#Aff6" tabindex="-1">6</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="4_10" data-track-context="researcher popup with no profile" href="#auth-Hsuan_Heng-Yeh-Aff2" data-author-popup="auth-Hsuan_Heng-Yeh-Aff2" data-author-search="Yeh, Hsuan-Heng">Hsuan-Heng Yeh</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="5_10" data-track-context="researcher popup with no profile" href="#auth-Chien_Chung-Lin-Aff5-Aff7-Aff8" data-author-popup="auth-Chien_Chung-Lin-Aff5-Aff7-Aff8" data-author-search="Lin, Chien-Chung">Chien-Chung Lin</a><sup class="u-js-hide"><a href="#Aff5" tabindex="-1">5</a>,<a href="#Aff7" tabindex="-1">7</a>,<a href="#Aff8" tabindex="-1">8</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="6_10" data-track-context="researcher popup with no profile" href="#auth-Chang_Yao-Chu-Aff9" data-author-popup="auth-Chang_Yao-Chu-Aff9" data-author-search="Chu, Chang-Yao">Chang-Yao Chu</a><sup class="u-js-hide"><a href="#Aff9" tabindex="-1">9</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="7_10" data-track-context="researcher popup with no profile" href="#auth-Tzu_Yu-Huang-Aff10" data-author-popup="auth-Tzu_Yu-Huang-Aff10" data-author-search="Huang, Tzu-Yu">Tzu-Yu Huang</a><sup class="u-js-hide"><a href="#Aff10" tabindex="-1">10</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="8_10" data-track-context="researcher popup with no profile" href="#auth-Meng_Ru-Shen-Aff11-Aff12" data-author-popup="auth-Meng_Ru-Shen-Aff11-Aff12" data-author-search="Shen, Meng-Ru">Meng-Ru Shen</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="https://orcid.org/0000-0003-0506-3505"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-0506-3505</a></span><sup class="u-js-hide"><a href="#Aff11" tabindex="-1">11</a>,<a href="#Aff12" tabindex="-1">12</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="9_10" data-track-context="researcher popup with no profile" href="#auth-Chun_Hung-Lin-Aff6-Aff13" data-author-popup="auth-Chun_Hung-Lin-Aff6-Aff13" data-author-search="Lin, Chun-Hung">Chun-Hung Lin</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="https://orcid.org/0000-0002-6795-8825"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-6795-8825</a></span><sup class="u-js-hide"><a href="#Aff6" tabindex="-1">6</a>,<a href="#Aff13" tabindex="-1">13</a></sup> &amp; </li><li class="c-article-author-list__show-more" aria-label="Show all 10 authors for this article" title="Show all 10 authors for this article"></li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="10_10" data-track-context="researcher popup with no profile" href="#auth-Wu_Chou-Su-Aff1-Aff2-Aff3-Aff5-Aff10" data-author-popup="auth-Wu_Chou-Su-Aff1-Aff2-Aff3-Aff5-Aff10" data-author-search="Su, Wu-Chou" data-corresp-id="c1">Wu-Chou Su<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="https://orcid.org/0000-0003-2953-4105"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-2953-4105</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a>,<a href="#Aff3" tabindex="-1">3</a>,<a href="#Aff5" tabindex="-1">5</a>,<a href="#Aff10" tabindex="-1">10</a></sup>&nbsp;</li></ul><button aria-expanded="false" class="c-article-author-list__button"><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-down-medium"></use></svg><span>Show authors</span></button>

                    

                    <p class="c-article-info-details" data-container-section="info">
                        
    <a data-test="journal-link" href="/ncomms" data-track="click" data-track-action="journal homepage" data-track-category="article body" data-track-label="link"><i data-test="journal-title">Nature Communications</i></a>

                        <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>&nbsp;15</b>, Article&nbsp;number:&nbsp;<span data-test="article-number">7885</span> (<span data-test="article-publication-year">2024</span>)
            <a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                    </p>
                    
        
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <ul class="c-article-metrics-bar u-list-reset">
                
                    <li class=" c-article-metrics-bar__item" data-test="access-count">
                        <p class="c-article-metrics-bar__count">9119 <span class="c-article-metrics-bar__label">Accesses</span></p>
                    </li>
                
                
                    <li class="c-article-metrics-bar__item" data-test="citation-count">
                        <p class="c-article-metrics-bar__count">13 <span class="c-article-metrics-bar__label">Citations</span></p>
                    </li>
                
                
                    
                        <li class="c-article-metrics-bar__item" data-test="altmetric-score">
                            <p class="c-article-metrics-bar__count">30 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                        </li>
                    
                
                
                    <li class="c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__details"><a href="/articles/s41467-024-51831-7/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
                    </li>
                
            </ul>
        </div>
    
                    
                </header>

                
    

                
    
    

    
    

                
            </div>

        <div class="c-article-body">
            <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>The IL6-GP130-STAT3 pathway facilitates lung cancer progression and resistance to tyrosine kinase inhibitors. Although glycosylation alters the stability of GP130, its effect on the ligand IL6 remains unclear. We herein find that N-glycosylated IL6, especially at Asn73, primarily stimulates JAK-STAT3 signaling and prolongs STAT3 phosphorylation, whereas N-glycosylation-defective IL6 (deNG-IL6) induces shortened STAT3 activation and alters the downstream signaling preference for the SRC-YAP-SOX2 axis. This signaling shift induces <u>e</u>pithelial-<u>m</u>esenchymal <u>t</u>ransition (EMT) and migration in vitro and metastasis in vivo, which are suppressed by targeted inhibitors and shRNAs against SRC, YAP, and SOX2. Osimertinib-resistant lung cancer cells secrete a large amount of deNG-IL6 through reduced N-glycosyltransferase gene expression, leading to clear SRC-YAP activation. deNG-IL6 contributes to drug resistance, as confirmed by in silico analysis of cellular and clinical transcriptomes and signal expression in patient specimens. Therefore, the N-glycosylation status of IL6 not only affects cell behaviors but also shows promise in monitoring the dynamics of lung cancer evolution.</p></div></div></section>

            
                
            

            
                
                    
        
            <section aria-labelledby="inline-recommendations" data-title="Inline Recommendations" class="c-article-recommendations" data-track-component="inline-recommendations">
                <h3 class="c-article-recommendations-title" id="inline-recommendations">Similar content being viewed by others</h3>
                <div class="c-article-recommendations-list">
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41388-025-03461-6/MediaObjects/41388_2025_3461_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41388-025-03461-6?fromPaywallRec=false" data-track="select_recommendations_1" data-track-context="inline recommendations" data-track-action="click recommendations inline - 1" data-track-label="10.1038/s41388-025-03461-6">Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">31 May 2025</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-022-21419-6/MediaObjects/41598_2022_21419_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41598-022-21419-6?fromPaywallRec=false" data-track="select_recommendations_2" data-track-context="inline recommendations" data-track-action="click recommendations inline - 2" data-track-label="10.1038/s41598-022-21419-6">NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">12 October 2022</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41420-022-01104-3/MediaObjects/41420_2022_1104_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41420-022-01104-3?fromPaywallRec=false" data-track="select_recommendations_3" data-track-context="inline recommendations" data-track-action="click recommendations inline - 3" data-track-label="10.1038/s41420-022-01104-3">Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">09 July 2022</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                </div>
            </section>
        
            <script>
                window.dataLayer = window.dataLayer || [];
                window.dataLayer.push({
                    recommendations: {
                        recommender: 'semantic',
                        model: 'specter',
                        policy_id: 'NA',
                        timestamp: 1751918588,
                        embedded_user: 'null'
                    }
                });
            </script>
        
    
                
                
                <div class="main-content">
                    
                        <section data-title="Introduction"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Introduction</h2><div class="c-article-section__content" id="Sec1-content"><p>Interleukin-6 (IL6) is produced by both cancerous and noncancerous human cells and binds to IL6-receptor alpha (IL6R, also known as GP80). The IL6-IL6R complex then associates with coreceptor GP130, primarily triggering the GP130-JAK-STAT3 signaling<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Yu, H., Lee, H., Herrmann, A., Buettner, R. &amp; Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 14, 736746 (2014)." href="#ref-CR1" id="ref-link-section-d19463446e851">1</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Jones, S. A. &amp; Jenkins, B. J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat. Rev. Immunol. 18, 773789 (2018)." href="#ref-CR2" id="ref-link-section-d19463446e851_1">2</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Rose-John, S. The soluble interleukin 6 receptor: advanced therapeutic options in inflammation. Clin. Pharmacol. Therapeut. 102, 591598 (2017)." href="/articles/s41467-024-51831-7#ref-CR3" id="ref-link-section-d19463446e854">3</a></sup> axis to regulate immune responses and cancer pathogenesis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Trikha, M., Corringham, R., Klein, B. &amp; Rossi, J. F. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin. Cancer Res. 9, 46534665 (2003)." href="#ref-CR4" id="ref-link-section-d19463446e858">4</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Hunter, C. A. &amp; Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448457 (2015)." href="#ref-CR5" id="ref-link-section-d19463446e858_1">5</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Garbers, C., Heink, S., Korn, T. &amp; Rose-John, S. Interleukin-6: designing specific therapeutics for a complex cytokine. Nat. Rev. Drug Discov. 17, 395412 (2018)." href="#ref-CR6" id="ref-link-section-d19463446e858_2">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Murakami, M., Kamimura, D. &amp; Hirano, T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity 50, 812831 (2019)." href="/articles/s41467-024-51831-7#ref-CR7" id="ref-link-section-d19463446e861">7</a></sup>. In non-small cell lung cancer (NSCLC), an increase in circulating IL6 is associated with poor survival of patients, and autocrine IL6-mediated GP130-JAK-STAT3 signaling is positively correlated with tumor progression, apoptotic resistance, and drug resistance<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Duan, Z. et al. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin. Cancer Res. 12, 50555063 (2006)." href="#ref-CR8" id="ref-link-section-d19463446e865">8</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Huang, W. L. et al. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells. Mol. Cancer 9, 309 (2010)." href="#ref-CR9" id="ref-link-section-d19463446e865_1">9</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Lee, H. J. et al. Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. Cancer Cell 26, 207221 (2014)." href="/articles/s41467-024-51831-7#ref-CR10" id="ref-link-section-d19463446e868">10</a></sup>. In addition to JAK-STAT3, IL6 activates the ERK, AKT, and SRC-YAP pathways via GP130 to regulate diverse biological processes<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Yu, H., Lee, H., Herrmann, A., Buettner, R. &amp; Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 14, 736746 (2014)." href="/articles/s41467-024-51831-7#ref-CR1" id="ref-link-section-d19463446e872">1</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Rokavec, M. et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J. Clin. Invest. 124, 18531867 (2014)." href="/articles/s41467-024-51831-7#ref-CR11" id="ref-link-section-d19463446e875">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519, 5762 (2015)." href="/articles/s41467-024-51831-7#ref-CR12" id="ref-link-section-d19463446e878">12</a></sup>.</p><p>Targeted therapy using epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) is the standard care for patients with lung adenocarcinoma harboring sensitive EGFR mutations<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Quintanal-Villalonga, A. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat. Rev. Clin. Oncol. 17, 360371 (2020)." href="/articles/s41467-024-51831-7#ref-CR13" id="ref-link-section-d19463446e885">13</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 14971500 (2004)." href="/articles/s41467-024-51831-7#ref-CR14" id="ref-link-section-d19463446e888">14</a></sup>. The third-generation EGFR-TKI osimertinib is currently the preferred first-line therapeutic<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Ramalingam, S. S. et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N. Engl. J. Med. 382, 4150 (2020)." href="/articles/s41467-024-51831-7#ref-CR15" id="ref-link-section-d19463446e892">15</a></sup>. Although EGFR-TKIs are highly effective in treating this group of patients, acquired resistance inevitably develops in most subjects<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Oxnard, G. R. et al. Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib. JAMA Oncol. 4, 15271534 (2018)." href="/articles/s41467-024-51831-7#ref-CR16" id="ref-link-section-d19463446e896">16</a></sup>. Common mechanisms of acquired resistance to EGFR-TKIs include on-target secondary mutations (e.g., T790M and T797S), genetic alterations that result in activation of multiple bypass pathways such as MET, HER2, KRAS, and PIK3CA<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Yang, Z. et al. Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients. Clin. Cancer Res. 24, 30973107 (2018)." href="/articles/s41467-024-51831-7#ref-CR17" id="ref-link-section-d19463446e900">17</a></sup>, and histological transformation from adenocarcinomas to aggressive neuroendocrine derivatives<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Sequist, L. V. et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci. Transl. Med. 3, 75ra26 (2011)." href="/articles/s41467-024-51831-7#ref-CR18" id="ref-link-section-d19463446e904">18</a></sup> where cancer cells gain cell plasticity and exhibit an <u>e</u>pithelial-<u>m</u>esenchymal <u>t</u>ransition (EMT) phenotype<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Lambert, A. W. &amp; Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer 21, 325338 (2021)." href="/articles/s41467-024-51831-7#ref-CR19" id="ref-link-section-d19463446e918">19</a></sup>.</p><p>Lineage plasticity is proposed as a shared pathway for resistance to anticancer agents, which encompasses phenotypic changes in cancer cells, such as EMT and reprogramming of cancer stem cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Lambert, A. W. &amp; Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer 21, 325338 (2021)." href="/articles/s41467-024-51831-7#ref-CR19" id="ref-link-section-d19463446e925">19</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Williams, E. D., Gao, D., Redfern, A. &amp; Thompson, E. W. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nat. Rev. Cancer 19, 716732 (2019)." href="/articles/s41467-024-51831-7#ref-CR20" id="ref-link-section-d19463446e928">20</a></sup>. EGFR-TKI-induced high IL6 secretion has been observed in lung cancer cell lines<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Yao, Z. et al. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc. Natl Acad. Sci. USA 107, 1553515540 (2010)." href="/articles/s41467-024-51831-7#ref-CR21" id="ref-link-section-d19463446e932">21</a></sup> and clinical samples<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Yang, Z. et al. Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients. Clin. Cancer Res. 24, 30973107 (2018)." href="/articles/s41467-024-51831-7#ref-CR17" id="ref-link-section-d19463446e936">17</a></sup>, which facilitates TKI resistance by promoting EMT in a TGF--dependent manner<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Yao, Z. et al. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc. Natl Acad. Sci. USA 107, 1553515540 (2010)." href="/articles/s41467-024-51831-7#ref-CR21" id="ref-link-section-d19463446e940">21</a></sup> or inhibiting apoptosis by activating the JAK1-STAT3 pathway<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Kim, S. M. et al. Activation of IL-6R/JAK1/STAT signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation. Mol. Cancer Ther. 11, 22542264 (2012)." href="/articles/s41467-024-51831-7#ref-CR22" id="ref-link-section-d19463446e944">22</a></sup>. IL6 also induces self-renewal of cancer stem cells (CSCs)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Korkaya, H., Liu, S. &amp; Wicha, M. S. Regulation of cancer stem cells by cytokine networks: attacking cancers inflammatory roots. Clin. Cancer Res. 17, 61256129 (2011)." href="/articles/s41467-024-51831-7#ref-CR23" id="ref-link-section-d19463446e949">23</a></sup> and dedifferentiation of tumor cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Senescence-Associated Pro-inflammatory Cytokines, VernotJ. P. and tumor cell plasticity. Front. Mol. Biosci. 7, 63 (2020)." href="/articles/s41467-024-51831-7#ref-CR24" id="ref-link-section-d19463446e953">24</a></sup> via activation of the GP130-SRC-YAP pathway<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519, 5762 (2015)." href="/articles/s41467-024-51831-7#ref-CR12" id="ref-link-section-d19463446e957">12</a></sup>. In EGFR-mutant lung adenocarcinoma, the osimertinib-activated YAP-TEAD complex has been implicated in cellular dormancy and resistance<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Kurppa, K. J. et al. Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell 37, 104122.e112 (2020)." href="/articles/s41467-024-51831-7#ref-CR25" id="ref-link-section-d19463446e961">25</a></sup>. Studies of transcriptional profiling following EGFR-TKI treatment and animal models revealed that SOX2 is a key transcription factor (TF) in promoting neuroendocrine transformation<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Ferone, G. et al. SOX2 is the determining oncogenic switch in promoting lung squamous cell carcinoma from different cells of origin. Cancer Cell 30, 519532 (2016)." href="/articles/s41467-024-51831-7#ref-CR26" id="ref-link-section-d19463446e965">26</a></sup> and plasticity-reprogramming processes in lung cancer<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Boumahdi, S. &amp; de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat. Rev. Drug Discov. 19, 3956 (2020)." href="/articles/s41467-024-51831-7#ref-CR27" id="ref-link-section-d19463446e969">27</a></sup>, in which IL6<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Mosteiro, L. et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science 354, 6315 (2016)." href="/articles/s41467-024-51831-7#ref-CR28" id="ref-link-section-d19463446e974">28</a></sup> or YAP<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Bora-Singhal, N. et al. YAP1 regulates OCT4 activity and SOX2 expression to facilitate self-renewal and vascular mimicry of stem-like cells. Stem cells 33, 17051718 (2015)." href="/articles/s41467-024-51831-7#ref-CR29" id="ref-link-section-d19463446e978">29</a></sup> could be inducers. This evidence suggests that the IL6-YAP-SOX2 pathway may be an unrevealed axis that facilitates the development of lineage plasticity and EGFR TKI resistance in lung cancer. However, how IL6 differentially activates the JAK-STAT3 or SRC-YAP-SOX2 axis is not yet clear.</p><p>Multiple forms of IL6 ranging from 20 to 30kDa in molecular weight have been observed<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Poupart, P. et al. B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J 6, 12191224 (1987)." href="#ref-CR30" id="ref-link-section-d19463446e985">30</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="May, L. T. et al. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. Biochem. Biophys. Res. Commun. 152, 11441150 (1988)." href="#ref-CR31" id="ref-link-section-d19463446e985_1">31</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Hirano, T. et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl Acad. Sci. USA 82, 54905494 (1985)." href="#ref-CR32" id="ref-link-section-d19463446e985_2">32</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="May, L. T., Santhanam, U. &amp; Sehgal, P. B. On the multimeric nature of natural human interleukin-6. J. Biol. Chem. 266, 99509955 (1991)." href="/articles/s41467-024-51831-7#ref-CR33" id="ref-link-section-d19463446e988">33</a></sup>, but no alternatively spliced isoforms have been reported, suggesting that IL6 undergoes cell type-specific post-translational modification (PTM). As the most common PTM, glycosylation<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Mereiter, S., Balmana, M., Campos, D., Gomes, J. &amp; Reis, C. A. Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell 36, 616 (2019)." href="/articles/s41467-024-51831-7#ref-CR34" id="ref-link-section-d19463446e992">34</a></sup> has been observed in human macrophage-derived IL6<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Parekh, R. B., Dwek, R. A., Rademacher, T. W., Opdenakker, G. &amp; Van Damme, J. Glycosylation of interleukin-6 purified from normal human blood mononuclear cells. Eur. J. Biochem. 203, 135141 (1992)." href="/articles/s41467-024-51831-7#ref-CR35" id="ref-link-section-d19463446e996">35</a></sup> and Kaposis sarcoma-associated herpesvirus-encoded viral IL6 homolog<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Dela Cruz, C. S. et al. N-linked glycosylation is required for optimal function of Kaposis sarcoma herpesvirus-encoded, but not cellular, interleukin 6. J. Exp. Med. 199, 503514 (2004)." href="/articles/s41467-024-51831-7#ref-CR36" id="ref-link-section-d19463446e1000">36</a></sup>. In a Kaposis sarcoma model, N-glycosylation is necessary for viral IL6 but not human IL6 to activate JAK-STAT3 signaling<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Dela Cruz, C. S. et al. N-linked glycosylation is required for optimal function of Kaposis sarcoma herpesvirus-encoded, but not cellular, interleukin 6. J. Exp. Med. 199, 503514 (2004)." href="/articles/s41467-024-51831-7#ref-CR36" id="ref-link-section-d19463446e1004">36</a></sup>. Although aberrant protein glycosylation has been observed in various cancer types and shown to enhance or repress cellular signaling<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Thomas, D., Rathinavel, A. K. &amp; Radhakrishnan, P. Altered glycosylation in cancer: a promising target for biomarkers and therapeutics. Biochimica. et biophysica. Acta Rev. Cancer 1875, 188464 (2021)." href="/articles/s41467-024-51831-7#ref-CR37" id="ref-link-section-d19463446e1009">37</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Pinho, S. S. &amp; Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer 15, 540555 (2015)." href="/articles/s41467-024-51831-7#ref-CR38" id="ref-link-section-d19463446e1012">38</a></sup>, whether the glycosylation status of IL6 in human lung cancer influences its biological functions remains unclear. Likewise, whether EGFR-TKI treatment affects the glycosylation status of proteins in lung cancer cells is unresolved.</p><p>Because IL6 activates several signaling pathways through interaction with GP130 and glycosylation of IL6 may change its biological functions, we hypothesize that the glycosylation patterns of human IL6 (hIL6) may contribute to its preference for specific downstream signaling pathways. Here we demonstrate that IL6 secreted from human lung cancer cells is modified by N-glycosylation, and that N-glycosylation of IL6 occurs primarily at asparagine (N) 73 and activates the canonical JAK-STAT3 signaling pathway. In contrast, <u>N</u>-<u>g</u>lycosylation-<u>de</u>fective IL6 (deNG-IL6) switches the signaling preference to the SRC-YAP pathway, which facilitates SOX2 expression and enhances EMT, migration, and metastasis. Additionally, the N-glycosylation process is suppressed in osimertinib-treated lung cancer cells, resulting in an increased proportion of deNG-IL6 and the acquisition of cell plasticity and subsequent TKI resistance.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Results</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading" id="Sec3">IL6 Is Modified by N-Glycosylation in NSCLC</h3><p>We sought to investigate whether IL6 orchestrates multiple signaling pathways via differential glycosylation. Large quantities of IL6 in malignant pleural effusions (MPEs) have been reported in lung cancer patients<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Yeh, H. H., Lai, W. W., Chen, H. H., Liu, H. S. &amp; Su, W. C. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 25, 43004309 (2006)." href="/articles/s41467-024-51831-7#ref-CR39" id="ref-link-section-d19463446e1041">39</a></sup>; thus, we isolated lung adenocarcinoma cells from the MPEs (termed MPECs) of 15 NSCLC patients to study the glycosylation pattern of lung cancer cell-derived IL6. Short-term cultured MPECs were verified by double-positive expression of the NSCLC markers pancytokeratin (PanCK) and thyroid transcription factor-1 (TTF1) (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1a</a>). IL6 secreted by each MPEC line detected by Western blotting (WB) showed two IL6 bands [upper, <u>h</u>eavy form (H-IL6); lower, <u>l</u>ight form (L-IL6)] (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1b</a>), and the H/L intensity ratios differed among the MPECs. We next measured the amount of IL6 secreted by multiple NSCLC cell lines, including PC14PE6/AS2 (AS2), H1299, A549, H226, HCC827, H1975, H1650, and H460 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1c</a>), and examined the IL6 pattern in the cell lines with low baseline secretion (H1299) and high baseline secretion (H226, H1975, and H460). Similar to the results for the MPECs, both H-IL6 and L-IL6 were detected with different H/L IL6 ratios (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1d</a>). Since no alternatively spliced IL6 isoforms have been reported, we assumed that the proteins represented by the two bands resulted from the PTM of IL6.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="IL6 Is Modified by N-Glycosylation in NSCLC."><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1: IL6 Is Modified by N-Glycosylation in NSCLC.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig1_HTML.png?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="884"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p><b>a</b> Process of lung cancer cell isolation from malignant pleural effusions (MPEs) from lung cancer patients (generating MPE cells, MPECs). PanCK and TTF1 in MPECs were stained by immunofluorescence (IF). Images are representative of three technical replicates. Scale bar, 20m. <b>b</b> Pattern of immunoprecipitated (IP) secreted IL6 in the CM of MPECs (MPEC Nos. 1-12), as determined by Western blotting (WB). <i>n</i>=1. The same process was used to analyze secreted IL6 throughout the study. <b>c</b> Quantity of total secreted IL6 in the NSCLC cell lines as measured by ELISAs. <i>n</i>=3 technical replicates, meanSEM. <b>d</b> Patterns of secreted IL6 of NSCLC cell lines. <i>n</i>=3 independent experiments, meanSEM. <b>e</b> Gene set enrichment analysis (GSEA) enrichment plot of N-linked glycosylation in cancerous lung tissue vs. normal lung tissue in the dataset GSE31210. NES, Nominal Enrichment Score. Nominal <i>p-</i>value was one-tailed test on the appropriate side of the null distribution. <b>f</b> Pattern of secreted IL6 in H460 cells (<i>n</i>=3 independent experiments, meanSEM) and MPECs (MPEC No. 13, <i>n</i>=1) treated with or without NGI-1 (10M) for 48h. <b>g</b> Pattern of secreted IL6 in MPECs (MPEC Nos. 14 and 15) with or without PNGase F digestion (<i>n</i>=1). <b>h</b> <i>IL6</i> mRNA levels in the AS2 and HCC827 cells stably expressing full-length WT-hIL6 (namely, AS2-IL6-WT and HCC827-IL6-WT cells), as measured by RT-PCR. <i>GAPDH</i> was the internal control. <b>i</b> Quantity of total IL6 in the CM of AS2-IL6-WT and HCC827-IL6-WT cells, as measured by ELISAs (<i>n</i>=3 technical replicates, meanSEM). <b>j</b> Pattern of secreted IL6 in AS2-IL6-WT and HCC827-IL6-WT cells. The percentage proportions of H-IL6 and L-IL6 were quantified in the segmented histogram. <i>n</i>=3 independent experiments (meanSEM). <b>k</b> Effect of NGI-1 (10M) on the pattern of secreted IL6 in the CM of AS2-IL6-WT and HCC827-IL6-WT cells. <i>n</i>=3 independent experiments (meanSEM). <b>l</b> Quantitative characterization of N-glycans on purified secreted WT-IL6 from CM of AS2-IL6-WT cells by lectin microarray, as assessed with GlycoStation<sup>TM</sup> Reader 1200 (GlycoTechnica). The raw data was calculated and output automatically by GlycoStation Tools Pro Suite 1.5 software. <i>n</i>=3 technical replicates, meanS.D. See also Supplementary Table&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>. <b>m</b> Quantitative characterization of N-glycans on purified secreted WT-IL6 from CM of AS2-IL6-WT cells treated with NGI-1 (10M) by lectin microarray, as assessed with GlycoStation<sup>TM</sup> Reader 1200 (GlycoTechnica). The raw data was calculated and output automatically by GlycoStation Tools Pro Suite 1.5 software. <i>n</i>=3 technical replicates, meanS.D. See also Supplementary Table&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>N-glycosylation is the most common PTM of secreted proteins<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Roth, J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem. Rev. 102, 285303 (2002)." href="/articles/s41467-024-51831-7#ref-CR40" id="ref-link-section-d19463446e1182">40</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Bard, F. &amp; Chia, J. Cracking the glycome encoder: signaling, trafficking, and glycosylation. Trends Cell Biol. 26, 379388 (2016)." href="/articles/s41467-024-51831-7#ref-CR41" id="ref-link-section-d19463446e1185">41</a></sup>, and elevated protein N-glycosylation has been reported in various cancers<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. &amp; Clausen, H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell Biol. 21, 729749 (2020)." href="/articles/s41467-024-51831-7#ref-CR42" id="ref-link-section-d19463446e1189">42</a></sup>. We then analyzed the expression trend of N-linked glycosylation process-related genes by <u>g</u>ene <u>s</u>et <u>e</u>nrichment <u>a</u>nalysis (GSEA)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 1554515550 (2005)." href="/articles/s41467-024-51831-7#ref-CR43" id="ref-link-section-d19463446e1206">43</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267273 (2003)." href="/articles/s41467-024-51831-7#ref-CR44" id="ref-link-section-d19463446e1209">44</a></sup> of the Gene Expression Omnibus (GEO) dataset GSE31210<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Okayama, H. et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 72, 100111 (2012)." href="/articles/s41467-024-51831-7#ref-CR45" id="ref-link-section-d19463446e1213">45</a></sup> (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1e</a>). Genes involved in the N-linked glycosylation process were enriched in cancer tissues; thus, we hypothesized that H-IL6 arises from N-linked glycosylation. Notably, treatment with the N-glycosylation inhibitor NGI-1<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Lopez-Sambrooks, C. et al. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nat. Chem. Biol. 12, 10231030 (2016)." href="/articles/s41467-024-51831-7#ref-CR46" id="ref-link-section-d19463446e1220">46</a></sup> diminished the amount of secreted H-IL6 from H460 cells and MPECs (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1f</a>). When total MPEC-derived IL6 was treated with peptide-N-glycosidase F (PNGase F), which cleaves entire N-glycan chains from corresponding asparagine residues, the amount of H-IL6 was decreased (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1g</a>). In addition, two N-glycosites consisting of the Asn-Xaa-Ser/Thr sequence were predicted in the hIL6 protein sequence by the NetNGlyc 1.0 server (<a href="http://www.cbs.dtu.dk/services/NetNGlyc/">http://www.cbs.dtu.dk/services/NetNGlyc/</a>)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S. &amp; Brunak, S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4, 16331649 (2004)." href="/articles/s41467-024-51831-7#ref-CR47" id="ref-link-section-d19463446e1238">47</a></sup> (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>): asparagine (N) 73 and N172 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>, top). The score for only N73 exceeded the threshold score of 0.5 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>, bottom), indicating its potential as an N-glycosite. In addition, four O-glycosites (T166, T170, T171, and S174) were also predicted in IL6 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">2</a> and Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2a</a>); however, the MS data (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6l</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">22</a>) provided evidence that, actually, O-glycan was detected only on T170, which existed in over 99% of secreted IL6 molecules.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="N-glycosylated IL6 promotes the tyrosine phosphorylation and nuclear retention of STAT3."><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 2: N-glycosylated IL6 promotes the tyrosine phosphorylation and nuclear retention of STAT3.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig2_HTML.png?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig2_HTML.png" alt="figure 2" loading="lazy" width="685" height="893"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p><b>a</b> Graphical depiction of N- and O- glycosites on the full-length human IL6 (hIL6) peptide. <b>b</b> Patterns of IL6 with various mutations in N-glycosites. Secreted WT-IL6, N73Q-IL6, N172Q-IL6, and N73Q+N172Q-IL6 were quantified and immunoprecipitated, and the pattern of IL6 was analyzed on the same WB with rhIL6 expressed in <i>E. coli</i>. NG-IL6: <u>N</u>-<u>g</u>lycosylated IL6; deNG-IL6: <u>N</u>-<u>g</u>lycosylation- <u>de</u>fective IL6; deG-IL6: <u>g</u>lycosylation-<u>de</u>ficient IL6. The stick diagram connecting to each form of IL6 band labeled by dotted line showed the locations of glycan chains on N-glycosites and O-glycosites. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, ***<i>p</i>&lt;0.0001, *<i>p</i>=0.0182, ***<i>p</i>&lt;0.0001. <b>c</b> Patterns of secreted IL6 in AS2-IL6-WT, AS2-IL6-N73Q, AS2-IL6-N172Q, and AS2-IL6-N73Q+N172Q cells with or without NGI-1 (10M) pretreatment for 48h. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, n.s. <i>p</i>=0.3423, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001. <b>d</b> Quantitative characterization of N-glycans on purified secreted WT-IL6 and N73Q-IL6 by lectin microarray, as assessed with GlycoStation<sup>TM</sup> Reader 1200 (GlycoTechnica). The raw data was calculated and output automatically by GlycoStation Tools Pro Suite 1.5 software. <i>n</i>=3 technical replicates, meanS.D. See also Supplementary Table&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>. <b>e</b> STAT3 and STAT3-pY705 levels induced by WT-IL6-CM or N73Q-IL6-CM (both IL6=1ng/mL) over time in AS2-Vec, Beas-2B, and NL-20 cells. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, AS2-Vec: *<i>p</i>=0.0139, **<i>p</i>=0.0282, n.s. 0.3663, ***0.0001; NL20: **0.0029, ***0.0004, **0.0014, **0.0010; Beas-2B: **0.0054, n.s. 0.9142, ***0.0006, ***&lt;0.0001. The samples derived from the same experiment but different gels for STAT3 and STAT3-pY705 were processed in parallel. <b>f</b> STAT3 intracellular localization under treatment with WT-IL6-CM or N73Q-IL6-CM (both IL6=1ng/mL) over time in AS2-Vec cells, as determined by IF. The magnified insets show STAT3 localization at 24h. Scale bars, 20m. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, **<i>p</i>=0.0012, ***<i>p</i>=0.0002, n.s. <i>p</i>=0.0939, ***<i>p</i>=0.0001. <b>g</b> Transcriptome of AS2-Vec cells treated with WT-IL6-CM or N73Q-IL6-CM over time (see also Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">10</a>). Hierarchical clustering showed differentially expressed genes at 3h. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Moreover, we transfected AS2 and HCC827 cells (which produce relatively low amounts of IL6) with a plasmid harboring human wild-type IL6 (WT-IL6), establishing AS2-IL6-WT and HCC827-IL6-WT cells. In these cells, IL6 increased at both the mRNA (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1h</a>) and protein levels (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1i</a>), and both H-IL6 and L-IL6 were detected (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1j</a>), which was then verified by MALDI-TOF (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">3</a>). NGI-1 treatment reduced the levels of H-IL6 in both cell lines (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1k</a>), confirming the existence of N-glycosylation. IL6 isolated from AS2-IL6-WT cells (termed WT-IL6) was subjected to lectin microarray analysis. Significant signals were detected for N-glycan-binding lectins, including PSA, LCA, ECA, ConA, etc., suggesting that WT-IL6 carries N-glycan structures (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1l</a> and Supplementary Table&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>). These signals were greatly diminished for WT-IL6 isolated from NGI-1-pretreated AS2-IL6-WT cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1m</a>), confirming the existence of N-glycosylation in lung cancer cell-derived IL6.</p><h3 class="c-article__sub-heading" id="Sec4">N-glycosylated IL6 promotes the tyrosine phosphorylation and nuclear retention of STAT3</h3><p>Since IL6 is modified by N-glycosylation in lung cancer, we sought to explore its possible functional roles. To determine the dominant N-glycosite (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>, Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">2</a>, and Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2a</a>), we generated three mutant IL6 plasmids by site-directed mutagenesis, replacing asparagine with glutamine<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Yamaguchi, K. et al. Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties. J. Biol. Chem. 266, 2043420439 (1991)." href="/articles/s41467-024-51831-7#ref-CR48" id="ref-link-section-d19463446e1463">48</a></sup>, corresponding to the N-glycosylation-defective IL6s, namely, N73Q-IL6, N172Q-IL6 and N73Q+N172Q-IL6 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">4a</a>). Concurrently, AS2-IL6-N73Q cells, AS2-IL6-N172Q cells, and AS2-IL6-N73Q+N172Q cells were established. Secreted WT-IL6, N73Q-IL6, N172Q-IL6, and N73Q+N172Q-IL6 were quantified (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">4b, c</a>), immunoprecipitated, and examined by WB, along with <u>r</u>ecombinant <u>h</u>uman IL6 (rhIL6) expressed in <i>E. coli</i> (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>). The Western blot for rhIL6 showed a single band representing the non-glycosylated IL6, designated as <b>deG-IL6</b> (<u>g</u>lycosylation-<u>de</u>ficient IL6). The blot for WT-IL6 form contained two major bands, one strong L-IL6 band and one weak H-IL6 band (Figs.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1j</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>), in addition to a faint deG-IL6 band. Compared with the Western blot for WT-IL6, the blot for N73Q-IL6 form lost the H-IL6 band by over 97% (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>), but the results for N172Q-IL6 form exhibited only a slight reduction in the abundance of the H-IL6 band (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>). N172Q-IL6 form exhibited four bands on the Western blot: H-IL6, L-IL6, deG-IL6, and an additional faint band (labeled with an asterisk) between the H-IL6 and L-IL6 bands (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>). The pattern of N73Q+N172Q-IL6 form was similar to that of N73Q-IL6 form. These results showed that the glycoform of H-IL6 band carried only one N-glycan primarily located at N73, and such N-glycosylation is absent in L-IL6 band. Besides, there was no obvious IL6 band detected at a higher molecular weight (MW) than that of the H-IL6 band (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">4d</a>), suggesting that double N-glycosylated form at N73 and N172 may not exist in our IL6 samples. The stick diagram connected to each form of the IL6 band illustrated the actual locations of glycan chains on N-glycosites and O-glycosites (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>), as both H-IL6 and L-IL6 contained an O-glycan at T170, in accordance with the MS analysis (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6l</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">22</a>).</p><p>In addition, treatment with NGI-1 (10M) significantly reduced the abundance of the H-IL6 band (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2c</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">4d</a>). The patterns of IL6 isolated from AS2-IL6-WT cells pretreated with NGI-1 or treated with PNGase F (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2c</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">4d</a>) in vitro were similar to those of IL6 isolated from untreated AS2-N73Q-IL6 cells. In comparison, the pattern of IL6 isolated from AS2-IL6-N73Q cells was not changed by NGI-1 or PNGase F treatment. Furthermore, the N-glycan intensity of N73Q-IL6 in the lectin microarray analysis was obviously reduced by ~50%, as compared to that of WT-IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2d</a>).</p><p>Henceforth, we propose a nomenclature for each IL6 band based on its molecular weight position as depicted on the Western blot (from top to bottom), as follows: The H-IL6 band in Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1</a>, redefined in Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2</a>, possesses the highest molecular weight and is designated as <b>NG-IL6</b> for <u>N</u>-<u>g</u>lycosylated IL6. The majority of NG-IL6 glycoform carries glycans on N73+T170, while a minority carries glycans on N172+T170, albeit rarely detected. The L-IL6 band in Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1</a>, redefined in Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2</a>, is termed <b>deNG-IL6</b> for <u>N</u>-<u>g</u>lycosylation-<u>de</u>fective IL6, as the glycan chain resided solely on T170. Additionally, the IL6 band with the smallest molecular weight (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b, c</a>) is named <b>deG-IL6</b> (<u>g</u>lycosylation-<u>de</u>ficient IL6), indicating the absence of both N- and O-glycans. This form was observed in various glycosylation-defective IL6 variants (N73Q-IL6, N172Q-IL6, N73Q+N172Q-IL6) and rhIL6 from <i>E. coli</i>.</p><p>N-glycosylation modulates the functions of glycoproteins<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. &amp; Clausen, H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell Biol. 21, 729749 (2020)." href="/articles/s41467-024-51831-7#ref-CR42" id="ref-link-section-d19463446e1601">42</a></sup>. Based on protein sequence alignment (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">5a</a>) and the 3-D structure of hIL6 (1ALU, <a href="https://www.rcsb.org/structure/1ALU">https://www.rcsb.org/structure/1ALU</a>) and the IL6-GP80-GP130 hexameric complex (1P9M, <a href="https://www.rcsb.org/structure/1P9M">https://www.rcsb.org/structure/1P9M</a>) in the Protein Data Bank<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Bobby, R. et al. Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6. FEBS J. 281, 24712483 (2014)." href="/articles/s41467-024-51831-7#ref-CR49" id="ref-link-section-d19463446e1622">49</a></sup>, we found that the N73 residue was in space near both K47 (K74 in full-length IL6) in the AB loop and K151 (K178 in full-length IL6) in the E-helix within site III of hIL6<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Bobby, R. et al. Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6. FEBS J. 281, 24712483 (2014)." href="/articles/s41467-024-51831-7#ref-CR49" id="ref-link-section-d19463446e1627">49</a></sup>, which is located in the IL6-GP130 interface and thus essential for ligand-receptor binding (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">5b</a>). Hence, we hypothesized that the N-glycosylation of IL6 at N73 affects the interaction of IL6 with GP130.</p><p>Because we could not obtain sufficient amounts of either bioactive NG-IL6 or deNG-IL6, we used <u>c</u>onditioned <u>m</u>edium (CM) from AS2-IL6-WT cells (WT-IL6-CM) or AS2-IL6-N73Q cells (N73Q-IL6-CM) to treat AS2-Vec cells (transfected with empty vector), normal human bronchial NL-20 cells and Beas-2B cells for different durations. Before treatment, the IL6 content in each CM was measured by an ELISA (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">6a</a>) and adjusted to 1ng/mL (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">6b</a>). In addition, the cytokine array results demonstrated that the constituents and quantity of cytokines contained in both undiluted and diluted WT-IL6-CM and N73Q-IL6-CM were nearly the same and the differences were negligible (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">6c, d</a>); thus, the observed biological changes are likely induced primarily by different N-glycosylations of IL6.</p><p>WT-IL6-CM-induced STAT3-pY705 was clearly retained for 24h but not that of N73Q-IL6-CM, in both cancerous and normal cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2e</a>). Time-dependent IF imaging revealed that treatment with either WT-IL6-CM or N73Q-IL6-CM stimulated the nuclear import of STAT3 at 0.5h (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2f</a>). Notably, WT-IL6-CM induced significantly longer nuclear retention of STAT3 than N73Q-IL6-CM up to 24h (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2g</a>, magnified inset). The difference in the STAT3 nuclear retention time was concordant with the persistence of the active STAT3 signal observed by WB (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2e</a>), showing different dynamics of STAT3 activation induced by the two forms of IL6. The amount of active STAT3 at 0.5h was reduced by neutralizing antibodies against GP130 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">7</a>), GP80 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">8</a>), and IL6 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">9</a>), indicating that the IL6-GP80-GP130 axis mediates WT-IL6-CM- and N73Q-IL6-CM-triggered STAT3 signaling.</p><p>To assess the effects of differential STAT3 activation on transcriptional outcomes, we assessed changes in the transcriptome of the AS2-Vec cells induced by WT-IL6-CM or N73Q-IL6-CM from 0.5 to 24h by microarray. Genes with a <u>f</u>old <u>c</u>hange (FC) in expression &gt;1.5 after normalization to the control medium treatment value were clustered with GeneSpring software (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">10</a> and Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2g</a>). The heatmap showed that N73Q-IL6-CM triggered markedly different gene expression profiles with enhanced intensity, particularly at 3h, compared to WT-IL6-CM (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2g</a>). These results are not fully explained by dynamic changes in STAT3 activation, suggesting that deNG-IL6 induces pathways other than canonical JAK-STAT3 signaling to change the transcriptomic profiles.</p><h3 class="c-article__sub-heading" id="Sec5">deNG-IL6 induces gene signatures of EMT</h3><p>To explore the functional effects of deNG-IL6 on cell behaviors, we analyzed genes with N73Q-IL6-CM-induced differential expression with <u>I</u>ngenuity <u>P</u>athway <u>A</u>nalysis (IPA) software. IPA-built-in Disease or Functional Annotation (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3a</a>) predicted that the N73Q-IL6-CM-induced genes increased cell movement, migration, invasion, and EMT. Hierarchical clustering with GeneSpring showed that the expression of the top-ranked involved molecules was markedly increased by N73Q-IL6-CM, especially at 3h (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3b</a>), revealing that these genes may primarily contribute to metastasis. To further elucidate the functions of NG-IL6 and deNG-IL6, we analyzed the WT-IL6-CM- and N73Q-IL6-CM-induced transcriptomes by GSEA (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3c</a>). N73Q-IL6-CM induced an enriched expression of hallmark EMT-related genes compared to WT-IL6-CM.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="deNG-IL6 Induces EMT, Migration, and Metastasis in NSCLC."><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 3: deNG-IL6 Induces EMT, Migration, and Metastasis in NSCLC.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig3_HTML.png?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig3_HTML.png" alt="figure 3" loading="lazy" width="685" height="896"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p><b>a</b> IPA-identified Disease and Functional Annotation in the N73Q-IL6-CM-treated cells. A significant correlation was defined as <i>p</i>&lt;0.001, evaluated by a right-tailed Fishers Exact Test. <b>b</b> Hierarchical clustering of the IPA-enriched EMT/metastasis-related genes. <b>c</b> GSEA enrichment plot of EMT process-related genes in the AS2-Vec cells under WT-IL6-CM and N73Q-IL6-CM treatment. Nominal <i>p</i>-value was one-tailed test on the appropriate side of the null distribution. <b>d</b> The morphology of (bright field, left panel, scale bars, 200m) and F-ACTIN stress fibers (IF, right panel, scale bars, 20m) in AS2-Vec, Beas-2B, and NL-20 cells under WT-IL6-CM or N73Q-IL6-CM treatment (24h) are shown. F-ACTIN was stained with phalloidin-TRITC (gray) and detected with an FV3000 microscope (60x). <b>e</b> Expression of EMT-associated proteins in AS2-Vec cells treated with WT-IL6-CM or N73Q-IL6-CM for 24h. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, E-CADHERIN: ***<i>p</i>=0.0005; CLAUDIN1: ***<i>p</i>&lt;0.0001; SLUG: ***<i>p</i>&lt;0.0001; N-CADHERIN: ***<i>p</i>&lt;0.0001; -SMA: ***<i>p</i>&lt;0.0001; -ACTIN: n.s. <i>p</i>=0.9997. The samples derived from the same experiment but different gels for E-CADHERIN, CLAUDIN1, SLUG, N-CADHERIN, -SMA, and -ACTIN were processed in parallel. <b>f</b> Stress fibers in the AS2-Vec cells under N73Q-IL6-CM treatment (24h) with or without -GP130 neutralizing Ab pretreatment (2h). Images are representative of three independent experiments. Scale bars, 20m. See also Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">12</a>. <b>g</b> Expression of mesenchymal proteins in AS2-Vec cells under N73Q-IL6-CM treatment (24h) with -GP80, -IL6, and -GP130 neutralizing Ab pretreatment for 2h. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, SLUG: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; N-CADHERIN: ***<i>p</i>&lt;0.0001, ***<i>p</i>=0.0001, ***<i>p</i>&lt;0.0001; -SMA: ***<i>p</i>=0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; -ACTIN: n.s. <i>p</i>=0.9926, n.s. <i>p</i>=0.6517, n.s. <i>p</i>=0.8847. The samples derived from the same experiment but different gels for SLUG, N-CADHERIN, -SMA, and -ACTIN were processed in parallel. <b>h</b> Migration of AS2-Vec, AS2-IL6-WT, and AS2-IL6- N73Q cells through Transwell membranes <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, ***<i>p</i>=0.0001. <b>i</b> Migration of CL1-0 cells in a Transwell coculture system cocultured with AS2-Vec, AS2-IL6-WT, and AS2-IL6-N73Q cells. <i>n</i>=3 independent experiments, the percentage of migrated CL1-0 cells is presented as the meanSEM, two-tailed unpaired <i>t</i>-test, ***<i>p</i>&lt;0.0001. <b>j</b> In vivo metastasis of AS2-Vec, AS2-IL6-WT, and AS2-IL6-N73Q cells injected intravenously into nude mice (<i>n</i>=3 per cell type, 3 repeated independent experiments; see also Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">15</a>) evaluated by gross anatomical examination (left) and TissueFAXS-imaged H&amp;E staining (right). Each replicate experiment was terminated upon the death of the first animal; the necrotic lungs in these mice are indicated by dashed circles and were not used in further experiments. <b>k</b> The tumor area over the total lung area from (<b>J</b>), as quantified by HistoQuest. <i>n</i>=3 independent animals for each glycoform in each experiment, 3 independent experiments, meanSEM, two-way ANOVA. <b>l</b> In vivo metastasis of AS2-IL6-WT-pLuc and AS2-IL6-N73Q-pLuc cells in nude mice after i.v. injection (<i>n</i>=3 per cell type) detected with IVIS. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>We also characterized differentially expressed proteins in the AS2-IL6-WT and AS2-IL6-N73Q cells by two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">11a</a>). Four spots indicating proteins differentially overexpressed in the AS2-IL6-N73Q cells were identified. Spots 1 and 2 were mainly composed of cytoskeleton-related proteins (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">11b</a>), while a few mitochondrial proteins were characterized in spots 3 and 4.</p><h3 class="c-article__sub-heading" id="Sec6">deNG-IL6 promotes EMT, migration and metastasis in NSCLC</h3><p>To evaluate how the N-glycosylation status of IL6 influences the EMT behavior of stimulated cells, we treated AS2-Vec, NL-20, and Beas-2B cells with WT-IL6-CM or N73Q-IL6-CM for 24h, and phalloidin-stained ACTIN filaments (F-ACTIN) were observed by confocal microscopy. N73Q-IL6-CM induced a spindle-like morphology in all three cell types (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3d</a>). In the WT-IL6-CM-treated cells, the majority of ACTIN filaments (F-ACTIN) delineated intercellular tight junctions, and few F-ACTIN stress fibers were found within the cytosol. In contrast, an increased number of stress fibers across the entire cytosolic compartment was observed in the N73Q-IL6-CM-treated cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3d</a>, arrowheads), indicating that N-glycosylation-defective N73Q-IL6 possesses a strong EMT-promoting capacity.</p><p>We surveyed the expression of IL6-regulated EMT-related proteins in the AS2-Vec cells treated with WT-IL6-CM or N73Q-IL6-CM. Marked decreases in the levels of the epithelial proteins E-CADHERIN<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Xiong, H. et al. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J. Biol. Chem. 287, 58195832 (2012)." href="/articles/s41467-024-51831-7#ref-CR50" id="ref-link-section-d19463446e1919">50</a></sup> and CLAUDIN1<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Wei, W. et al. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer. Stem cells 32, 25712582 (2014)." href="/articles/s41467-024-51831-7#ref-CR51" id="ref-link-section-d19463446e1923">51</a></sup> and increases in the levels of the mesenchymal proteins SLUG<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Yao, C. et al. IGF/STAT3/NANOG/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer. Stem Cells 34, 820831 (2016)." href="/articles/s41467-024-51831-7#ref-CR52" id="ref-link-section-d19463446e1927">52</a></sup>, N-CADHERIN<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Na, Y. R., Lee, J. S., Lee, S. J. &amp; Seok, S. H. Interleukin-6-induced twist and N-cadherin enhance melanoma cell metastasis. Melanoma Res. 23, 434443 (2013)." href="/articles/s41467-024-51831-7#ref-CR53" id="ref-link-section-d19463446e1931">53</a></sup>, and -SMA<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Gallucci, R. M., Lee, E. G. &amp; Tomasek, J. J. IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. J. Invest. Dermatol. 126, 561568 (2006)." href="/articles/s41467-024-51831-7#ref-CR54" id="ref-link-section-d19463446e1935">54</a></sup> were observed in the N73Q-IL6-CM-treated cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3e</a>). Furthermore, blockade of GP130 with a neutralizing Ab reduced N73Q-IL6-CM-induced stress fiber formation (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3f</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">12</a>, arrowheads). Blockade of GP130 and GP80, as well as IL6 neutralization, effectively reduced the expression of mesenchymal proteins, including SLUG, N-CADHERIN, and -SMA (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3g</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">13</a>).</p><p>We next examined the migration of AS2-Vec, AS2-IL6-WT, and AS2-IL6-N73Q cells by Transwell assays. The AS2-IL6-N73Q cells demonstrated the strongest migratory capacity, followed by the AS2-IL6-WT cells and the AS2-Vec cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3h</a>), indicating that IL6 and, to a greater extent, deNG-IL6 enhance migration in an autocrine manner. To determine whether IL6 can promote the migration of neighboring cells in a paracrine manner, we cocultured CL1-0 cells (lung adenocarcinoma cells with low migratory potential) with AS2-Vec, AS2-IL6-WT, or AS2-IL6-N73Q cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3i</a>). Similar to the results above, CL1-0 cells cocultured with AS2-IL6-N73Q cells demonstrated the strongest migratory ability, followed by those cocultured with AS2-IL6-WT cells and those cocultured with AS2-Vec cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3i</a>). In addition, the migration capacity of AS2-IL6-N172Q cells was not significantly stronger than that of AS2-IL6-WT cells (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">14</a>). In contrast, the migration capacity of AS2-IL6- N73Q+N172Q cells was comparable to that of AS2-IL6-N73Q cells. These data provide good evidence that the deNG-IL6-mediated promotion of cell migration was attributed mainly to the loss of N-glycosylation on N73 and that the contribution of N-glycosylation on N172 was minimal.</p><p>We then assessed the in vivo metastatic potential of the AS2-Vec, AS2-IL6-WT, and AS2-IL6-N73Q cells (<i>n</i>=3 per group, triplicate). Cells were injected intravenously (i.v.) into nude mice, which were then observed daily. At the death of the first animal, all of the mice were euthanized, terminating the experiment. In each of three experiments, the first mouse that died was from the AS2-IL6-N73Q group. Upon gross anatomical examination (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3j</a>, left panel) and hematoxylin and eosin (H&amp;E) staining (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3j</a>, right panel), a marked increase in lung metastases was observed in the AS2-IL6-N73Q group. Because necropsy revealed that the lungs of the earliest succumbing mouse were necrotic (as indicated by the dashed circles; these lungs were not used for further analysis), only two lung sections from this group were analyzed (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3j</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">15</a>). Ratio of the <u>t</u>umor area to the total <u>l</u>ung area (T/L) in the mice was quantified with the TissueFAXS system and used to represent the lung metastatic capacity (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3k</a>). The AS2-IL6-N73Q group presented a remarkable average T/L value of 53.11%, consistent with the in vitro metastatic propensity (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3h</a>), while the AS2-Vec and AS2-IL6-WT groups presented mean T/L values of 3.2% and 0.65%, respectively. We also established AS2-IL6-WT-pLuc and AS2-IL6-N73Q-pLuc cells and evaluated in vivo metastasis by the IVIS system (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3l</a>). Similarly, the AS2-IL6-N73Q-pLuc cells showed a strong lung metastatic capacity. Collectively, our in vivo data suggest that deNG-IL6 potentiates lung cancer cell metastasis.</p><h3 class="c-article__sub-heading" id="Sec7">deNG-IL6 switches the GP130 signaling preference from the JAK-STAT3 axis to the SRC-YAP Axis</h3><p>Next, we sought to clarify the signaling downstream of deNG-IL6-GP130 that potentiates metastasis. Constitutively aberrant activation of STAT3 contributes to the migration and metastasis of cancer cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Yu, H., Lee, H., Herrmann, A., Buettner, R. &amp; Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 14, 736746 (2014)." href="/articles/s41467-024-51831-7#ref-CR1" id="ref-link-section-d19463446e2013">1</a></sup>. In addition to STAT3, IL6 activates ERK, AKT, and SRC via GP130<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Hunter, C. A. &amp; Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448457 (2015)." href="/articles/s41467-024-51831-7#ref-CR5" id="ref-link-section-d19463446e2017">5</a></sup>; thus, we examined the expression of the total and active forms of these effectors in both the AS2-IL6-WT cells and the AS2-IL6-N73Q cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4a</a>). Notably, higher levels of SRCpY416 were detected in the AS2-IL6-N73Q cells than in the AS2-IL6-WT cells, whereas ERK1/2, pERK, AKT, AKTpY308, and AKTpY473 showed comparable levels, suggesting the involvement of SRC in the deNG-IL6-induced alternative signaling pathway.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="deNG-IL6 Switches the GP130 Signaling Preference from the JAK-STAT3 Axis to the SRC-YAP Axis."><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 4: deNG-IL6 Switches the GP130 Signaling Preference from the JAK-STAT3 Axis to the SRC-YAP Axis.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig4_HTML.png?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig4_HTML.png" alt="figure 4" loading="lazy" width="685" height="837"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p><b>a</b> Expression of proteins indicating the activation of ERK, AKT, and SRC in AS2-Vec, AS2-IL6-WT, and AS2-IL6-N73Q cells. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, pERK: n.s. <i>p</i>=0.5646; ERK1/2: n.s. <i>p</i>=0.9914; AKTpY308: n.s. <i>p</i>=0.6477; AKTpS473: n.s. <i>p</i>=0.0967; AKT: n.s. <i>p</i>=0.7452; SRCpY416: ***<i>p</i>&lt;0.0001; SRC: n.s. 0.2598; -ACTIN: n.s. <i>p</i>=1.000. FC: fold change relative to AS2-IL6-WT. The samples derived from the same experiment but different gels for pERK, ERK1/2, AKTpY308, AKTpY473, AKT, SRCpY416, SRC, and -ACTIN were processed in parallel. <b>b</b> Hierarchical clustering of N73Q-IL6-induced genes downstream of SRC identified by IPA. <b>c</b> Recruitment of STAT3 and SRC to WT-IL6- and N73Q-IL6-activated GP130 determined based on IF images acquired with an FV3000 microscope (60x). Images are representative of three technical replicates. Scale bars, 20m. <b>d</b> Expression of proteins indicating the activation of STAT3 and SRC in the cytosolic and nuclear fractions of the AS2-IL6-WT and AS2-IL6-N73Q cells. <i>n</i> = 3 independent experiments,&nbsp;mean  SEM, two-tailed unpaired <i>t</i>-test, STAT3pY705:&nbsp;***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; STAT3: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; SRCpY416: ***<i>p</i>&lt;0.0001, **<i>p</i>=0.0065; SRC: ***<i>p</i>&lt;0.0001, **<i>p</i>=0.0075; LAMIN A/C: n.s. <i>p</i>=0.1567, n.s. <i>p</i>=1.0000; -ACTIN: n.s. <i>p</i>=1.0000, n.s. <i>p</i>=1.0000. FC: fold change relative to AS2-IL6-WT. The samples derived from the same experiment but different gels for STAT3pY705, STAT3, SRCpY416, SRC, LAMIN A/C, and -ACTIN were processed in parallel. <b>e</b> Effect of IL6 antibody (5g/mL), JAK-STAT3 inhibitors (S3I-201=10M, ruxolitinib=2.5M), and SRC inhibitors (PP1=10M, PP2=10M, tirbanibulin=10M) on the migration of AS2-IL6-WT and AS2-IL6-N73Q cells through the space made by culture inserts. Images were obtained at 0 and 24h. Scale bars, 200m. Quantitative results are next to the images. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, AS2-IL6-N73Q cells: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; AS2-IL6-WT cells: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, **<i>p</i>=0.0026, **<i>p</i>=0.0082, ***<i>p</i>&lt;0.0001. <b>f</b> Expression of SRC in the AS2-IL6-N73Q cells transduced with shSRC-bearing VSV-G particles. <i>n</i>=3 independent experiments, meanSEM, one-tailed unpaired <i>t</i>-test, SRCpY416: **<i>p</i>=0.0022, **<i>p</i>=0.0011; SRC: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; -ACTIN: n.s. <i>p</i>=0.4500, n.s. <i>p</i>=0.4267. FC: fold change relative to shpLKO.1. The samples derived from the same experiment but different gels for STAT3pY705, STAT3, SRCpY416, SRC, and -ACTIN were processed in parallel. <b>g</b> Migration of the <i>SRC</i>-silenced AS2-IL6-N73Q cells. Scale bars, 200m. <i>n</i>=3 independent experiments, meanSEM, one-tailed unpaired <i>t</i>-test, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001. <b>h</b> In vivo metastasis of SRC-silenced AS2-IL6-N73Q cells injected intravenously into nude mice (<i>n</i>=3 per cell type). TissueFAXS-acquired images of H&amp;E-stained lungs are shown (left). The tumor area over the total lung area was quantified by HistoQuest. <i>n</i>=3 animals in each group, meanSEM, one-tailed unpaired <i>t</i>-test, **<i>p</i>=0.0062, **<i>p</i>=0.0062. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Further IPA prediction showed that the SRC-regulated genes were notably elevated in the N73Q-IL6-CM-treated AS2-Vec cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4b</a>), suggesting that defective N-glycosylation of IL6 alters the preference of GP130 to activate its downstream signals. By IF imaging, we observed that WT-IL6-CM led GP130 to preferentially recruit STAT3 to the receptor complex (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4c</a>, left panel, merged image, light orange), while N73Q-IL6-CM triggered GP130 to alternatively recruit SRCs (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4c</a>, right panel, merged image, yellow), indicating that deNG-IL6 switches the effector preference of GP130 from STAT3 to SRC. In addition, an enriched amount of active STAT3 was observed in the AS2-IL6-WT cells, particularly in the nuclear lysates (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4d</a>). In comparison, the amount of active SRC was enriched in the cytosolic lysates of the AS2-IL6-N73Q cells. These observations were consistent with the signals of GP130-recruited intracellular STAT3 and SRC (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4c</a>), demonstrating that the pattern of N-glycosylation of IL6 influences the preference of downstream signals of GP130.</p><p>IL6 neutralization effectively inhibited the migration of AS2-IL6-N73Q (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4e</a>), AS2-Vec (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">16</a>), and AS2-IL6-WT cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4e</a>). To confirm the role of active SRC in N73Q-IL6-induced migration, we treated the AS2-Vec (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">16</a>), AS2-IL6-WT, and AS2-IL6-N73Q cells with the SRC inhibitors PP1, PP2, and tirbanibulin and assessed their migratory capacity (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4e</a>, upper panel). Compared to the mock control, the SRC inhibitors efficiently inhibited the migration of the AS2-IL6-N73Q cells, while the STAT3 inhibitor S3I-201 and the JAK2 inhibitor ruxolitinib showed modest inhibitory effects. In contrast, S3I-201 and ruxolitinib inhibited the migration of AS2-vec and AS2-IL6-WT cells more effectively than SRC inhibitors (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">16</a>), suggesting that STAT3 shows a lower contribution to migration than SRC does in AS2-IL6-N73Q cells. Silencing of SRC (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4f</a>) impeded the migration of the AS2-IL6-N73Q cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4g</a>). In addition, the in vivo metastases assessed by i.v. inoculation in nude mice showed that the AS2-IL6-N73Q cells transduced with empty vector (shpLKO.1 cells) demonstrated a strong metastatic capacity (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4h</a>), whereas both the SRC-sh1 and SRC-sh2 cells showed a significantly decreased number of lung metastatic foci and T/L ratio (68.95%, 0.04%, and 0.23%, respectively, <i>p</i>&lt;0.001, Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4h</a>). These data showed that the switch of the GP130 downstream effector to SRC is essential for deNG-IL6-induced metastasis.</p><p>To determine whether the glycan attached to N73 or N172 is accountable for the signaling switch, we evaluated the signaling expression in whole-cell lysates, as well as nuclear and cytosolic fractions, extracted from AS2-Vec cells, AS2-IL6-WT cells, AS2-IL6-N73Q cells, and AS2-IL6-N172Q cells. Compared to AS2-IL6-WT cells, a signaling shift from the JAK-STAT3 pathway to the alternatively activated SRC-YAP-SOX axis was exclusively observed in AS2-IL6-N73Q cells (but not in AS2-IL6-N172Q cells) in both whole-cell lysates (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">17a</a>) and nuclear (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">17b</a>) and cytosolic (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">17c</a>) fractions. These findings suggest that N-glycosylation on N73, rather than N172, is accountable for the switch in IL6 downstream signaling from the STAT3 axis to the SRC axis.</p><p>In addition, to confirm that the N-glycan but not the amino acid substitution changed the properties of IL6, we also established AS2 cells that stably expressed N73A-IL6 and N73V-IL6 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">18ac</a>). Compared to WT-IL6, both N73A-IL6 and N73V-IL6 demonstrated a decrease in NG-IL6 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">18c</a>), similar to N73Q-IL6. Both N73A-IL6-CM and N73V-IL6-CM induced similar patterns of STAT3 activation (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">18d</a>) and localization of STAT3 and SRC (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">18e</a>) as N73Q-IL6-CM. Furthermore, similar to AS2-IL6-N73Q cells, both AS2-IL6-N73A and AS2-IL6-N73V cells presented strong in vitro migratory (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">18f</a>) and in vivo metastatic capacities (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">18g, h</a>). The above findings indicated that the loss of N-glycosylation but not the change in amino acids on IL6 induces the signaling shift.</p><h3 class="c-article__sub-heading" id="Sec8">SOX2 contributes to deNG-IL6-induced SRC-YAP axis-promoted migration and metastasis</h3><p>Because YAP is a transcriptional regulator downstream of GP130-SRC<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519, 5762 (2015)." href="/articles/s41467-024-51831-7#ref-CR12" id="ref-link-section-d19463446e2340">12</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Romera-Hernandez, M. et al. Yap1-driven intestinal repair is controlled by group 3 innate lymphoid cells. Cell Rep. 30, 3745.e33 (2020)." href="/articles/s41467-024-51831-7#ref-CR55" id="ref-link-section-d19463446e2343">55</a></sup>, we analyzed our microarray data (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2h</a>) by GSEA, characterized the enriched YAP conserved signature in the N73Q-IL6CM-treated AS2-Vec cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5a</a>) and found that these cells exhibited elevated expression of YAP-regulated genes (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5b</a>). In addition, proteins of the YAP pathway, including YAP, LATS1, TAZ and MST1, were found to be activated and enriched in the nuclear fraction of the AS2-IL6-N73Q cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5c</a>), concordant with the elevated cytosolic active SRC (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig4">4d</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="SOX2 Contributes to deNG-IL6-Induced SRC-YAP Axis-Promoted Migration and Metastasis."><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 5: SOX2 Contributes to deNG-IL6-Induced SRC-YAP Axis-Promoted Migration and Metastasis.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig5_HTML.png?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig5_HTML.png" alt="figure 5" loading="lazy" width="685" height="889"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p><b>a</b> GSEA enrichment plot for the conserved YAP signature in the AS2-Vec cells under WT-IL6 and N73Q-IL6 treatment. Nominal <i>p-</i>value was one-tailed test on the appropriate side of the null distribution. <b>b</b> Hierarchical clustering of the N73Q-IL6-induced YAP downstream genes identified by IPA. <b>c</b> Expression of YAP pathway-associated proteins in the nuclear fraction of the AS2-IL6-WT and AS2- IL6-N73Q cells. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, YAPpY357: ***<i>p</i>&lt;0.0001; YAP: ***<i>p</i>&lt;0.0001; pLATS: ***<i>p</i>=0.0001; LATS1: ***<i>p</i>&lt;0.0001; pTAZ: ***<i>p</i>=0.0001; TAZ: ***<i>p</i>&lt;0.0001; MST1: ***<i>p</i>&lt;0.0001; LAMIN A/C: n.s. <i>p</i>=0.0779. FC: fold change relative to AS2-IL6-WT. The samples derived from the same experiment but different gels for YAPpY357, YAP, pLATS, LATS1, pTAZ, TAZ, MST1, and LAMIN A/C were processed in parallel. <b>d</b> Expression of stemness-associated proteins in the AS2-IL6-WT and AS2-IL6-N73Q cells. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, SOX2: ***<i>p</i>&lt;0.0001; NANOG: ***<i>p</i>&lt;0.0001; OCT3/4: ***<i>p</i>=0.0010; -ACTIN: n.s. <i>p</i>=0.9814. FC: fold change relative to AS2-IL6-WT. The samples derived from the same experiment but different gels for SOX2, NANOG, OCT3/4, and -ACTIN were processed in parallel. <b>e</b> Expression of stemness-associated proteins in the AS2-IL6-N73Q cells treated with YAPi VP at increasing doses. <i>n</i>=3 independent experiments, percentage expression relative to none, meanSEM, two-tailed unpaired <i>t</i>-test, YAP: ***<i>p</i>&lt;0.0001, **<i>p</i>=0.0013, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; TAZ: ***<i>p</i>=0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; SOX2: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; -ACTIN: n.s. <i>p</i>=0.5000, n.s. <i>p</i>=0.5000, n.s. <i>p</i>=0.5000, n.s. <i>p</i>=0.5000, n.s. <i>p</i>=0.5000, n.s. <i>p</i>=0.5000. The samples derived from the same experiment but different gels for YAP, TAZ, SOX2, and -ACTIN were processed in parallel. <b>f</b> Migration of the AS2-IL6-N73Q cells under VP treatment. <i>n</i>=3 independent experiments, meanSEM, one-tailed unpaired <i>t</i>-test, ***<i>p</i>&lt;0.0001. <b>g</b> Expression of the <i>YAP</i> gene (<b>g</b>) and YAP protein (<b>h</b>) in the AS2-IL6-N73Q cells transduced with shSRC-bearing VSV-G particles. <i>n</i>=3 independent experiments, percentage expression relative to shpLKO.1, meanSEM, one-tailed unpaired <i>t</i>-test, YAP: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; -ACTIN: n.s. <i>p</i>=0.5000, n.s. <i>p</i>=0.5000. The cDNA or protein samples derived from the same experiment but different gels for <i>YAP</i>, <i>GAPDH</i>, YAP, and -ACTIN were processed in parallel. <b>i</b> Migration of the <i>YAP</i>-silenced AS2-IL6-N73Q cells. Scale bars, 200m. <i>n</i>=3 independent experiments, meanSEM, one-tailed unpaired <i>t</i>-test, ***<i>p</i>=0.0001, ***<i>p</i>&lt;0.0001. <b>j</b> In vivo metastasis of the <i>YAP</i>-silenced AS2-IL6-N73Q cells injected intravenously into nude mice (<i>n</i>=3 per cell type). TissueFAXS-acquired images of H&amp;E-stained lungs are shown (left). The tumor area over the total lung area was quantified by HistoQuest. <i>n</i>=3 animals in each group, meanSEM, one-tailed unpaired <i>t</i>-test, **<i>p</i>=0.0015, **<i>p</i>=0.0015. <b>k</b> Expression of <i>SOX2</i> mRNA (<b>k</b>) and protein (<b>l</b>) in the <i>SOX2</i>-silenced AS2-IL6-N73Q cells. <i>n</i>=3 independent experiments, percentage expression relative to shpLKO.1, meanSEM, one-tailed unpaired <i>t</i>-test, SOX2: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; -ACTIN: n.s. <i>p</i>=0.5000, n.s. <i>p</i>=0.5000. The cDNA or protein samples derived from the same experiment but different gels for <i>SOX2</i>, <i>GAPDH</i>, SOX2, and -ACTIN were processed in parallel. <b>m</b> Migration of the <i>SOX2</i>-silenced AS2-IL6-N73Q cells. Scale bars, 200 m.&nbsp;<i>n</i>=3 independent experiments, meanSEM, one-tailed unpaired <i>t</i>-test, *** <i>p</i>&lt;0.0001, ***<i>p</i>=0.0001. <b>n</b> In vivo metastasis of the <i>SOX2</i>-silenced AS2-IL6-N73Q cells intravenously injected into nude mice (<i>n</i>=3 per cell type). TissueFAXS-acquired images of H&amp;E-stained lungs are shown (left). The tumor area over the total lung area was quantified by HistoQuest. <i>n</i>=3 animals in each group, meanSEM, one-tailed unpaired <i>t</i>-test, **<i>p</i>=0.0023, *<i>p</i>=0.0023. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Activated YAP promotes regeneration of the intestinal epithelium and enhances the expression and activity of stemness-related proteins, including SOX2, NANOG, and OCT3/4<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519, 5762 (2015)." href="/articles/s41467-024-51831-7#ref-CR12" id="ref-link-section-d19463446e2711">12</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Bora-Singhal, N. et al. YAP1 regulates OCT4 activity and SOX2 expression to facilitate self-renewal and vascular mimicry of stem-like cells. Stem cells 33, 17051718 (2015)." href="/articles/s41467-024-51831-7#ref-CR29" id="ref-link-section-d19463446e2714">29</a></sup>. SOX2 was markedly enriched in the AS2-IL6-N73Q cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5d</a>). To verify the role of YAP in deNG-IL6-promoted migration and metastasis, we treated the AS2-IL6-N73Q cells with the YAP inhibitor (YAPi) verteporfin (VP)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="Tsuji, T. et al. YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. Nat. Commun. 11, 74 (2020)." href="/articles/s41467-024-51831-7#ref-CR56" id="ref-link-section-d19463446e2721">56</a></sup>. VP simultaneously reduced the levels of YAP, TAZ, and downstream SOX2 in a dose-dependent manner (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5e</a>) and impeded the migration of the AS2-IL6-N73Q cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5f</a>). <i>YAP</i> silencing in the AS2-IL6-N73Q cells with VSV-Gs with two independent shRNAs led to a successful reduction in <i>YAP</i> at both the RNA (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5g</a>) and protein levels (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5h</a>). Compared to the shpLKO.1 cells, both the YAP-sh1 and YAP-sh2 cells exhibited impeded in vitro migration (28.85% and 50.48%, respectively, <i>p</i>&lt;0.001, Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5i</a>) and in vivo metastasis (0.004% and 0.008, respectively, <i>p</i>&lt;0.001, Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5j</a>).</p><p>We used the same strategy to further address the role of SOX2 in deNG-IL6-promoted migration and metastasis mediated through SRC and YAP. Similarly, SOX2 was successfully reduced at both the RNA and protein levels (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5k, l</a>). Both in vitro migration (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5m</a>) and in vivo metastasis (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5n</a>) were reduced in the <i>SOX2</i>-silenced SOX2-sh1 and SOX2-sh2 cells compared to the shpLKO.1 cells. By pharmaceutical and genetic inhibitory approaches, we demonstrated that deNG-IL6 promotes the migration and metastasis of lung cancer cells via a switch of GP130 downstream signaling from STAT3 to the SRC-YAP-SOX2 axis.</p><h3 class="c-article__sub-heading" id="Sec9">Osimertinib induces expression of deNG-IL6 and subsequent activation of the SRC-YAP-SOX2 axis</h3><p>Increased IL6 expression was reported in osimertinib-resistant NSCLC cells and patients<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Kim, S. M. et al. Activation of IL-6R/JAK1/STAT signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation. Mol. Cancer Ther. 11, 22542264 (2012)." href="/articles/s41467-024-51831-7#ref-CR22" id="ref-link-section-d19463446e2780">22</a></sup>, but glycosylation pattern and the biological properties of IL6 are unclear. To study this issue, we established osimertinib-resistant (OR) PC9 and HCC827 lung adenocarcinoma cell lines (PC9-OR and HCC827-OR cells, respectively) harboring mutant EGFR, and the resistance was maintained by constant culture in medium containing osimertinib (5 M). Compared to the corresponding parental cells (PC9-P and HCC827-P), PC9-OR and HCC827-OR cells exhibited increased resistance to osimertinib (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6a</a>) and elevated IL6 secretion (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6b</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">19</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-6" data-title="Inhibition of osimertinib-induced deNG-IL6 restores TKI sensitivity in TKI-resistant NSCLC."><figure><figcaption><b id="Fig6" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 6: Inhibition of osimertinib-induced deNG-IL6 restores TKI sensitivity in TKI-resistant NSCLC.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/6" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig6_HTML.png?as=webp"><img aria-describedby="Fig6" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig6_HTML.png" alt="figure 6" loading="lazy" width="685" height="877"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-6-desc"><p><b>a</b> Survival of parental and OR PC9 and HCC827 cells with osimertinib treatment (72h). <i>n</i>=6 independent experiments per data point, meanSEM. <b>b</b> Levels of IL6 secreted by the parental and OR PC9 and HCC827 cells after 72h of attachment. <i>n</i>=3 technical replicates, meanSEM, two-tailed unpaired <i>t</i>-test, PC9-OR: ***<i>p</i>&lt;0.0001; HCC827-OR: ***<i>p</i>&lt;0.0001. <b>c</b> mRNA expression of <i>IL6</i> in OR cells transduced with sh<i>IL6</i>-expressing VSV-G particles. The samples were derived from the same experiment for <i>IL6</i> and <i>GAPDH</i> were seperated in the same gel. <b>d</b> Quantity of total secreted IL6 in OR-sh<i>IL6</i> cells as measured by ELISAs. <i>n</i>=3 technical replicates, meanSEM, one-tailed unpaired <i>t</i>-test, PC9-OR: ***<i>p</i>&lt;0.0001; HCC827-OR: ***<i>p</i>&lt;0.0001. <b>e</b> Morphology of OR and OR-sh<i>IL6</i> cells treated with osimertinib (5M) for 72h. Scale bar, 100m. <b>f</b> Survival of PC9-OR-sh<i>IL6</i> and HCC827-OR-sh<i>IL6</i> cells treated with osimertinib at 5M (72h). <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, PC9-OR: ***<i>p</i>&lt;0.0001; HCC827-OR: ***<i>p</i>&lt;0.0001. <b>g</b> Pattern of secreted IL6 in the parental and OR PC9 and HCC827 cells. Because the PC9-P and HCC827-P cells secreted little IL6, which prevented analysis of its glycosylation pattern, we established PC9-IL6-WT and HCC827-IL6-WT cells as control cell lines. The proportions of heavy IL6 in these cells were quantified and are shown in the right panel. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, PC9-OR: ***<i>p</i>&lt;0.0001; HCC827-OR: ***<i>p</i>&lt;0.0001. <b>h</b> GSEA of N-linked glycosylation pathways and EMT, SRC and YAP activation statuses in the transcriptome dataset GSE106765 from the HCC827-OR-Taka cells. Nominal <i>p</i>-value was one-tailed test on the appropriate side of the null distribution. <b>i</b> Expression of N-OST genes in the parental and OR PC9 and HCC827 cells, as detected by qPCR. <i>n</i>=3 independent experiments, meanSEM, one-tailed unpaired <i>t</i>-test, PC9-OR: **<i>p</i>=0.0065, *<i>p</i>=0.0193, n.s. <i>p</i>=0.1579, ***<i>p</i>&lt;0.0001, **<i>p</i>=0.0099, **<i>p</i>=0.0047; HCC827-OR: 827-OR: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, *<i>p</i>=0.0160, ***<i>p</i>=0.004, **<i>p</i>=0.0025, **<i>p</i>=0.0014. <b>j</b> N-glycosylated IL6 detected by lectin blotting with <u>w</u>heat <u>g</u>erm <u>a</u>gglutinin (WGA). The proportions of WGA-detected NG-IL6 in WT-IL6 or OR-IL6 were quantified and are shown in the ri<u>g</u>ht p<u>a</u>nel. <i>n</i>=3 independent experiments, meanSEM, one-tailed unpaired <i>t</i>-test, PC9-OR: ***<i>p</i>&lt;0.0001; HCC827-OR: ***<i>p</i>&lt;0.0001. <b>k</b> Quantitative characterization of N-glycans on purified secre<i>t</i>ed WT-IL6 or OR-IL6 from CM of PC9 or HCC827 cell derivatives by lectin microarray, as assessed with GlycoStation<sup>TM</sup> Reader 1200 (GlycoTechnica). The raw data was calculated and output automatically by GlycoStation Tools Pro Suite 1.5 software. <i>n</i>=3 technical replicates, meanS.D. See also Supplementary Table&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">1</a>. <b>l</b> Characterization of glycosylation in IL6 by MS. See also Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">22</a>. <b>m</b> Pattern of secreted WT-IL6 or OR-IL6 with or without PNGase F digestion. The percentage proportions of H-IL6 and L-IL6 were quantified in the segmented histogram. <i>n</i>=3 independent experiments, meanSEM. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/6" data-track-dest="link:Figure6 Full size image" aria-label="Full size image figure 6" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>For determination of the function of osimertinib-induced IL6 in resistance, IL6 was inhibited by either an IL6-neutralizing antibody or shRNA against <i>IL6</i> in PC9-OR and HCC827-OR cells. The IL6 antibody reduced the survival of PC9-OR and HCC827-OR cells by ~15% at 20 g/mL in osimertinib-containing medium (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">20</a>). Silencing <i>IL6</i> successfully reduced the mRNA levels (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6c</a>) and secretion levels of IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6d</a>) and restored the sensitivity to osimertinib at tolerant concentrations of OR cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6e</a>). The survival was reduced to 57.2% and 16.5% in PC9-OR and HCC827-OR cells, respectively (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6f</a>). In summary, elevated IL6 secretion contributes to cellular resistance to osimertinib.</p><p>We next examined the pattern of IL6 glycoforms secreted by PC9-OR and HCC827-OR cells and the corresponding parental cell lines. Because the PC9-P and HCC827-P cells secreted little IL6, which prevented analysis of its glycosylation pattern, we established PC9-IL6-WT and HCC827-IL6-WT cells as control cell lines (Figs.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6g</a>, <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1j</a>). Both H-IL6 and L-IL6 were detected in the CM of the PC9-IL6-WT and HCC827-IL6-WT cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6g</a>, upper left and lower left). Unlike the distribution of H-IL6 and L-IL6 in the parental cells, almost all the IL6 secreted by the PC9-OR and HCC827-OR cells was L-IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6g</a>, upper right and lower right), similar to the distribution of deNG-IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1k</a>). Therefore, we hypothesized that long-term EGFR-TKI exposure may influence the expression of oligosaccharyltransferases for N-glycosylation (N-OSTs) and then interfere with the N-glycosylation process on IL6.</p><p>We then analyzed the transcriptome profile of HCC827 cells with or without acquired osimertinib resistance established by Takahashi (renamed P-Taka or OR-Taka, GSE106765)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Takahashi, A. et al. Ankyrin repeat domain 1 overexpression is associated with common resistance to afatinib and osimertinib in EGFR-mutant lung cancer. Sci. Rep. 8, 14896 (2018)." href="/articles/s41467-024-51831-7#ref-CR57" id="ref-link-section-d19463446e3072">57</a></sup>. The expression of N-glycosylation-related genes was enriched in the osimertinib-sensitive P-Taka cells but downregulated in the OR-Taka cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6h</a>), where genes involved in signatures of EMT and activation of SRC and YAP were enriched in the OR-Taka cells, indicating that osimertinib concomitantly reduced the expression of N-OSTs and enhanced SRC-YAP-regulated cellular plasticity to mediate metastasis and resistance. We also analyzed datasets from lung cancer cells treated with other EGFR TKIs (gefitinib, afatinib, erlotinib, and WZ4002) published by other groups (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">21</a>). Decreased N-glycosylation accompanied by increased EMT and SRC-YAP activation gene sets was also observed in the lung cancer cells treated with EGFR-TKIs, indicating that TKI treatment stress may repress the N-glycosylation process in lung cancer cells.</p><p>The most common N-glycosylation-related <u>N</u>-<u>o</u>ligo<u>s</u>accharide<u>t</u>ransferase (N-OST) genes include the enzymatically active subunits <i>STT3A</i> and <i>STT3B</i> and the cooperative scaffold members <i>RPN1</i>, <i>RPN2</i>, <i>DAD1</i>, and <i>DDOST</i><sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Lopez-Sambrooks, C. et al. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nat. Chem. Biol. 12, 10231030 (2016)." href="/articles/s41467-024-51831-7#ref-CR46" id="ref-link-section-d19463446e3117">46</a></sup>. We compared their mRNA levels in our PC9-OR and HCC827-OR cells versus the parental cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6i</a>). All of the N-OST genes showed significantly downregulated expression in the OR cells, explaining their generation of L-IL6. To determine whether the main component of OR-IL6 was deNG-IL6, we analyzed IL6 from PC9-IL6-WT, PC9-OR, HCC827-IL6-WT, and HCC827-OR cells by lectin blotting probed with wheat-germ-agglutinin (WGA), which recognizes N-acetylglutamate on the target protein (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6j</a>). WT-IL6 from PC9 and HCC827 cells showed positive bands, suggesting that they harbor N-glycosylation. In comparison, the band density suggested that NG-IL6 was reduced by ~80% in both OR cell lines. Furthermore, we analyzed the N-glycans on WT-IL6 and OR-IL6 with a lectin microarray. Because PC9-OR cells secreted a much lower level of IL6 than HCC827-OR cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6b</a>), we only analyzed the N-glycans on WT-IL6 and OR-IL6 from the HCC827 cell series (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6k</a>). We further employed MS to examine the glycosylation status of WT-IL6 and OR-IL6. Purified WT-IL6 and OR-IL6 were subjected to digestion with the protease Glu-C or trypsin to generate IL6 peptides containing N73 or N172, respectively. N-glycans were subsequently removed by treatment with PNGase F. Digested IL6 samples were analyzed by LC-ESI-MS (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">22</a>). Both WT-IL6 and OR-IL6 were found to contain three glycosylation sites: N73, N172 and T170 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">22</a> and Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6l</a>). However, these three sites are not homogeneously glycosylated: 28% and 20% of WT-IL6 and OR-IL6 proteins were glycosylated at N73, respectively, i.e., OR-IL6 displayed a 29% reduction in N73 glycosylation compared to WT-IL6. In contrast, there were no significant differences in the percentages of proteins glycosylated at either N172 or T170. The glycosylation percentage was minimal at N172 (4% and 3% of WT-IL6 and OR-IL6, respectively), whereas glycosylation was prevalent at T170 (&gt;99% and 96% of WT-IL6 and OR-IL6, respectively).</p><p>Based on the MS data, there are presumably four distinct glycoforms of WT-IL6. Twenty-eight percent of WT-IL6 molecules exhibit diglycosylation at N73+T170, corresponding to H-IL6 and NG-IL6. Sixty-eight percent of WT-IL6 molecules show monoglycosylation at T170, represented by L-IL6 and deNG-IL6. The remaining 4% of WT-IL6 molecules may contain either two (at N172+T170) or three (at N73+N172+T170) glycan chains. However, owing to the limited recognition sites of proteases, the precise percentages of IL6 with single or double N-glycosylation could not be determined simultaneously with the peptide products from a single digestion. The conclusion appears to be consistent with the results of the WB shown in Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6g</a>. In the Western blots, two prominent bands corresponding to WT-IL6 were observed: a dense L-IL6 band indicative of deNG-IL6 and the H-IL6 band representing NG-IL6. Notably, no discernible band was detected at a higher molecular weight than the H-IL6 band (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b, c</a>), suggesting that the quantity of heavily glycosylated IL6 (at N73+N172+T170) must be below the detection limit and was too low to be detected. When treated with PNGase F (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6m</a>), the heavy forms of WT-IL6 were reduced in both the PC9 and HCC827 cell series, whereas little influence was observed in that of OR-IL6. These data provide evidence that OR-IL6 is poorly N-glycosylated.</p><p>Cytokine array analysis demonstrated that IL6 is predominantly differentially expressed in the CM from OR cells compared to parental cells (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">19</a>). To assess the effect of OR-IL6 on STAT3 signaling, we treated PC9-P and HCC827-P cells with WT-IL6-CM (adjusted to 1ng/mL) from PC9-IL6-WT and HCC827-IL6-WT cells, respectively, or OR-IL6-containing CM (adjusted to 1ng/mL) from PC9-OR and HCC827-OR cells, respectively. WT-IL6-CM induced a stronger intensity of the STAT3-pY705 band at 24h than that induced by OR-CM (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7a</a>) in both cell lines. Time-dependent IF imaging revealed that treatment with either WT-IL6-CM or OR-CM stimulated the nuclear import of STAT3 (magenta) at 0.5h (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7b</a>). Notably, WT-IL6-CM induced significantly longer nuclear retention of STAT3 than OR-CM up to 24h (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7b</a>, magnified inset), whereas OR-CM stimulated stronger cell surface recruitment of SRC (green) than WT-IL6-CM throughout the time course, indicating that OR-IL6, with lower N-glycosylation, tends to activate SRC rather than STAT3 signals. This signaling alteration was also observed in the OR cells compared to their corresponding parental cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7c</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-7" data-title="Osimertinib-induced deNG-IL6 activates the SRC-YAP-SOX2 axis and migration in TKI-resistant NSCLC."><figure><figcaption><b id="Fig7" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 7: Osimertinib-induced deNG-IL6 activates the SRC-YAP-SOX2 axis and migration in TKI-resistant NSCLC.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/7" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig7_HTML.png?as=webp"><img aria-describedby="Fig7" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig7_HTML.png" alt="figure 7" loading="lazy" width="685" height="889"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-7-desc"><p><b>a</b> STAT3 and STAT3-pY705 levels induced by PC9-IL6-CM, PC9-OR-CM, HCC827-IL6-CM, or HCC827-OR-CM (IL6=1ng/mL) over time in PC9-P or HCC827-P cells. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, PC9: ***<i>p</i>&lt;0.0001, **<i>p</i>=0.0044, ***<i>p</i>&lt;0.0001, ***<i>p</i>=0.0001; HCC-827: *<i>p</i>=0.0324, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001. The samples derived from the same experiment but different gels for STAT3 and STAT3-pY705 were processed in parallel. <b>b</b> Intracellular localization of STAT3 and SRC in PC9-P or HCC827-P cells treated with PC9-IL6-CM, PC9-OR-CM, HCC827-IL6-CM, or HCC827-OR-CM (IL6=1ng/mL) over time, as determined by IF. The magnified insets show STAT3 or SRC localization at 24h. Scale bars, 20m. <i>n</i>=3 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, PC9-STAT3: **<i>p</i>=0.0085, ***<i>p</i>=0.002, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; PC9-SRC: ***<i>p</i>=0.0002, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001, ***<i>p</i>=0.0002; HCC827-STAT3: n.s. <i>p</i>=0.1262, **<i>p</i>=0.0018, **<i>p</i>=0.0025, ***<i>p</i>=0.0001; HCC827-SRC: n.s. <i>p</i>=0.0803, ***<i>p</i>=0.0007, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001. <b>c</b> Intracellular localization of STAT3 and SRC in PC9-OR and HCC827-OR cells as determined based on IF images acquired with an FV3000 microscope (60x). Images are representative of <i>n</i>=3 independent experiments. Scale bars, 20m. <b>d</b> Expression of proteins indicating the activation of SRC and YAP in the cytosolic and nuclear fractions of the parental and OR PC9 and HCC827 cells. <i>n</i>=3 independent experiments, expression fold change (FC) relative to corresponding parental cells, meanSEM, two-tailed unpaired <i>t</i>-test, PC9-SRCpY416: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; PC9-SRC: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; PC9-YAPpY357: ***<i>p</i>&lt;0.0001, ***p&lt;0.0001; PC9-YAP: ***<i>p</i>&lt;0.0001, ***<i>p</i>=0.0004; HCC827-SRCpY416: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; HCC827-SRC: n.s. <i>p</i>=0.8569, ***<i>p</i>&lt;0.0001; HCC827-YAP-pY357: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001; HCC827-YAP: ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001. The samples derived from the same experiment but different gels for SRCpY416, SRC, YAPpY357, YAP, -ACTIN, and LAMIN A/C were processed in parallel. <b>e</b> Time-dependent survival of the PC9-OR and HCC827-OR cells under treatment with osimertinib (5M) in combination with VP (5M). <i>n</i>=4 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, PC9-OR: n.s. <i>p</i>=0.7764, ***<i>p</i>=0.0006, ***<i>p</i>=0.0001; HCC827-OR: n.s. <i>p</i>=0.9049, ***<i>p</i>&lt;0.0001, ***<i>p</i>&lt;0.0001. <b>f</b> Analysis of the synergistic effect in PC9-OR and HCC827-OR cells treated with osimertinib in combination with DMSO or VP at various concentration combinations by Synergy Finder Plus under the two-tailed Zero interaction potency (ZIP) model. <b>g</b> Migration of PC9-IL6, PC9-OR, HCC827-IL6, and HCC827-OR cells through Transwell membranes. <i>n</i>=4 independent experiments, meanSEM, two-tailed unpaired <i>t</i>-test, PC9: ***<i>p</i>=0.0001, HCC827: ***<i>p</i>&lt;0.0001. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/7" data-track-dest="link:Figure7 Full size image" aria-label="Full size image figure 7" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>We further examined the expression of proteins involved in SRC-YAP signaling in the OR cells and the corresponding parental cells (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7d</a>). Compared to the PC9-P cells, the PC9-OR cells had an increased amount of SRCpY416 in the cytosol. In addition, in the PC9-OR cells, the levels of YAPpY357 were increased in both the cytosolic and nuclear fractions. Similarly, the levels of cytosolic SRCpY416 and YAPpY357 and nuclear YAP and YAPpY357 were elevated in the HCC827-OR cells compared to the HCC827-P cells. Next, to evaluate the requirement of YAP in osimertinib resistance, we treated the PC9-OR and HCC827-OR cells with fixed-dose osimertinib (5 M) in combination with the YAP inhibitor (YAPi) verteporfin (VP) at 5 M for different durations (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7e</a>). VP significantly increased sensitivity to osimertinib in PC9-OR and HCC827-OR cells in a time-dependent manner (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7e</a>). When the OR cells were simultaneously treated with osimertinib and the YAPi at various concentration combinations, a synergistic cytotoxic effect (as determined by Synergy Finder Plus: <a href="http://www.synergyfinderplus.org/">http://www.synergyfinderplus.org/</a>)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Zheng, S. et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genom. Proteom. Bioinform. 20, 587596 (2022)." href="/articles/s41467-024-51831-7#ref-CR58" id="ref-link-section-d19463446e3418">58</a></sup> was observed (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7f</a>), indicating that YAP is essential to the maintenance of osimertinib resistance. With the evidence that deNG-IL6-mediated SRC-YAP activation promotes cell migration (Figs.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig3">3</a><a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig5">5</a>), we assessed the effects of OR-IL6 on cell migration (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7g</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">23</a>). The PC9-OR and HCC827-OR cells showed stronger migratory capacities than the PC9-IL6-WT and HCC827-IL6-WT cells, respectively. These data suggest that deNG-IL6 secreted by OR cells not only sustains cell survival (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6e, f</a>) but also favors cell migration (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig7">7g</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">23</a>).</p><p>To demonstrate the presence of deNG-IL6 in NSCLC patients, we isolated MPECs from MPEs of patients who were nave (before treatment) or resistant (after development of resistance) to EGFR TKIs and performed short-term culture (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">24</a>). Secreted IL6 in the CM was collected by IP and analyzed by WB. TKI-nave MPECs secreted more H-IL6 than L-IL6, whereas the majority of IL6 from TKI-resistant MPECs was L-IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8a</a>). Because the quantity of MPEC-derived IL6 was not enough for lectin array analysis, we analyzed them by WGA blotting. Only H-IL6 from TKI-nave MPECs was detected by WGA blotting (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8b</a>). Quantification results showed a reduction in the proportion of NG-IL6 and an increase in deNG-IL6 in the CM of EGFR TKI-resistant MPECs (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8c</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-8" data-title="EGFR TKI-resistant NSCLC patients show high deNG-IL6 expression and a shift signaling preference from JAK-STAT3 to the SRC-YAP axis."><figure><figcaption><b id="Fig8" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 8: EGFR TKI-resistant NSCLC patients show high deNG-IL6 expression and a shift signaling preference from JAK-STAT3 to the SRC-YAP axis.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/8" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig8_HTML.png?as=webp"><img aria-describedby="Fig8" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig8_HTML.png" alt="figure 8" loading="lazy" width="685" height="925"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-8-desc"><p><b>a</b> Pattern of secreted IL6 in MPECs derived from MPE of EGFR-TKI-nave (TN01-TN04) and EGFR-TKI-resistant (TR01-TR05) patients as detected by WB (<i>n</i>=1). <b>b</b> N-glycosylated IL6 detected by lectin blotting with WGA (n=1). <b>c</b> Percentage proportions of NG-IL6 and deNG-IL6 in the CM of EGFR-TKI-nave and EGFR-TKI-resistant MPECs (<i>n</i>=1). <b>d</b> GSEA enrichment plot showing genes related to the N-glycosylation process derived from transcriptome data for patient tumors before and after the development of osimertinib resistance<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Zheng, S. et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genom. Proteom. Bioinform. 20, 587596 (2022)." href="/articles/s41467-024-51831-7#ref-CR58" id="ref-link-section-d19463446e3493">58</a></sup> named OSTu and ORTu, respectively. Sequential process by which 15 patients were selected according to the indicated criteria (left panel). The right panel shows the GSEA enrichment plots for N-glycosylation signature genes (right panel, top) and heatmaps for the enrichment scores (right panel, bottom) of selected patients (determined by Morpheus). Nominal <i>p</i>-value was one-tailed test on the appropriate side of the null distribution. <b>e</b> Expression and intracellular location of STAT3 and SRC in paired lung cancer tissues from six NSCLC patients (TKI_01-TKI_06) before (TKI-nave) and after development of resistance (TKI resistant) to EGFR TKI as determined by TissueFAXS-imaged IF (see also Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">28</a> for H&amp;E staining). The paired tissues from the same patient were attached to the same slide to perform IF staining. Images are selected magnified region from the full tissue. Scale bars, 20m. <b>f</b> Expression of nuclear STAT3 and membranous SRC as quantified by TissueQuest. Source data are provided as a Source Data file.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/8" data-track-dest="link:Figure8 Full size image" aria-label="Full size image figure 8" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>To elucidate the clinical correlation between the reduced expression of N-OSTs and osimertinib resistance, we analyzed online-available RNA sequencing (RNA-seq) data obtained from the lung tumors of fifteen patients who received osimertinib treatment<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Roper, N. et al. Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer. Cell Rep. Med. 1, 10007 (2020)." href="/articles/s41467-024-51831-7#ref-CR59" id="ref-link-section-d19463446e3520">59</a></sup> and developed resistance. Of the fifteen RNA-seq datasets, only ten provided paired data of tumors collected before and after the acquisition of resistance (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">25</a>), corresponding to <u>o</u>simertinib-<u>s</u>ensitive (OS) or OR tumors, namely, OSTu and ORTu, respectively. Notably, GSEA showed that the N-glycosylation process was enhanced in OSTu and decreased in ORTu (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8d</a>, upper right).</p><p>Resistance mechanisms of the ORTu were characterized by <u>w</u>hole-<u>e</u>xome <u>s</u>equencing (WES)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Roper, N. et al. Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer. Cell Rep. Med. 1, 10007 (2020)." href="/articles/s41467-024-51831-7#ref-CR59" id="ref-link-section-d19463446e3549">59</a></sup>. In most cases, resistance was acquired via known genomic alterations, such as <i>EGFR</i> C797S and the amplification of <i>KRAS</i> and <i>MET</i> (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">25</a>), whereas some developed through an undefined mechanism. We excluded ORTus that harbored known genomic mutations and obtained a group of three datasets from three patients: LAT010 (mixed NSCLC and SCLC transformation), LAT011 (<u>n</u>euro<u>e</u>ndocrine differentiation, NE), and LAT017 (<i>EGFR</i> and <i>YES1</i> amplification). LAT010 and LAT011 were categorized as EMT-related cases based on transformation to the aggressive NE subtype<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Quintanal-Villalonga, A. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat. Rev. Clin. Oncol. 17, 360371 (2020)." href="/articles/s41467-024-51831-7#ref-CR13" id="ref-link-section-d19463446e3579">13</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Sequist, L. V. et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci. Transl. Med. 3, 75ra26 (2011)." href="/articles/s41467-024-51831-7#ref-CR18" id="ref-link-section-d19463446e3582">18</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Williams, E. D., Gao, D., Redfern, A. &amp; Thompson, E. W. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nat. Rev. Cancer 19, 716732 (2019)." href="/articles/s41467-024-51831-7#ref-CR20" id="ref-link-section-d19463446e3585">20</a></sup>.</p><p>We then analyzed the enrichment in six gene sets of interest related to the N-glycosylation process, EMT, and SRC-YAP-related signaling by single-sample GSEA (ssGSEA)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108112 (2009)." href="/articles/s41467-024-51831-7#ref-CR60" id="ref-link-section-d19463446e3592">60</a></sup>. The ssGSEA scores for these processes for each patient were compiled into a heatmap. Compared to the OSTu, the ORTu in the three patients exhibited a decreased N-glycosylation process and enhanced EMT traits and SRC-YAP signaling (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8d</a>, lower right). This difference was more pronounced after subtracting the ssGSEA scores from the OSTu. Among the three patients, the most significant difference between OSTu and ORTu was observed in patient LAT017, who showed <i>YES1</i> amplification (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">25</a>).</p><p>YES1 is an SRC family kinase that phosphorylates YAP at Y357, promoting its nuclear translocation and transcriptional activity and thus facilitating the progression of cancer<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Heinz, M. C. et al. Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage. Cancer Res. 82, 19531968 (2022)." href="/articles/s41467-024-51831-7#ref-CR61" id="ref-link-section-d19463446e3608">61</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Hamanaka, N. et al. YES1 is a targetable oncogene in cancers harboring YES1 gene amplification. Cancer Res. 79, 57345745 (2019)." href="/articles/s41467-024-51831-7#ref-CR62" id="ref-link-section-d19463446e3611">62</a></sup>. Based on this information and because we demonstrated that deNG-IL6 triggers EMT and metastasis via alternative activation of the SRC-YAP-SOX2 axis in previous experiments, we further analyzed the RNA-seq data from patient LAT017 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">26a</a>). Consistent with our in vitro and in vivo data, the expression of N-glycosylation-related genes was reduced after acquisition of osimertinib resistance; moreover, signatures of EMT and activation of the SRC and YAP pathways were simultaneously enriched (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">26a</a>). We also analyzed the expression of transcription factors (TFs) within the 1K bases upstream of six N-OST genes in patient LAT017 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">26b, c</a>) and revealed concordant downregulation of TF expression in the ORTu (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">26d</a>).</p><p>We further used paired lung cancer tissues obtained at EGFR-TKI-nave and EGFR-TKI-resistant statuses from six patients (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">27</a>, Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">28</a>, and Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8e</a>). In the EGFR-TKI-nave tissues, we observed strong nuclear STAT3 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8e</a>, upper panel) but weak membranous SRC expression. In contrast, in the EGFR-TKI-resistant group, the expression of membranous SRC was prominent, and nuclear STAT3 staining was barely observed. (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8e</a>, lower panel). The difference was highlighted by TissueQuest quantification (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8f</a>).</p><p>In summary, we demonstrated that in NSCLC, IL6 undergoes N-glycosylation primarily at the N73 residue and O-glycosylation at the T170 residue. The loss of glycan on N73 leads to a switch of downstream signal preference from the JAK-STAT3 axis to the SRC-YAP-SOX2 axis, thereby triggering cell plasticity. Additionally, we have uncovered a bypass mechanism that drives osimertinib resistance by reducing the N-glycosylation of IL6, consequently shifting the survival-dependent pathway from the JAK-STAT3 axis to the SRC-YAP-SOX2 axis (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig9">9</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-9" data-title="Long-Term EGFR TKI Treatment Induces deNG-IL6 to Drive Resistance."><figure><figcaption><b id="Fig9" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 9: Long-Term EGFR TKI Treatment Induces deNG-IL6 to Drive Resistance.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/9" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig9_HTML.png?as=webp"><img aria-describedby="Fig9" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig9_HTML.png" alt="figure 9" loading="lazy" width="685" height="709"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-9-desc"><p>In non-small cell lung cancer (NSCLC) cells, autocrine IL6 (NG-IL6) predominantly exhibits N-glycosylation at residue N73 and O-glycosylation at residue T170 in an EGFR TKI-nave environment. NG-IL6 predominantly activates the canonical JAK-STAT3 axis, promoting cell proliferation. However, long-term treatment with EGFR TKIs leads to increased secretion of IL6 while concurrently suppressing the expression of N-glycosyltransferase complex components, primarily STT3A or STT3B, RPN1/2, DAD1, and DDOST. This suppression results in diminished N-glycosylation at N73 of NG-IL6, which subsequently reduces N-glycosylation at N73 of NG-IL6. Consequently, the proportion of NG-IL6 decreases, while the proportion of deNG-IL6 increases upon the acquisition of resistance. deNG-IL6, in turn, shifts signaling preference from the JAK-STAT3 axis to the SRC-YAP-SOX2 axis. The alternatively activated SRC-YAP-SOX2 signaling facilitates cellular plasticity and contributes to the development of drug resistance.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41467-024-51831-7/figures/9" data-track-dest="link:Figure9 Full size image" aria-label="Full size image figure 9" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec10-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec10">Discussion</h2><div class="c-article-section__content" id="Sec10-content"><p>To date, how IL6 differentially regulates its multiple downstream signals and whether the variation of induced downstream signals has clinical implications remain unclear. Here, we showed that IL6 from both lung cancer cell lines and clinical specimens is modified by N-glycosylation. deNG-IL6 induces a switch in GP130 downstream signals from canonical JAK-STAT3 to the SRC-YAP-SOX2 axis. The changes resulted in different gene expression profiles and enhanced in vitro migration and in vivo lung metastasis. Moreover, we discovered that long-term treatment with the EGFR-TKI osimertinib induces a reduction in N-OST expression and an elevation of deNG-IL6, which results in EGFR-TKI resistance in lung cancer cells.</p><p>In this study, two potential N-glycosites (N73 and N172) and four possible O-glycosites (T166, T171, T170, and S174) were predicted to exist in hIL6. MS results indicated that the glycan chains reside at N73, N172, and T170. Utilizing site-directed mutagenesis (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>) and NGI-1 treatment (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2c</a>), we identified four distinct IL6 bands via Western blot analysis, corresponding to four different glycosylation forms as follows (from top to bottom): (1) NG-IL6 carrying an N-glycan (N73 or N172) and an O-glycan (T170), (2) the band marked with an asterisk (*) likely representing N-glycosylation (N73 or N172) alone, (3) deNG-IL6 containing an O-glycan (T170) exclusively, and (4) deG-IL6 lacking any glycan. Notably, the NG-IL6 band was nearly absent in the analysis of N73Q-IL6, suggesting that the predominant attachment sites for IL6 glycan chains are N73+T170 rather than N172+T170. Moreover, no discernible bands higher than NG-IL6 were observed, indicating that tri-glycosylated IL6 (N73+N172+T170) may be either non-existent or negligible. This observation is further supported by MS data obtained from HCC827 WT-IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6l</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">22</a>), which revealed that the N-glycans of NG-IL6 originate mainly from N73 (&gt;85%) rather than N172 (&lt;15%).</p><p>N73 emerges as the predominant N-glycosylation site, a conclusion reinforced by the MS-based glycan analysis of WT-IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6l</a>). However, lectin microarray analysis revealed only an ~50% reduction in the signal intensity of N-glycan in N73Q-IL6 (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2d</a>), presenting a somewhat contradictory outcome. This discrepancy is likely due to the utilization of a polyclonal anti-IL6 antibody for the IP-based isolation process. Consequently, the resultant mixture possibly encompassed not only the desired N73Q-IL6 but also other components, such as antibody fragments and/or nonspecific proteins co-precipitated from the conditioned medium.</p><p>Additionally, AS2-IL6-N172Q cells exhibited no significant difference in migration capacity compared to AS2-IL6-WT cells (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">14</a>), suggesting that the impact of N172 glycosylation on cell migration is minimal. Our findings substantiate the notion that N73 is the principle N-glycosite in IL6, with the abundance of attached N-glycans reduced by approximately one-third when the cells acquired resistance to osimertinib.</p><p>Intriguingly, N172Q-IL6 exhibited four distinct bands on the Western blot: the NG-IL6, deNG-IL6, and deG-IL6 bands and a faint asterisk-labeled band between the NG-IL6 and deNG-IL6 bands (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>). Notably, the distance between the asterisk-labeled band and the deG-IL6 band mirrors that between the NG-IL6 and deNG-IL6 bands (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2b</a>). Furthermore, treatment with NGI-1 resulted in a reduction in the intensity of the faint asterisk-labeled band (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig2">2c</a>), suggesting that this faint band possibly represents IL6 N-glycosylation solely at N73. Regarding N172Q-IL6, the appearance of the asterisk-labeled band and the increase in deG-IL6 band intensity imply that the change in the amino acid at residue 172 may interfere with glycosylation at T170.</p><p>In the CM of established lung cancer cell lines, it appears that deNG-IL6 (L-IL6) is the predominant species. However, in the CM of cancer cells from patient MPECs, most cases showed equal expression of the two species (Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1b</a>). In our studies, blockade of the IL6 receptors GP130 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">7</a>) and GP80 (Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">8</a>) reduced the STAT3 activity induced by both WT-IL6 and N73Q-IL6 in various cell lines. Notably, the inhibition was more effective in the N73Q-IL6-treated cells than in the WT-IL6-treated cells, suggesting that WT-IL6 may have a stronger binding affinity to its receptors and be more resistant to antibody blockade. We assume that NG-IL6, with stronger receptor binding ability, even with only 30% occupancy in CM, may outperform deNG-IL6 in conducting signal transduction. However, when the occupancy of NG-IL6 in CM is reduced, deNG-IL6 becomes dominant in signaling.</p><p>Targeting N-glycosylation by NGI-1 combined with EGFR-TKIs has been shown to overcome EGFR-TKI resistance in NSCLC<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Lopez Sambrooks, C. et al. Oligosaccharyltransferase inhibition overcomes therapeutic resistance to EGFR tyrosine kinase inhibitors. Cancer Res. 78, 50945106 (2018)." href="/articles/s41467-024-51831-7#ref-CR63" id="ref-link-section-d19463446e3741">63</a></sup>. The study concluded that the tumor growth delay was due to N-glycosylation-defective EGFR reducing the activation of receptors and dissociating EGFR signaling from other coexpressed receptors. In hepatocellular carcinoma, IL6-induced JAK-1 phosphorylates PD-L1, enhancing the recruitment of STT3A and thus increasing PD-L1 N-glycosylation, which favors the stability of PD-L1 and promotes immune evasion<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Chan, L. C. et al. IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. J. Clin. Invest. 129, 33243338 (2019)." href="/articles/s41467-024-51831-7#ref-CR64" id="ref-link-section-d19463446e3745">64</a></sup>. These studies indicated that elevated N-glycosylation and glycosyltransferase expression resulted in unfavorable disease progression and poor survival in cancer patients. However, some reports have shown that reduced glycosylation could promote the progression of malignancies. For example, downregulation of the levels of the dystroglycan glycosyltransferases LARGE2 and ISPD was found to be associated with poor survival in patients with clear cell renal cell carcinoma<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Miller, M. R. et al. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. Mol. Cancer 14, 141 (2015)." href="/articles/s41467-024-51831-7#ref-CR65" id="ref-link-section-d19463446e3749">65</a></sup>, and loss of the polypeptide N-acetylgalactosaminyltransferase-3 (GALNT3) in pancreatic adenocarcinoma was associated with increased aggressiveness of cancer cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Chugh, S., Meza, J., Sheinin, Y. M., Ponnusamy, M. P. &amp; Batra, S. K. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. Br. J. Cancer 114, 13761386 (2016)." href="/articles/s41467-024-51831-7#ref-CR66" id="ref-link-section-d19463446e3753">66</a></sup>. Accordingly, we found that reduced N-glycosylation on IL6 led to a high metastatic potential and resistance to EGFR-TKIs in NSCLC cells.</p><p>Peng and colleagues showed that high environmental glucose acts as a stressor that induces the O-GlcNAcylation of intracellular YAP-1 and promotes tumorigenicity<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Peng, C. et al. Regulation of the Hippo-YAP pathway by glucose sensor O-GlcNAcylation. Mol. Cell 68, 591604.e595 (2017)." href="/articles/s41467-024-51831-7#ref-CR67" id="ref-link-section-d19463446e3760">67</a></sup>, suggesting that stress from the tumor microenvironment can shape the glycosylation pattern of key proteins in cancer cells. Our in silico data indicated that a group of specific TFs may act as TKI stress sensors and repress the expression of N-OSTs. Reduced N-OST expression may result in globally defective N-linked glycosylation of the cellular proteome and subsequently change cell behaviors. Interestingly, we found that defective N-linked glycosylation of a key regulator, such as IL6, is sufficient to induce prominent biological changes such as EMT, migration, metastasis, and drug resistance in NSCLC cells.</p><p>Collectively, our data revealed that IL6 is modified with N-glycosylation mainly on N73 residue and O-glycosylation on T170 residue in NSCLC. The loss of glycan on N73 induces a switch of downstream signal preference from the JAK-STAT3 axis to the SRC-YAP-SOX2 axis, triggers subsequent cell plasticity. We also demonstrated that an increase in deNG-IL6 production can be induced by environmental stressors, such as EGFR-TKI treatment. This change in the glycosylation status of IL6 can switch the downstream signaling preference of the GP130 receptor from JAK-STAT3 to the SRC-YAP-SOX2 axis. Lung cancer cells with high levels of deNG-IL6 tend to possess EMT-related properties, metastasize to other organs, and exhibit EGFR-TKI resistance. These findings raise the possibility of controlling cancer cell behavior by simply changing the glycosylation pattern on a key regulator and predicting the appearance of EGFR-TKI resistance by monitoring circulating IL6 glycoforms in NSCLC patients.</p></div></div></section><section data-title="Methods"><div class="c-article-section" id="Sec11-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec11">Methods</h2><div class="c-article-section__content" id="Sec11-content"><h3 class="c-article__sub-heading" id="Sec12">Human <u>m</u>alignant <u>p</u>leural <u>e</u>ffusion (MPE)</h3><p>The MPE samples from patients who underwent thoracentesis or thoracotomy at National Cheng Kung University Hospital were collected as previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Hung, T. L. et al. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis. Clin. Cancer Res. 9, 26052612 (2003)." href="/articles/s41467-024-51831-7#ref-CR68" id="ref-link-section-d19463446e3789">68</a></sup>. The TKI-nave MPEs were collected from patients with histologically proven NSCLC and symptomatic malignant pleural effusion at the time of initial diagnosis, <i>n</i>=19, female=13, male=6, mean age=64.8 (49, 88). TKI-resistant MPEs were collected from patients who received EGFR TKI treatment and developed resistance, <i>n</i>=5, female=4, male=1, mean age=67.4 (54, 92). Paired TKI-nave and TKI-resistant NSCLC lung tissues were obtained from the Human Biobank of National Cheng Kung University Hospital, <i>n</i>=6, female=4, male=2, TKI-nave mean age=59.67 (45, 71); TKI-resistant mean age=61.67 (48, 73). Source data are provided as a Source Data file. No sex or gender analysis was carried out. All subjects gave informed consent to publish those data before contributing samples to the Human Biobank of National Cheng Kung University Hospital.</p><h3 class="c-article__sub-heading" id="Sec13">Cell lines</h3><p>The following human lung cancer cell lines were purchased from the American Type Culture Collection: adenocarcinoma (A549, RRID:CVCL_0023; H1299, RRID:CVCL_0060; HCC827, RRID:CVCL_2063; H1650, RRID:CVCL_1483; and H1975, RRID:CVCL_1511), large cell carcinoma (H460, RRID:CVCL_0459), squamous cell carcinoma (H226, RRID:CVCL_1544), and normal human bronchial epithelial cell lines (NL-20, RRID:CVCL_3756; Beas-2B, RRID:CVCL_0168). The human lung adenocarcinoma cell line PC14PE6 was provided by Dr. Fidler (MD Anderson Cancer Center, Houston, TX, USA). PC14PE6/AS2 (AS2)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Yeh, H. H., Lai, W. W., Chen, H. H., Liu, H. S. &amp; Su, W. C. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 25, 43004309 (2006)." href="/articles/s41467-024-51831-7#ref-CR39" id="ref-link-section-d19463446e3810">39</a></sup> was established from ascites in SCID mice generated by inoculation of PC14PE6 cells into the peritoneal cavity. Human lung adenocarcinoma cell lines PC9 (RRID:CVCL_B260) and CL1-0 (RRID:CVCL_3871)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Chu, Y. W. et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol. 17, 353360 (1997)." href="/articles/s41467-024-51831-7#ref-CR69" id="ref-link-section-d19463446e3814">69</a></sup> were kindly provided by Dr. Chih-Hsin Yang (National Taiwan University, Taipei, Taiwan) and Dr. Pan-Chyr Yang (National Taiwan University), respectively. All cell lines were authenticated by short tandem repeat-polymerase chain reaction (STR-PCR) at the Biosource Collection and Research Center (BCRC) and the Center for Genomic Medicine at National Cheng-Kung University, Taiwan.</p><h3 class="c-article__sub-heading" id="Sec14">Mouse models</h3><p>Six- to eight-week-old male and female nude mice (BALB/cAnN.Cg-Foxn1nu/CrlNarl: <a href="https://www.nlac.narl.org.tw/p3_animal2_detail.asp?cid=1&amp;nid=9&amp;ppage=0&amp;type=2">https://www.nlac.narl.org.tw/p3_animal2_detail.asp?cid=1&amp;nid=9&amp;ppage=0&amp;type=2</a>) were purchased from the National Laboratory Animal Center (Taipei, Taiwan).</p><h3 class="c-article__sub-heading" id="Sec15">Cell culture</h3><p>PC9, H1650, H1299, HCC827, H1975, H226, H460 and CL1-0 cells were maintained in RPMI 1640 medium (Gibco) supplemented with 10% <u>f</u>etal <u>b</u>ovine <u>s</u>erum (FBS; Gibco) and 1% antibiotic-antimycotic (anti-anti, Gibco), and A549 cells were maintained in F12K medium (Gibco) supplemented with 10% FBS and 1% anti-anti. Beas-2B cells were maintained in BEBM supplemented with the components of a BEGM Kit (Lonza). The AS2 human lung adenocarcinoma cell line was maintained in MEM- medium (Gibco) supplemented with 10% FBS, 1% anti-anti, 1% sodium pyruvate (Gibco), and 1 MEM vitamin solution (Gibco). Cells stably expressing empty vector, wild-type <i>IL6</i> (<i>IL6-WT</i>), or N-glycosylation mutant <i>IL6</i> (<i>IL6-N73Q</i>, <i>IL6-N73A</i>, <i>IL6-N73V</i>, <i>IL6-N172Q</i>, and <i>IL6-N73Q</i>+<i>N172Q</i>) were established by transfection with TurboFect Transfection Reagent (Thermo Fisher), followed by selection of individual clones with 500g/mL geneticin (G418) (Calbiochem). AS2-IL6-WT-pLuc and AS2-IL6-N73Q-pLuc cells were generated by transfection of AS2-IL6-WT and AS2-IL6-N73Q cells with the pGL4.50 (Luc2/CMV/Hygro) plasmid (Promega) through TurboFect (Thermo Fisher) and selection with 500g/mL hygromycin B (H3274, Sigma-Aldrich), respectively. Gene silencing was performed by transducing target cells with VSV-G particles harboring pLKO.1 empty vector or shRNA against human <i>SRC</i>, <i>YAP</i>, <i>SOX2</i>, or <i>IL6</i> mRNA (purchased from RNA Technology Platform and Gene Manipulation Core, Academia Sinica, Taipei, Taiwan) and selected using 2g/mL puromycin (Sigma-Aldrich). The <u>o</u>simertinib-<u>r</u>esistant (OR) cells were established by constant culture in medium containing 5 M osimertinib. All cell lines were maintained in an incubator at 37C supplemented with 5% CO<sub>2</sub>.</p><h3 class="c-article__sub-heading" id="Sec16">Preparation of <u>c</u>onditioned <u>m</u>edium (CM)</h3><p>A total of 210<sup>6</sup> cells were seeded in a 10cm dish with 11mL of culture medium with or without specific treatment. The <u>c</u>onditioned <u>m</u>edium (CM) was collected at designated times and then centrifuged at 750<i>g</i>. The supernatant was collected and stored at 80C until further application. Intact or adjusted CM was applied according to the requirements of different experiments. For collection of the OR-CM, the OR cells were seeded in osimertinib-free culture medium. <i>For cell treatment and immunoprecipitation</i>, the IL6 concentration of the CM was measured by ELISAs and adjusted to 1ng/mL with supplemented culture medium prior to use. <i>For the cytokine array</i>, intact or diluted CM was applied. For diluted CM, the IL6 concentration was adjusted to 1ng/mL with supplemented culture medium prior to assay.</p><h3 class="c-article__sub-heading" id="Sec17">IL6 ELISA</h3><p>One milliliter of the CM supernatant was used for measurement of IL6 concentration. An IL6 ELISA was performed using a human IL6 CytoSet ELISA kit (Life Technology, CHC1263) following the manufacturers protocol.</p><h3 class="c-article__sub-heading" id="Sec18">Prediction of glycosylation sites</h3><p>The full-length IL6 protein sequence obtained from NCBI Protein (GenBank: AAC41704.1) was analyzed with the NetNGlyc 1.0 server (RRID:SCR_001570, <a href="https://services.healthtech.dtu.dk/service.php?NetNGlyc-1.0">https://services.healthtech.dtu.dk/service.php?NetNGlyc-1.0</a>) to identify potential N-linked glycosylation sites and with the NetOGlyc 4.0 server (RRID:SCR_009026, <a href="https://services.healthtech.dtu.dk/service.php?NetOGlyc-4.0">https://services.healthtech.dtu.dk/service.php?NetOGlyc-4.0</a>) to identify potential O-linked glycosylation sites<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S. &amp; Brunak, S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4, 16331649 (2004)." href="/articles/s41467-024-51831-7#ref-CR47" id="ref-link-section-d19463446e3964">47</a></sup>. A default threshold score was applied, and the result was confirmed by nine of nine calculation networks showing jury agreement by their internal calculation assessment. Residues with higher prediction scores showed higher potential as N-glycosites or O-glycosites.</p><h3 class="c-article__sub-heading" id="Sec19">Protein extraction</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec20">Total cellular protein lysates</h4><p>Cells were washed twice with ice-cold 1x phosphate-buffered saline (PBS) and lysed with 200L of radioimmunoprecipitation assay (RIPA) lysis buffer [50mM Tris (pH 7.5), 1% (v/v) NP-40, 0.5% (v/v) sodium deoxycholate, 150mM NaCl, 0.1% (v/v) sodium dodecyl sulfate (SDS), 10mM Na<sub>3</sub>VO<sub>4</sub>, and protease inhibitor cocktail from Roche Applied Sciences]. Whole-cell lysates were cleared by centrifugation at 20,000<i>g</i> and 4C for 10min, and protein concentrations were determined by the Bradford assay (BioRad) according to the manufacturers protocol.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec21">Nuclear and cytosolic fractionation</h4><p>Cells were collected by trypsinization and washed with 1x PBS three times. The cells were permeabilized with low salt buffer (10mM HEPES, pH=7.4, 10mM KCl, 50g/mL digitonin) and then centrifuged at 750<i>g</i> and 4C for 10min. The supernatant was the cytosolic fraction of cellular proteins. The pellets were then extracted with RIPA buffer followed by centrifugation at 20,000<i>g</i> and 4C for 10min. The resulting supernatants were the nuclear fraction of cellular proteins.</p><h3 class="c-article__sub-heading" id="Sec22">Western blotting (WB)</h3><p>For detection of changes in protein levels, whole-cell lysates containing 15g of protein were separated by 812% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The transferred membranes were blocked with 5% skim milk and hybridized with primary Ab at 4C overnight. After hybridization with secondary Ab, the protein bands were visualized by enhanced chemiluminescence (ECL) and imaged by exposure to X-ray film (Fujifilm) or in an iBright CL1500 Imaging System (Thermo Fisher). The images were analyzed using Gel-Pro Analyzer 4.0 (Media Cybernetics, Inc.) and Prism (GraphPad, Inc., RRID:SCR_005375) software. All immunoblot analyses were performed in triplicate (<i>n</i>=3) except for those performed with patient specimens (<i>n</i>=1). The following Ab were used for WB: IL6 (Santa Cruz, sc-32296; RRID:AB_627804); STAT3 (BD, 610189; RRID:AB_397588); STAT3-pY705 (CST, 9131;RRID:AB_331757); SRC (CST, 2108; RRID_331137); SRC-pY416 (CST, 2101; RRID:AB_331697); YAP (CST, 4912; RRID:AB_2218911); YAP-pY357 (Abcam, ab62751; RRID:AB_956486); -ACTIN (Millipore, MAB1501; RRID:AB_2223041); SLUG (Abcam, ab-27568; RRID:AB_777968); CLAUDIN1 (Life Technology, 374900; RRID:AB_2533323); E-CADHERIN (BD, 610181; RRID:AB_397581); N-CADHERIN (BD, 610921; RRID:AB_398236); -SMA (Abcam, ab-5694; RRID:AB_2223021); AKT (CST, 4691; RRID:AB_915783); AKT-pY308 (CST, 4056; RRID:AB_331163); AKT-pY473 (CST, 9271; RRID:AB_329825); SOX2 (Santa Cruz, sc-365823; RRID:AB_10842165); ERK1/2 (Santa Cruz, sc-514302; RRID:AB_2571739); pERK (Santa Cruz, sc-7383; RRID:AB_627545); LAMIN A/C (Merck Millipore, 05-714; RRID:AB_309928); NANOG (GeneTex, GTX-627421; RRID:AB_11169335); OCT3/4 (Santa Cruz, sc-5279; RRID:AB_628051); LATS1 (CST, 3477; RRID:AB_2133513); pLATS (CST, 8654; RRID:AB_10971635); TAZ (Abcam, ab224239; RRID:AB_2889852); pTAZ (CST, 59971; RRID:AB_2799578); MST1 (CST, 3682; RRID:AB_2144632).</p><h3 class="c-article__sub-heading" id="Sec23">Immunoprecipitation (IP)</h3><p><i>For WB</i>, ten milliliters of adjusted CM supernatant was used for each IP reaction. The concentration of IL6 in the CM supernatant was measured by ELISAs and adjusted to 1ng/mL with culture media containing supplements. In addition, 10ng of <u>r</u>ecombinant <u>h</u>uman IL6 protein (rhIL6, Sino Biological, 10395-HNAE) was added to 10mL culture media containing supplements as a positive control sample. The adjusted CM was then precleaned with nProtein A Sepharose beads (GE Healthcare, GE17-5280-01) to remove nonspecific binding. IL6 antibody (2g, GeneTex, GTX110527; RRID:AB_10721789) was used in each IP reaction, rotated at low speed overnight at 4C. The Ag-Ab complex was pulled down with 50L of nProtein A at 4C for 2h and released in 26 L of RIPA lysis buffer plus 6x sample buffer by boiling. The IL6 products were then subjected to WB for pattern analysis. <i>For the lectin microarray</i>, CM supernatant from a hollow fiber bioreactor in which the IL6 concentration was adjusted to 1g/mL was applied. A total amount of 100g IL6 was pulled down following the above procedures.</p><h3 class="c-article__sub-heading" id="Sec24">Cell treatment conditions</h3><p><i>For NGI-1</i> (Sigma-Aldrich, SML1620) <i>treatment</i>, 210<sup>6</sup> cells were seeded in a 10cm dish and allowed to attach overnight. The medium was replaced with fresh culture medium containing NGI-1 at 10M. After 48h of treatment, the CM was collected for analysis of the IL6 patterns. <i>For treatment of various CM</i>, cells were seeded and allowed to attach overnight in serum-free medium for 12h (810<sup>5</sup> cells/6-cm dish for WB, 110<sup>5</sup> cells/chamber slide for IF imaging). The serum-free medium was subsequently replaced with CM containing different IL6 glycoforms adjusted to 1ng/mL and treated for the designated duration. <i>For treatments with neutralizing antibodies</i> GP130 (R&amp;D, MAB228; RRID:AB_2233737) and GP80 (R&amp;D, MAB227; RRID:AB_2127908), AS2-Vec cells were pretreated with these antibodies for 2h followed by treatment with WT-IL6 or N73Q-IL6 CM. For IL6 (R&amp;D, MAB206; RRID:AB_2127617)-neutralizing antibody treatment, WT-IL6 or N73Q-IL6 CM was incubated with the antibody at 37C for 2h and then added to AS2-Vec cells. <i>For cytotoxicity assays</i>, 410<sup>3</sup> cells/well 96-well in plates were let attached overnight. To assess the time-dependent response, cells were treated with osimertinib at a tolerant concentration of 5M alone or in combination with the YAP inhibitor verteporfin (VP) at 5M for the indicated durations. To assess synergistic responses, cells were treated with VP alone at 0  10M or in combination with osimertinib at 0  5M. Survival of cells was evaluated with MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay.</p><h3 class="c-article__sub-heading" id="Sec25">Digestion of N-glycans on IL6 by PNGase F</h3><p>IL6 in the CM previously described was immunoprecipitated. After elution, the SDS in the product was neutralized by the addition of 15% Triton X-100 (Sigma-Aldrich) to a final concentration of 0.7% before subsequent treatment. PNGase F (Sigma-Aldrich, P7367) was then added to the precipitated product (final concentration=1 U/g protein) with 10x buffer and ddH<sub>2</sub>O. The digestion reaction was performed by incubation at 37C for 72h. The digested samples were subjected to WB for pattern analysis.</p><h3 class="c-article__sub-heading" id="Sec26">Isolation of tumor cells from MPEs</h3><p>The purity of the attached tumor cells in the target fractions was determined by assessment of double-positive expression of TTF1 (Santa Cruz, sc-8762; RRID:AB_793530) and PanCK (Santa Cruz, sc-8018; RRID:AB_627396) under FV3000 confocal microscopy (Olympus). MPE-derived tumor cells were resuspended, cultured in RPMI 1640 medium supplemented with 10% FBS and maintained in an incubator at 37C with 5% CO<sub>2</sub>. Precipitated cells were cultured in 10-cm dishes and allowed to attach for 24h, after which the medium was replaced with fresh RPMI 1640 medium supplemented with 10% FBS and 1% Anti-Anti.</p><h3 class="c-article__sub-heading" id="Sec27">Plasmid cloning</h3><p>Full-length human IL6 cDNA derived from A549 cells was cloned into the pRcCMV vector (Invitrogen, V750-20) using BamHI (NEB, R0136) and EcoRI (NEB, R0101) restriction sites, and the resulting vector was named pRcCMV-WT-IL6. Site-directed mutagenesis of IL6 by substitution of the N73 residue with Gln, Ala, or Val, was performed using the pRcCMV-WT-IL6 plasmid with a QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, 210518) according to the manufacturers instructions. The mutant forms were named pRcCMV-N73Q-IL6, pRcCMV-N73A-IL6, pRcCMV-N73V-IL6, pRcCMV-N172Q-IL6, and pRcCMV-N73Q+N172Q-IL6, respectively. The primers used for site-directed mutagenesis are listed in Supplementary Table&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">2</a>.</p><h3 class="c-article__sub-heading" id="Sec28">
                           <u>H</u>ollow <u>f</u>iber <u>b</u>ioreactor culture (HFB)</h3><p>For collection of IL6 for lectin array analysis, a hollow fiber bioreactor was applied to improve productivity. In total, 110<sup>8</sup> cells were implanted into a hollow fiber cartridge (FiberCell Systems, Inc., C-2008) after 5days of preculture according to the manufacturers protocol. CM in the cartridge was collected every 5days and centrifuged at 750g and 4C for 5min. The supernatant was collected and stored at 80C until further use.</p><h3 class="c-article__sub-heading" id="Sec29">MS analysis and protein <u>id</u>entification (ID)</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec30">Protein identification</h4><p>IL6 immunoprecipitated from HFB-derived lung cancer cell CM was resolved by 12% SDS-PAGE and visualized by Coomassie blue staining (Brilliant Blue G-Colloidal Concentrate, Sigma-Aldrich, 2025-1EA). Stained bands with an MW of ~20~30kDa were excised and in-gel digested with trypsin (1 U/g protein) (Sigma-Aldrich). The digested peptides were subsequently subjected to fractionation with a nano-HPLC system (LC Packings) coupled to an ion trap mass spectrometer (LCQ DECA XP Plus, Thermo Finnigan) equipped with an electrospray ion source. The resulting MS/MS spectra containing monoisotopic peptide masses were assigned and used for a search of the Swiss-Prot database with the Mascot search engine (Matrix Science, RRID: SCR_014322).</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec31">Glycosylation analysis</h4><p>Preparation of the IL6 protein was performed by the filter-aided sample preparation (FASP) method<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Wisniewski, J. R., Zougman, A., Nagaraj, N. &amp; Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359362 (2009)." href="/articles/s41467-024-51831-7#ref-CR70" id="ref-link-section-d19463446e4142">70</a></sup>. In brief, IL6 (10 g samples) was reduced with 25mM dithiothreitol and alkylated with 50mM iodoacetamide in 0.1M Tris-HCl (pH 8.5) with 8M urea. Afterward, the buffer was replaced with 50mM tetraethylammonium bromide (TEAB) for protein digestion. A total of 2g of glutamyl endopeptidase C (Glu-C) (Promega, V5111) or 1 g of trypsin (Promega, V1651) was utilized for the analysis of IL6 peptides containing Asn73 (N73) or Asn 172 (N172), respectively. Then, N-glycans were removed by treatment with PNGase F. Digested IL6 samples were analyzed by LCESI-MS on an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific) connected to an EASY-nLC 1200 system (Thermo Fisher Scientific) and EASY-Spray Source (Thermo Fisher Scientific). The digestion solution was injected (5L) at a 1L/min flow rate onto an EASY-Column (C18, 0.075mm150mm, ID 3 m; Thermo Fisher Scientific). Chromatographic separation was performed using 0.1% formic acid in water as mobile phase A and 0.1% formic acid in 80% acetonitrile as mobile phase B at a 300nL/min flow rate. Briefly, the gradient employed was 5% buffer B at 2min increasing to 60% buffer B at 55min. Full-scan MS conditions: mass range, m/z 3751800 (AGC target, 5E5) with lock mass; resolution, 60,000 at m/z 200; and maximum injection time, 50ms. MS/MS scanning was performed in top speed mode with 3s cycles with CID and HCD, while the dynamic exclusion duration was set to 60s with a 10 ppm tolerance around the selected precursor and its isotopes. The electrospray voltage was maintained at 1.8kV, and the capillary temperature was set at 275C. For glycopeptide identification, Byonic software 4.2.10 (Protein Metrics; RRID:SCR_016735) was used for the identification of summary formulas of glycans associated with glycopeptides (protein database, target protein; glycan database, 132 entries for N-glycans and 9 entries for O-glycans; precursor mass tolerance, 10ppm; fragment mass tolerance, 0.5Da; cleavage sites: K and R by trypsin and E and D by Glu-C; maximum missed cleavages, 5; and cysteine carbamidomethylation and methionine oxidation; FDR 0.01)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="Bern, M., Kil, Y. J. &amp; Becker, C. Byonic: advanced peptide and protein identification software. Curr. Protocol. Bioinform. 13, 13 20 1113 20 14 (2012)." href="/articles/s41467-024-51831-7#ref-CR71" id="ref-link-section-d19463446e4146">71</a></sup>. The percentage of glycosylation at N73 was determined from the areas in the LC spectra from the peptide sequence TCN<sup>73</sup>KSNMCE with/without deamidation at N73, and the percentages of glycosylation at N172 and O170 were calculated from the areas by Xcalibur in the LC spectra from the peptide sequence NLDAITTPDPT<sup>170</sup>TN<sup>172</sup>ASLLTK with/without deamidation at N172. The identified peptides are shown in Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">22</a>.</p><h3 class="c-article__sub-heading" id="Sec32">RNA extraction, RT-PCR, and qPCR</h3><p>Total RNA was extracted from the examined cells and tissues with TRIzol Reagent (Invitrogen, 15596026) following the manufacturers protocol. cDNA samples were synthesized from 1g of total RNA using the AMV Reverse Transcription System Kit (Promega, A3500) under the following thermal cycling conditions: 42C for 60min, 99C for 5min, and 4C for 30min. Fifty nanograms of cDNA was subjected to RT-PCR, followed by agarose gel electrophoresis with SYBR Green. The expression of target genes was visualized with a UVP BioSpectrum Imaging System. Quantification of the transcript expression of human glycosyltransferases by qPCR was performed with 50 ng of cDNA in&nbsp;Power SYBR Green Master Mix (Applied Bioscience, 4367659)&nbsp;using a Step One Real-Time PCR Detection System (Applied Bioscience). The relative expression of target genes was calculated by percentage changes of 2<sup>CT</sup> values. The primer sequences used for qPCR analysis of glycosyltransferase expression were kindly provided by Prof. Chuan-Fa Chang. The primer sequences used for qPCR and RT-PCR are listed in Supplementary Table&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">2</a>.</p><h3 class="c-article__sub-heading" id="Sec33">Cytokine array</h3><p>Cytokine array assays were performed using the C-Series Human Cytokine Antibody Array (Ray-Bio, AAH-CYT-5-8) with intact or diluted CM following the manufacturers protocol.</p><h3 class="c-article__sub-heading" id="Sec34">Characterization of N-linked glycosylation by lectin microarray</h3><p>Immunoprecipitated IL6 from CM of AS2-IL6-WT (with or without pretreatment with NGI-1), AS2-IL6-N73Q, HCC827-IL6, and HCC827-OR cells was separated by 12% SDS-PAGE to remove excess IgG and stained with InstantBlue Coomassie Protein Stain (Abcam, ab119211). IL6 bands were excised and electroeluted with a D-tube of 3 MWCO. The eluted samples were then desalted by D-tube (Merck Millipore, 71506) dialysis against 1x PBS for 5days (fresh 1x PBS was replaced every 12h) and concentrated in 3kDa Amicon Ultra-0.5 concentration tubes (Millipore, UFC500396). Lectin microarray assays were performed as described in GlycoStation Standard Experimental Protocol Ver.1.0. Briefly, the concentrations of the different IL6 glycoforms were determined by BCA Protein Assay reagent and adjusted to 50g/mL in 1x PBS. One microgram of each glycoform was labeled with Cy3 Mono-Reactive Dye (GE Healthcare, PA23001) and applied to a lectin microarray chip (LecChip Ver. 1.0 and LecChip Probing Solution, GlycoTechnica) for hybridization overnight at 4C. The resulting lectin chip was scanned with an evanescent-field fluorescence scanner (GlycoStation Reader 1200; GlycoTechnica) system (<a href="https://www.glycotechnica.com/en/tools/">https://www.glycotechnica.com/en/tools/</a>). The net intensity of lectin signals was averaged from triplicate spots and automatically calculated with GlycoStation Tools Pro Suite 1.5&nbsp;software.</p><h3 class="c-article__sub-heading" id="Sec35">Migration assays</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec36">Transwell</h4>
                    <h3 class="c-article__sub-heading" id="FPar1">CL1-0 cell coculture</h3>
                    <p>AS2-Vec, AS2-IL6-WT, and AS2-IL6-N73Q cells (2.510<sup>5</sup>) were plated in a 24-well plate. After 24h, the medium was replaced with fresh culture medium. In total, 110<sup>4</sup> CL1-0 cells were plated in a Transwell MilliCell (Millipore, MCEP24H48), which was set on top of each AS2 cell derivative and incubated for 24h. The cells that migrated through the membrane with an 8m pore size in the Transwell chamber were stained with Lius staining solution (ASK). Images were acquired by an Olympus BX50 microscope (Olympus) under a 10x objective with VImage 2014 software, and the area of migrated cells was analyzed using ImageJ software&nbsp;(National Institutes of Health, RRID:SCR_003070).</p>
                  
                    <h3 class="c-article__sub-heading" id="FPar2">Autonomous migration</h3>
                    <p>AS2-Vec, AS2-IL6-WT, AS2-IL6-N73Q, AS2-IL6-N172Q, and AS2-IL6-N73Q+N172Q cells (110<sup>4</sup>) were plated in a Transwell MilliCell (Millipore), which was set on top of each AS2 cell derivative and incubated for 24h. The cells that migrated through the membrane in the chamber were stained with Lius staining solution (ASK). Images were acquired by an Olympus BX50 microscope (Olympus) under a 10x objective with VImage 2014 software, and the area of migrated cells was analyzed using ImageJ software&nbsp;(National Institutes of Health, RRID:SCR_003070).</p>
                  <h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec37">Culture inserts</h4><p>Appropriate cells were seeded (110<sup>4</sup>) into both sides of a culture insert (ibidi, 81176) with mitomycin C (5g/mL, Sigma-Aldrich, M4287) and then allowed to attach overnight. The inserts were carefully removed, and the medium was replaced with fresh culture medium or, for inhibitor-treated cells, with medium containing the IL6-neutralizing antibody (5g/mL, R&amp;D, MAB206), STAT3 inhibitor S3I-201 (10 M, Sigma-Aldrich, 573102), JAK inhibitor ruxolitinib (2.5M, Selleck Chemicals, S1378), and SRC inhibitors PP1 (10M, Sigma-Aldrich, P0040), PP2 (10M, Selleck Chemicals, S7008), and tirbanibulin (10M, MedChemExpress, HY-10340). Images were acquired by a Nikon ECLIPSE Ti microscope (Nikon) under a 20x objective at 0h and 24h after insert removal, and the area of migrated cells was analyzed using ImageJ&nbsp;software (National Institutes of Health, RRID: SCR_003070).</p><h3 class="c-article__sub-heading" id="Sec38">Animal experiments</h3><p>All animal experiments were conducted under the Institutional Animal Care and Use Committee of NCKU (NCKU IACUC)-approved animal protocol No. 103091, No.104104, and No.107174, following the guidance of the of the Laboratory Animal Center of NCKU and the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). For analysis of the influence of IL6 glycoforms on lung metastasis, 110<sup>6</sup> AS2-Vec, AS2-IL6-WT, AS2-IL6-N73Q, AS2-IL6-N73A, and AS2-IL6-N73V cells were transplanted into female nude mice (randomized into three groups for comparison of AS2-Vec, AS2-IL6-WT, and AS2-IL6-N73Q cells, and two groups for comparison of AS2-IL6-N73A and AS2-IL6-N73V cells) by i.v. injection. Mice were observed every other day. For IVIS observation, 110<sup>6</sup> AS2-IL6-WT-pLuc and AS2-IL6-N73Q-pLuc cells were transplanted into male nude mice (randomized into two groups) by i.v. injection and observed with IVIS Spectrum Noninvasive Quantitative Molecular Imaging System (Xenogen) twice a week for 4weeks. Prior to IVIS measurement each time, the mice were administered 200L of D-luciferin (dissolved in normal saline at 3.7mg/mL, Biosynth, L-8220) through intraperitoneal (i.p.) injection. Due to individual variation, if the maximum metastasis reached 60% of total lung area or the animal was dead before the set end point, the experiment would be humanely terminated by euthanasia with CO<sub>2</sub> upon that time. Lungs of these nude mice were harvested, fixed with formalin and embedded in paraffin (generating formalin-fixed, paraffin-embedded (FFPE) samples). We used both female and male nude mice for in vivo study due to the shortage of mice under the SARS-COVID-19 pandemic.</p><h3 class="c-article__sub-heading" id="Sec39">Histology</h3><p>For histological analysis, 4m FFPE sections from the longitudinal central plane of the lungs harvested in the i.v. injection experiments, or paired TKI-nave and TKI-resistant NSCLC lung tissues were stained with H&amp;E following a standard protocol and scanned with the TissueFAXS System (TissueGnostics GmbH). Both tumor area and total lung area were quantified using HistoQuest software (TissueGnostics GmbH, RRID:SCR_014823) and visually confirmed by a pathologist in a blinded manner. The metastatic capacity of lung tumor cells secreting various IL6 glycoforms was evaluated by calculating the ratio of the tumor area to the total lung area.</p><h3 class="c-article__sub-heading" id="Sec40">Microarray analysis</h3><p>AS2-Vec cells were treated with WT-IL6-containing and N73Q-IL6-containing CM for 0.5, 3, 6, or 24h. Total RNA was extracted and subjected to microarray analysis. The integrity of all the RNA samples was evaluated using a Bioanalyzer 2100 (Agilent Technologies) according to the manufacturers protocol. Analysis of gene expression in each sample was performed utilizing an Agilent SurePrint G3 Human GE 860K Microarray (Agilent Technologies), and scanning was performed using an Agilent microarray scanner (Agilent Technologies). The acquired images were analyzed using Feature Extraction 10.5.1.1 software (Agilent Technologies). The experiments were performed in triplicate. The WT-IL6-CM-induced and N73Q-IL6-CM-induced gene expression at 0.5, 3, 6, and 24h was normalized to that at 0h. Differentially expressed genes (fold change&gt;1.5) were characterized and clustered using GeneSpring software (RRID:SCR_009196, Agilent Technologies, assisted by Welgene, Inc., Taiwan). The data were subsequently analyzed with Ingenuity Pathway Analysis (IPA) software (Qiagen, RRID:SCR_008653) and GSEA<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 1554515550 (2005)." href="/articles/s41467-024-51831-7#ref-CR43" id="ref-link-section-d19463446e4271">43</a></sup>.</p><h3 class="c-article__sub-heading" id="Sec41">In silico transcriptome analysis</h3><p>The datasets of EGFR-TKI-treated human lung cancer cells GSE31210, GSE60189, GSE59239, GSE106765, GSE122005, GSE38121, and GSE71587 were obtained from the NCBI GEO database, and patient RNA-seq results were obtained from the supplemental information from Roper et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Roper, N. et al. Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer. Cell Rep. Med. 1, 10007 (2020)." href="/articles/s41467-024-51831-7#ref-CR59" id="ref-link-section-d19463446e4283">59</a></sup>. Data were converted to .gct files prior to GSEA. The.gct files contained the <u>r</u>obust <u>m</u>ulti<u>a</u>rray (RMA) normalized data matrix obtained from GEO with a probe set identifier. Enrichment analyses were performed by GSEA using the standard default settings with well-documented gene sets encompassing signatures of the N-glycosylation process, EMT, and SRC-YAP signaling obtained from the Molecular Signatures Database (MSigDB) (<a href="https://www.gsea-msigdb.org/gsea/msigdb">https://www.gsea-msigdb.org/gsea/msigdb</a>). Heatmaps showing ssGSEA scores and ssGSEA scores were generated with Morpheus open-source software (RRID:SCR_014975, <a href="https://software.broadinstitute.org/morpheus/">https://software.broadinstitute.org/morpheus/</a>).</p><h3 class="c-article__sub-heading" id="Sec42">Immunofluorescence staining and confocal microscopy</h3><p>Cells in a 4-well chamber slide (Millipore, PEZGS0416) were fixed with 4% paraformaldehyde (PFA) for 10min and then washed three times with 1x PBS for 10min each time. The cells were then permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) for 10min and washed three times with 1x PBS for 10min each time. The samples were then blocked with antibody diluent (Dako, S3022) for 1h at room temperature. For analysis of the expression of TTF1 (Santa Cruz, sc-8762; RRID:AB_793530) and PanCK (Santa Cruz, sc-8018; RRID:AB_627396) or the localization of STAT3 (CST, 9193; RRID:AB_331757), SRC (CST, 2108; RRID:AB_331137), and GP130 (Santa Cruz, sc-376280; RRID:AB_10986409), the samples were reacted with the appropriate primary Ab diluted in antibody diluent overnight at 4C and then washed three times. The samples were then reacted with appropriate secondary Ab diluted in antibody diluent at room temperature for 1h and washed three times. Nuclear staining was performed with Hoechst 33342 dye at 20 g/mL (Sigma-Aldrich, 14533) for 1min, and the samples were then washed three times with 1x PBS. The samples were subsequently mounted with Fluoromount-G (Electron Microscopy Sciences, 50-259-73) and sealed with cover glasses. Immunofluorescence images were acquired with an FV3000 confocal microscope (Olympus) and analyzed using FV10-ASW (Olympus) or TissueQuest (TissueGnostics GmbH) software. For analysis of the formation of F-ACTIN, cells and blocked samples were reacted with phalloidin-TRITC (Life Technology, R415) for 1h at room temperature; the subsequent experimental steps were carried out as described above. For analysis of the expression and localization of STAT3 and SRC in paired TKI-nave and TKI-resistant NSCLC tissues, 4m FFPE sections were applied, and the paired tissues were attached to the same slide to perform the IF process at the same time. Immunofluorescence images were acquired with a TissueFAXS System (TissueGnostics GmbH) and analyzed using TissueQuest (TissueGnostics GmbH) software.</p><h3 class="c-article__sub-heading" id="Sec43">Study approval</h3><p>Research associated with the collection of human specimens was conducted in accordance with the Declaration of Helsinki (2008) of the World Medical Association. This study was approved by the institutional review boards (IRBs) of National Cheng Kung University Hospital (NCKU Hospital, Tainan, Taiwan). Written informed consent was obtained from each study subject (B-ER-1010170, BR-100-034, A-BR-102-098, A-ER-105-451).</p><h3 class="c-article__sub-heading" id="Sec44">Statistics and reproducibility</h3><p>Statistical analyses were performed using Prism software (GraphPad, Inc., RRID:SCR_005375). The results of WB, qPCR, confocal microscopy, and migration and soft agar assays were statistically analyzed by the Students <i>t-</i>test. In vivo lung metastasis assay results were analyzed by two-way ANOVA. For Ingenuity Pathway Analysis (IPA) - identified Disease and Functional Annotation, a significant correlation was defined as <i>p</i>&lt;0.001, evaluated by a right-tailed Fishers Exact Test. The synergistic effect of combination treatment with the YAPi and osimertinib was evaluated by Synergy Finder Plus (<a href="http://www.synergyfinderplus.org/">http://www.synergyfinderplus.org/</a>) under the two-tailed Zero interaction potency (ZIP) model<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Zheng, S. et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genom. Proteom. Bioinform. 20, 587596 (2022)." href="/articles/s41467-024-51831-7#ref-CR58" id="ref-link-section-d19463446e4348">58</a></sup>. A <i>p</i>-value of &lt;0.05 was considered significant. The data are presented as the meanSEM for quantitative results. No statistical method was used to predetermine sample size.</p><h3 class="c-article__sub-heading" id="Sec45">Reporting summary</h3><p>Further information on research design is available in the&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM3">Nature Portfolio Reporting Summary</a> linked to this article.</p></div></div></section>
                    
                </div>
            

            <div class="u-mt-32">
                <section data-title="Data availability"><div class="c-article-section" id="data-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content" id="data-availability-content">
              
              <p>The RNA microarray datasets generated in this study were deposited into the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database under accession number GSE269782 and are available at the following URL: <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269782">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269782</a>. The RNAseq and microarray datasets of human lung adenocarcinoma demonstrated in Figs.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig1">1e</a>, <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig6">6h</a>, and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">21</a> were downloaded from NCBIs GEO: <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31210">GSE31210</a>; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269782">GSE106765</a>; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60189">GSE60189</a>; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59293">GSE59239</a>; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=gse122005">GSE122005</a>; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38121">GSE38121</a>; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71587">GSE71587</a>; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE37699">GSE37699</a>. Datasets of human lung adenocarcinoma demonstrated in Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-024-51831-7#Fig8">8d</a> and Supplementary Fig.&nbsp;<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-024-51831-7#MOESM1">26</a> were from the supplementary information attached to the article of Roper N. et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Roper, N. et al. Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer. Cell Rep. Med. 1, 10007 (2020)." href="/articles/s41467-024-51831-7#ref-CR59" id="ref-link-section-d19463446e4513">59</a></sup>. For glycosylation analysis, protein mass spectrometry raw data and analytical tool data have updated in a repository via ProteomeXchange (<a href="https://www.proteomexchange.org">https://www.proteomexchange.org</a>) with project accession: PXD051771.&nbsp;<a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41467-024-51831-7#Sec47">Source data</a> are provided with this paper.</p>
            </div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">Yu, H., Lee, H., Herrmann, A., Buettner, R. &amp; Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. <i>Nat. Rev. Cancer</i> <b>14</b>, 736746 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrc3818" data-track-item_id="10.1038/nrc3818" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrc3818" aria-label="Article reference 1" data-doi="10.1038/nrc3818">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvVSmtLnF" aria-label="CAS reference 1">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25342631" aria-label="PubMed reference 1">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Revisiting%20STAT3%20signalling%20in%20cancer%3A%20new%20and%20unexpected%20biological%20functions&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fnrc3818&amp;volume=14&amp;pages=736-746&amp;publication_year=2014&amp;author=Yu%2CH&amp;author=Lee%2CH&amp;author=Herrmann%2CA&amp;author=Buettner%2CR&amp;author=Jove%2CR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Jones, S. A. &amp; Jenkins, B. J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. <i>Nat. Rev. Immunol.</i> <b>18</b>, 773789 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41577-018-0066-7" data-track-item_id="10.1038/s41577-018-0066-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41577-018-0066-7" aria-label="Article reference 2" data-doi="10.1038/s41577-018-0066-7">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhslymur7N" aria-label="CAS reference 2">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30254251" aria-label="PubMed reference 2">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Recent%20insights%20into%20targeting%20the%20IL-6%20cytokine%20family%20in%20inflammatory%20diseases%20and%20cancer&amp;journal=Nat.%20Rev.%20Immunol.&amp;doi=10.1038%2Fs41577-018-0066-7&amp;volume=18&amp;pages=773-789&amp;publication_year=2018&amp;author=Jones%2CSA&amp;author=Jenkins%2CBJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Rose-John, S. The soluble interleukin 6 receptor: advanced therapeutic options in inflammation. <i>Clin. Pharmacol. Therapeut.</i> <b>102</b>, 591598 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/cpt.782" data-track-item_id="10.1002/cpt.782" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fcpt.782" aria-label="Article reference 3" data-doi="10.1002/cpt.782">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsFWjt77I" aria-label="CAS reference 3">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20soluble%20interleukin%206%20receptor%3A%20advanced%20therapeutic%20options%20in%20inflammation&amp;journal=Clin.%20Pharmacol.%20Therapeut.&amp;doi=10.1002%2Fcpt.782&amp;volume=102&amp;pages=591-598&amp;publication_year=2017&amp;author=Rose-John%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Trikha, M., Corringham, R., Klein, B. &amp; Rossi, J. F. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. <i>Clin. Cancer Res.</i> <b>9</b>, 46534665 (2003).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXosVGjsrw%3D" aria-label="CAS reference 4">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14581334" aria-label="PubMed reference 4">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929399" aria-label="PubMed Central reference 4">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Targeted%20anti-interleukin-6%20monoclonal%20antibody%20therapy%20for%20cancer%3A%20a%20review%20of%20the%20rationale%20and%20clinical%20evidence&amp;journal=Clin.%20Cancer%20Res.&amp;volume=9&amp;pages=4653-4665&amp;publication_year=2003&amp;author=Trikha%2CM&amp;author=Corringham%2CR&amp;author=Klein%2CB&amp;author=Rossi%2CJF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Hunter, C. A. &amp; Jones, S. A. IL-6 as a keystone cytokine in health and disease. <i>Nat. Immunol</i>. <b>16</b>, 448457 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ni.3153" data-track-item_id="10.1038/ni.3153" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fni.3153" aria-label="Article reference 5" data-doi="10.1038/ni.3153">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtF2murbF" aria-label="CAS reference 5">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25898198" aria-label="PubMed reference 5">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6%20as%20a%20keystone%20cytokine%20in%20health%20and%20disease&amp;journal=Nat.%20Immunol&amp;doi=10.1038%2Fni.3153&amp;volume=16&amp;pages=448-457&amp;publication_year=2015&amp;author=Hunter%2CCA&amp;author=Jones%2CSA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Garbers, C., Heink, S., Korn, T. &amp; Rose-John, S. Interleukin-6: designing specific therapeutics for a complex cytokine. <i>Nat. Rev. Drug Discov.</i> <b>17</b>, 395412 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrd.2018.45" data-track-item_id="10.1038/nrd.2018.45" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrd.2018.45" aria-label="Article reference 6" data-doi="10.1038/nrd.2018.45">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXovVagtbw%3D" aria-label="CAS reference 6">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29725131" aria-label="PubMed reference 6">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Interleukin-6%3A%20designing%20specific%20therapeutics%20for%20a%20complex%20cytokine&amp;journal=Nat.%20Rev.%20Drug%20Discov.&amp;doi=10.1038%2Fnrd.2018.45&amp;volume=17&amp;pages=395-412&amp;publication_year=2018&amp;author=Garbers%2CC&amp;author=Heink%2CS&amp;author=Korn%2CT&amp;author=Rose-John%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Murakami, M., Kamimura, D. &amp; Hirano, T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. <i>Immunity</i> <b>50</b>, 812831 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.immuni.2019.03.027" data-track-item_id="10.1016/j.immuni.2019.03.027" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.immuni.2019.03.027" aria-label="Article reference 7" data-doi="10.1016/j.immuni.2019.03.027">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXnsFGksLY%3D" aria-label="CAS reference 7">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30995501" aria-label="PubMed reference 7">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Pleiotropy%20and%20specificity%3A%20insights%20from%20the%20interleukin%206%20family%20of%20cytokines&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2019.03.027&amp;volume=50&amp;pages=812-831&amp;publication_year=2019&amp;author=Murakami%2CM&amp;author=Kamimura%2CD&amp;author=Hirano%2CT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Duan, Z. et al. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. <i>Clin. Cancer Res.</i> <b>12</b>, 50555063 (2006).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-06-0861" data-track-item_id="10.1158/1078-0432.CCR-06-0861" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-06-0861" aria-label="Article reference 8" data-doi="10.1158/1078-0432.CCR-06-0861">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XovF2hu7s%3D" aria-label="CAS reference 8">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16951221" aria-label="PubMed reference 8">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Signal%20transducers%20and%20activators%20of%20transcription%203%20pathway%20activation%20in%20drug-resistant%20ovarian%20cancer&amp;journal=Clin.%20Cancer%20Res.&amp;doi=10.1158%2F1078-0432.CCR-06-0861&amp;volume=12&amp;pages=5055-5063&amp;publication_year=2006&amp;author=Duan%2CZ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Huang, W. L. et al. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells. <i>Mol. Cancer</i> <b>9</b>, 309 (2010).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/1476-4598-9-309" data-track-item_id="10.1186/1476-4598-9-309" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/1476-4598-9-309" aria-label="Article reference 9" data-doi="10.1186/1476-4598-9-309">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsF2hs7rK" aria-label="CAS reference 9">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21122157" aria-label="PubMed reference 9">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027602" aria-label="PubMed Central reference 9">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Signal%20transducer%20and%20activator%20of%20transcription%203%20activation%20up-regulates%20interleukin-6%20autocrine%20production%3A%20a%20biochemical%20and%20genetic%20study%20of%20established%20cancer%20cell%20lines%20and%20clinical%20isolated%20human%20cancer%20cells&amp;journal=Mol.%20Cancer&amp;doi=10.1186%2F1476-4598-9-309&amp;volume=9&amp;publication_year=2010&amp;author=Huang%2CWL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">Lee, H. J. et al. Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. <i>Cancer Cell</i> <b>26</b>, 207221 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccr.2014.05.019" data-track-item_id="10.1016/j.ccr.2014.05.019" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccr.2014.05.019" aria-label="Article reference 10" data-doi="10.1016/j.ccr.2014.05.019">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXht1agsL7I" aria-label="CAS reference 10">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25065853" aria-label="PubMed reference 10">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Drug%20resistance%20via%20feedback%20activation%20of%20Stat3%20in%20oncogene-addicted%20cancer%20cells&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccr.2014.05.019&amp;volume=26&amp;pages=207-221&amp;publication_year=2014&amp;author=Lee%2CHJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">Rokavec, M. et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. <i>J. Clin. Invest.</i> <b>124</b>, 18531867 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI73531" data-track-item_id="10.1172/JCI73531" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI73531" aria-label="Article reference 11" data-doi="10.1172/JCI73531">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXmtVGgur4%3D" aria-label="CAS reference 11">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24642471" aria-label="PubMed reference 11">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973098" aria-label="PubMed Central reference 11">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6R%2FSTAT3%2FmiR-34a%20feedback%20loop%20promotes%20EMT-mediated%20colorectal%20cancer%20invasion%20and%20metastasis&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI73531&amp;volume=124&amp;pages=1853-1867&amp;publication_year=2014&amp;author=Rokavec%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. <i>Nature</i> <b>519</b>, 5762 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature14228" data-track-item_id="10.1038/nature14228" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature14228" aria-label="Article reference 12" data-doi="10.1038/nature14228">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2015Natur.519...57T" aria-label="ADS reference 12">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXjvVGjsrk%3D" aria-label="CAS reference 12">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25731159" aria-label="PubMed reference 12">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318" aria-label="PubMed Central reference 12">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20gp130-Src-YAP%20module%20links%20inflammation%20to%20epithelial%20regeneration&amp;journal=Nature&amp;doi=10.1038%2Fnature14228&amp;volume=519&amp;pages=57-62&amp;publication_year=2015&amp;author=Taniguchi%2CK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">Quintanal-Villalonga, A. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. <i>Nat. Rev. Clin. Oncol.</i> <b>17</b>, 360371 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41571-020-0340-z" data-track-item_id="10.1038/s41571-020-0340-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41571-020-0340-z" aria-label="Article reference 13" data-doi="10.1038/s41571-020-0340-z">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32152485" aria-label="PubMed reference 13">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397755" aria-label="PubMed Central reference 13">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Lineage%20plasticity%20in%20cancer%3A%20a%20shared%20pathway%20of%20therapeutic%20resistance&amp;journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;doi=10.1038%2Fs41571-020-0340-z&amp;volume=17&amp;pages=360-371&amp;publication_year=2020&amp;author=Quintanal-Villalonga%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. <i>Science</i> <b>304</b>, 14971500 (2004).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.1099314" data-track-item_id="10.1126/science.1099314" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.1099314" aria-label="Article reference 14" data-doi="10.1126/science.1099314">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2004Sci...304.1497P" aria-label="ADS reference 14">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXksVGmsbs%3D" aria-label="CAS reference 14">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15118125" aria-label="PubMed reference 14">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=EGFR%20mutations%20in%20lung%20cancer%3A%20correlation%20with%20clinical%20response%20to%20gefitinib%20therapy&amp;journal=Science&amp;doi=10.1126%2Fscience.1099314&amp;volume=304&amp;pages=1497-1500&amp;publication_year=2004&amp;author=Paez%2CJG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">Ramalingam, S. S. et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. <i>N. Engl. J. Med.</i> <b>382</b>, 4150 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa1913662" data-track-item_id="10.1056/NEJMoa1913662" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa1913662" aria-label="Article reference 15" data-doi="10.1056/NEJMoa1913662">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnsFGgtL4%3D" aria-label="CAS reference 15">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31751012" aria-label="PubMed reference 15">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Overall%20survival%20with%20osimertinib%20in%20untreated%2C%20EGFR-mutated%20advanced%20NSCLC&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa1913662&amp;volume=382&amp;pages=41-50&amp;publication_year=2020&amp;author=Ramalingam%2CSS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">Oxnard, G. R. et al. Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib. <i>JAMA Oncol.</i> <b>4</b>, 15271534 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jamaoncol.2018.2969" data-track-item_id="10.1001/jamaoncol.2018.2969" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjamaoncol.2018.2969" aria-label="Article reference 16" data-doi="10.1001/jamaoncol.2018.2969">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30073261" aria-label="PubMed reference 16">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20resistance%20mechanisms%20and%20clinical%20implications%20in%20patients%20with%20EGFR%20T790M-positive%20lung%20cancer%20and%20acquired%20resistance%20to%20osimertinib&amp;journal=JAMA%20Oncol.&amp;doi=10.1001%2Fjamaoncol.2018.2969&amp;volume=4&amp;pages=1527-1534&amp;publication_year=2018&amp;author=Oxnard%2CGR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Yang, Z. et al. Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients. <i>Clin. Cancer Res.</i> <b>24</b>, 30973107 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-17-2310" data-track-item_id="10.1158/1078-0432.CCR-17-2310" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-17-2310" aria-label="Article reference 17" data-doi="10.1158/1078-0432.CCR-17-2310">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXht1alurvK" aria-label="CAS reference 17">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29506987" aria-label="PubMed reference 17">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Investigating%20novel%20resistance%20mechanisms%20to%20third-generation%20EGFR%20tyrosine%20kinase%20inhibitor%20osimertinib%20in%20non-small%20cell%20lung%20cancer%20patients&amp;journal=Clin.%20Cancer%20Res.&amp;doi=10.1158%2F1078-0432.CCR-17-2310&amp;volume=24&amp;pages=3097-3107&amp;publication_year=2018&amp;author=Yang%2CZ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Sequist, L. V. et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. <i>Sci. Transl. Med.</i> <b>3</b>, 75ra26 (2011).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/scitranslmed.3002003" data-track-item_id="10.1126/scitranslmed.3002003" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscitranslmed.3002003" aria-label="Article reference 18" data-doi="10.1126/scitranslmed.3002003">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21430269" aria-label="PubMed reference 18">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132801" aria-label="PubMed Central reference 18">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Genotypic%20and%20histological%20evolution%20of%20lung%20cancers%20acquiring%20resistance%20to%20EGFR%20inhibitors&amp;journal=Sci.%20Transl.%20Med.&amp;doi=10.1126%2Fscitranslmed.3002003&amp;volume=3&amp;publication_year=2011&amp;author=Sequist%2CLV">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Lambert, A. W. &amp; Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. <i>Nat. Rev. Cancer</i> <b>21</b>, 325338 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41568-021-00332-6" data-track-item_id="10.1038/s41568-021-00332-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41568-021-00332-6" aria-label="Article reference 19" data-doi="10.1038/s41568-021-00332-6">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXjsVCquro%3D" aria-label="CAS reference 19">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33547455" aria-label="PubMed reference 19">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=Linking%20EMT%20programmes%20to%20normal%20and%20neoplastic%20epithelial%20stem%20cells&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fs41568-021-00332-6&amp;volume=21&amp;pages=325-338&amp;publication_year=2021&amp;author=Lambert%2CAW&amp;author=Weinberg%2CRA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">Williams, E. D., Gao, D., Redfern, A. &amp; Thompson, E. W. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. <i>Nat. Rev. Cancer</i> <b>19</b>, 716732 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41568-019-0213-x" data-track-item_id="10.1038/s41568-019-0213-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41568-019-0213-x" aria-label="Article reference 20" data-doi="10.1038/s41568-019-0213-x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXitV2hsb7J" aria-label="CAS reference 20">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31666716" aria-label="PubMed reference 20">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055151" aria-label="PubMed Central reference 20">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Controversies%20around%20epithelial-mesenchymal%20plasticity%20in%20cancer%20metastasis&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fs41568-019-0213-x&amp;volume=19&amp;pages=716-732&amp;publication_year=2019&amp;author=Williams%2CED&amp;author=Gao%2CD&amp;author=Redfern%2CA&amp;author=Thompson%2CEW">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">Yao, Z. et al. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. <i>Proc. Natl Acad. Sci. USA</i> <b>107</b>, 1553515540 (2010).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1009472107" data-track-item_id="10.1073/pnas.1009472107" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1009472107" aria-label="Article reference 21" data-doi="10.1073/pnas.1009472107">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2010PNAS..10715535Y" aria-label="ADS reference 21">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtFaqu7%2FN" aria-label="CAS reference 21">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20713723" aria-label="PubMed reference 21">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932568" aria-label="PubMed Central reference 21">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20IL-6%20axis%20mediates%20selective%20and%20adaptive%20mechanisms%20of%20resistance%20to%20molecular%20targeted%20therapy%20in%20lung%20cancer&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.1009472107&amp;volume=107&amp;pages=15535-15540&amp;publication_year=2010&amp;author=Yao%2CZ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">Kim, S. M. et al. Activation of IL-6R/JAK1/STAT signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation. <i>Mol. Cancer Ther.</i> <b>11</b>, 22542264 (2012).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/1535-7163.MCT-12-0311" data-track-item_id="10.1158/1535-7163.MCT-12-0311" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F1535-7163.MCT-12-0311" aria-label="Article reference 22" data-doi="10.1158/1535-7163.MCT-12-0311">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhsVyksrvI" aria-label="CAS reference 22">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22891040" aria-label="PubMed reference 22">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Activation%20of%20IL-6R%2FJAK1%2FSTAT%20signaling%20induces%20de%20novo%20resistance%20to%20irreversible%20EGFR%20inhibitors%20in%20non-small%20cell%20lung%20cancer%20with%20T790M%20resistance%20mutation&amp;journal=Mol.%20Cancer%20Ther.&amp;doi=10.1158%2F1535-7163.MCT-12-0311&amp;volume=11&amp;pages=2254-2264&amp;publication_year=2012&amp;author=Kim%2CSM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Korkaya, H., Liu, S. &amp; Wicha, M. S. Regulation of cancer stem cells by cytokine networks: attacking cancers inflammatory roots. <i>Clin. Cancer Res.</i> <b>17</b>, 61256129 (2011).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-10-2743" data-track-item_id="10.1158/1078-0432.CCR-10-2743" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-10-2743" aria-label="Article reference 23" data-doi="10.1158/1078-0432.CCR-10-2743">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXht1Ggs7jP" aria-label="CAS reference 23">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21685479" aria-label="PubMed reference 23">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312242" aria-label="PubMed Central reference 23">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20cancer%20stem%20cells%20by%20cytokine%20networks%3A%20attacking%20cancer%E2%80%99s%20inflammatory%20roots&amp;journal=Clin.%20Cancer%20Res.&amp;doi=10.1158%2F1078-0432.CCR-10-2743&amp;volume=17&amp;pages=6125-6129&amp;publication_year=2011&amp;author=Korkaya%2CH&amp;author=Liu%2CS&amp;author=Wicha%2CMS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">Senescence-Associated Pro-inflammatory Cytokines, VernotJ. P. and tumor cell plasticity. <i>Front. Mol. Biosci.</i> <b>7</b>, 63 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2020FrMat...7...63S" aria-label="ADS reference 24">ADS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=and%20tumor%20cell%20plasticity&amp;journal=Front.%20Mol.%20Biosci.&amp;volume=7&amp;publication_year=2020&amp;author=Senescence-Associated%20Pro-inflammatory%20Cytokines%2CVernotJP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">Kurppa, K. J. et al. Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. <i>Cancer Cell</i> <b>37</b>, 104122.e112 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2019.12.006" data-track-item_id="10.1016/j.ccell.2019.12.006" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2019.12.006" aria-label="Article reference 25" data-doi="10.1016/j.ccell.2019.12.006">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXotVent78%3D" aria-label="CAS reference 25">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31935369" aria-label="PubMed reference 25">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146079" aria-label="PubMed Central reference 25">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Treatment-induced%20tumor%20dormancy%20through%20YAP-mediated%20transcriptional%20reprogramming%20of%20the%20apoptotic%20pathway&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2019.12.006&amp;volume=37&amp;pages=104-122.e112&amp;publication_year=2020&amp;author=Kurppa%2CKJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Ferone, G. et al. SOX2 is the determining oncogenic switch in promoting lung squamous cell carcinoma from different cells of origin. <i>Cancer Cell</i> <b>30</b>, 519532 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2016.09.001" data-track-item_id="10.1016/j.ccell.2016.09.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2016.09.001" aria-label="Article reference 26" data-doi="10.1016/j.ccell.2016.09.001">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhs1GqtLbP" aria-label="CAS reference 26">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27728803" aria-label="PubMed reference 26">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065004" aria-label="PubMed Central reference 26">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=SOX2%20is%20the%20determining%20oncogenic%20switch%20in%20promoting%20lung%20squamous%20cell%20carcinoma%20from%20different%20cells%20of%20origin&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2016.09.001&amp;volume=30&amp;pages=519-532&amp;publication_year=2016&amp;author=Ferone%2CG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">Boumahdi, S. &amp; de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. <i>Nat. Rev. Drug Discov.</i> <b>19</b>, 3956 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41573-019-0044-1" data-track-item_id="10.1038/s41573-019-0044-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41573-019-0044-1" aria-label="Article reference 27" data-doi="10.1038/s41573-019-0044-1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvFCktL%2FM" aria-label="CAS reference 27">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31601994" aria-label="PubMed reference 27">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20great%20escape%3A%20tumour%20cell%20plasticity%20in%20resistance%20to%20targeted%20therapy&amp;journal=Nat.%20Rev.%20Drug%20Discov.&amp;doi=10.1038%2Fs41573-019-0044-1&amp;volume=19&amp;pages=39-56&amp;publication_year=2020&amp;author=Boumahdi%2CS&amp;author=Sauvage%2CFJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Mosteiro, L. et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. <i>Science</i> <b>354</b>, 6315 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.aaf4445" data-track-item_id="10.1126/science.aaf4445" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.aaf4445" aria-label="Article reference 28" data-doi="10.1126/science.aaf4445">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Tissue%20damage%20and%20senescence%20provide%20critical%20signals%20for%20cellular%20reprogramming%20in%20vivo&amp;journal=Science&amp;doi=10.1126%2Fscience.aaf4445&amp;volume=354&amp;publication_year=2016&amp;author=Mosteiro%2CL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">Bora-Singhal, N. et al. YAP1 regulates OCT4 activity and SOX2 expression to facilitate self-renewal and vascular mimicry of stem-like cells. <i>Stem cells</i> <b>33</b>, 17051718 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/stem.1993" data-track-item_id="10.1002/stem.1993" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fstem.1993" aria-label="Article reference 29" data-doi="10.1002/stem.1993">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtleqsLvK" aria-label="CAS reference 29">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25754111" aria-label="PubMed reference 29">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=YAP1%20regulates%20OCT4%20activity%20and%20SOX2%20expression%20to%20facilitate%20self-renewal%20and%20vascular%20mimicry%20of%20stem-like%20cells&amp;journal=Stem%20cells&amp;doi=10.1002%2Fstem.1993&amp;volume=33&amp;pages=1705-1718&amp;publication_year=2015&amp;author=Bora-Singhal%2CN">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Poupart, P. et al. B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). <i>EMBO J</i> <b>6</b>, 12191224 (1987).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/j.1460-2075.1987.tb02357.x" data-track-item_id="10.1002/j.1460-2075.1987.tb02357.x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fj.1460-2075.1987.tb02357.x" aria-label="Article reference 30" data-doi="10.1002/j.1460-2075.1987.tb02357.x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaL2sXkt1Wktr0%3D" aria-label="CAS reference 30">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3497029" aria-label="PubMed reference 30">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC553922" aria-label="PubMed Central reference 30">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=B%20cell%20growth%20modulating%20and%20differentiating%20activity%20of%20recombinant%20human%2026-kd%20protein%20%28BSF-2%2C%20HuIFN-beta%202%2C%20HPGF%29&amp;journal=EMBO%20J&amp;doi=10.1002%2Fj.1460-2075.1987.tb02357.x&amp;volume=6&amp;pages=1219-1224&amp;publication_year=1987&amp;author=Poupart%2CP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">May, L. T. et al. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. <i>Biochem. Biophys. Res. Commun.</i> <b>152</b>, 11441150 (1988).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0006-291X(88)80404-2" data-track-item_id="10.1016/S0006-291X(88)80404-2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0006-291X%2888%2980404-2" aria-label="Article reference 31" data-doi="10.1016/S0006-291X(88)80404-2">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaL1cXktVGjt70%3D" aria-label="CAS reference 31">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3259872" aria-label="PubMed reference 31">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Phosphorylation%20of%20secreted%20forms%20of%20human%20beta%202-interferon%2Fhepatocyte%20stimulating%20factor%2Finterleukin-6&amp;journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;doi=10.1016%2FS0006-291X%2888%2980404-2&amp;volume=152&amp;pages=1144-1150&amp;publication_year=1988&amp;author=May%2CLT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Hirano, T. et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). <i>Proc. Natl Acad. Sci. USA</i> <b>82</b>, 54905494 (1985).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.82.16.5490" data-track-item_id="10.1073/pnas.82.16.5490" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.82.16.5490" aria-label="Article reference 32" data-doi="10.1073/pnas.82.16.5490">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=1985PNAS...82.5490H" aria-label="ADS reference 32">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaL2MXlt1Wnt7s%3D" aria-label="CAS reference 32">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2410927" aria-label="PubMed reference 32">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC391148" aria-label="PubMed Central reference 32">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Purification%20to%20homogeneity%20and%20characterization%20of%20human%20B-cell%20differentiation%20factor%20%28BCDF%20or%20BSFp-2%29&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.82.16.5490&amp;volume=82&amp;pages=5490-5494&amp;publication_year=1985&amp;author=Hirano%2CT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">May, L. T., Santhanam, U. &amp; Sehgal, P. B. On the multimeric nature of natural human interleukin-6. <i>J. Biol. Chem.</i> <b>266</b>, 99509955 (1991).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0021-9258(18)92911-X" data-track-item_id="10.1016/S0021-9258(18)92911-X" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0021-9258%2818%2992911-X" aria-label="Article reference 33" data-doi="10.1016/S0021-9258(18)92911-X">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK3MXkt1Onsbw%3D" aria-label="CAS reference 33">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2033081" aria-label="PubMed reference 33">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=On%20the%20multimeric%20nature%20of%20natural%20human%20interleukin-6&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1016%2FS0021-9258%2818%2992911-X&amp;volume=266&amp;pages=9950-9955&amp;publication_year=1991&amp;author=May%2CLT&amp;author=Santhanam%2CU&amp;author=Sehgal%2CPB">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Mereiter, S., Balmana, M., Campos, D., Gomes, J. &amp; Reis, C. A. Glycosylation in the era of cancer-targeted therapy: where are we heading? <i>Cancer Cell</i> <b>36</b>, 616 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2019.06.006" data-track-item_id="10.1016/j.ccell.2019.06.006" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2019.06.006" aria-label="Article reference 34" data-doi="10.1016/j.ccell.2019.06.006">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtlersb%2FJ" aria-label="CAS reference 34">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31287993" aria-label="PubMed reference 34">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=Glycosylation%20in%20the%20era%20of%20cancer-targeted%20therapy%3A%20where%20are%20we%20heading%3F&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2019.06.006&amp;volume=36&amp;pages=6-16&amp;publication_year=2019&amp;author=Mereiter%2CS&amp;author=Balmana%2CM&amp;author=Campos%2CD&amp;author=Gomes%2CJ&amp;author=Reis%2CCA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Parekh, R. B., Dwek, R. A., Rademacher, T. W., Opdenakker, G. &amp; Van Damme, J. Glycosylation of interleukin-6 purified from normal human blood mononuclear cells. <i>Eur. J. Biochem.</i> <b>203</b>, 135141 (1992).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/j.1432-1033.1992.tb19838.x" data-track-item_id="10.1111/j.1432-1033.1992.tb19838.x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fj.1432-1033.1992.tb19838.x" aria-label="Article reference 35" data-doi="10.1111/j.1432-1033.1992.tb19838.x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK38Xht1KmtL8%3D" aria-label="CAS reference 35">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1730219" aria-label="PubMed reference 35">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Glycosylation%20of%20interleukin-6%20purified%20from%20normal%20human%20blood%20mononuclear%20cells&amp;journal=Eur.%20J.%20Biochem.&amp;doi=10.1111%2Fj.1432-1033.1992.tb19838.x&amp;volume=203&amp;pages=135-141&amp;publication_year=1992&amp;author=Parekh%2CRB&amp;author=Dwek%2CRA&amp;author=Rademacher%2CTW&amp;author=Opdenakker%2CG&amp;author=Damme%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Dela Cruz, C. S. et al. N-linked glycosylation is required for optimal function of Kaposis sarcoma herpesvirus-encoded, but not cellular, interleukin 6. <i>J. Exp. Med.</i> <b>199</b>, 503514 (2004).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.20031205" data-track-item_id="10.1084/jem.20031205" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.20031205" aria-label="Article reference 36" data-doi="10.1084/jem.20031205">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=N-linked%20glycosylation%20is%20required%20for%20optimal%20function%20of%20Kaposi%E2%80%99s%20sarcoma%20herpesvirus-encoded%2C%20but%20not%20cellular%2C%20interleukin%206&amp;journal=J.%20Exp.%20Med.&amp;doi=10.1084%2Fjem.20031205&amp;volume=199&amp;pages=503-514&amp;publication_year=2004&amp;author=Cruz%2CCS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Thomas, D., Rathinavel, A. K. &amp; Radhakrishnan, P. Altered glycosylation in cancer: a promising target for biomarkers and therapeutics. <i>Biochimica. et biophysica. Acta Rev. Cancer</i> <b>1875</b>, 188464 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bbcan.2020.188464" data-track-item_id="10.1016/j.bbcan.2020.188464" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bbcan.2020.188464" aria-label="Article reference 37" data-doi="10.1016/j.bbcan.2020.188464">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitl2msr%2FP" aria-label="CAS reference 37">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Altered%20glycosylation%20in%20cancer%3A%20a%20promising%20target%20for%20biomarkers%20and%20therapeutics&amp;journal=Biochimica.%20et%20biophysica.%20Acta%20Rev.%20Cancer&amp;doi=10.1016%2Fj.bbcan.2020.188464&amp;volume=1875&amp;publication_year=2021&amp;author=Thomas%2CD&amp;author=Rathinavel%2CAK&amp;author=Radhakrishnan%2CP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">Pinho, S. S. &amp; Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. <i>Nat. Rev. Cancer</i> <b>15</b>, 540555 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrc3982" data-track-item_id="10.1038/nrc3982" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrc3982" aria-label="Article reference 38" data-doi="10.1038/nrc3982">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtlKkt7fK" aria-label="CAS reference 38">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26289314" aria-label="PubMed reference 38">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Glycosylation%20in%20cancer%3A%20mechanisms%20and%20clinical%20implications&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fnrc3982&amp;volume=15&amp;pages=540-555&amp;publication_year=2015&amp;author=Pinho%2CSS&amp;author=Reis%2CCA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">Yeh, H. H., Lai, W. W., Chen, H. H., Liu, H. S. &amp; Su, W. C. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. <i>Oncogene</i> <b>25</b>, 43004309 (2006).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/sj.onc.1209464" data-track-item_id="10.1038/sj.onc.1209464" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fsj.onc.1209464" aria-label="Article reference 39" data-doi="10.1038/sj.onc.1209464">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XntVWks7o%3D" aria-label="CAS reference 39">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16518408" aria-label="PubMed reference 39">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Autocrine%20IL-6-induced%20Stat3%20activation%20contributes%20to%20the%20pathogenesis%20of%20lung%20adenocarcinoma%20and%20malignant%20pleural%20effusion&amp;journal=Oncogene&amp;doi=10.1038%2Fsj.onc.1209464&amp;volume=25&amp;pages=4300-4309&amp;publication_year=2006&amp;author=Yeh%2CHH&amp;author=Lai%2CWW&amp;author=Chen%2CHH&amp;author=Liu%2CHS&amp;author=Su%2CWC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Roth, J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. <i>Chem. Rev.</i> <b>102</b>, 285303 (2002).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/cr000423j" data-track-item_id="10.1021/cr000423j" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Fcr000423j" aria-label="Article reference 40" data-doi="10.1021/cr000423j">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XntlGrug%3D%3D" aria-label="CAS reference 40">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11841244" aria-label="PubMed reference 40">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Protein%20N-glycosylation%20along%20the%20secretory%20pathway%3A%20relationship%20to%20organelle%20topography%20and%20function%2C%20protein%20quality%20control%2C%20and%20cell%20interactions&amp;journal=Chem.%20Rev.&amp;doi=10.1021%2Fcr000423j&amp;volume=102&amp;pages=285-303&amp;publication_year=2002&amp;author=Roth%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">Bard, F. &amp; Chia, J. Cracking the glycome encoder: signaling, trafficking, and glycosylation. <i>Trends Cell Biol.</i> <b>26</b>, 379388 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.tcb.2015.12.004" data-track-item_id="10.1016/j.tcb.2015.12.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.tcb.2015.12.004" aria-label="Article reference 41" data-doi="10.1016/j.tcb.2015.12.004">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XjslKrtA%3D%3D" aria-label="CAS reference 41">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26832820" aria-label="PubMed reference 41">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Cracking%20the%20glycome%20encoder%3A%20signaling%2C%20trafficking%2C%20and%20glycosylation&amp;journal=Trends%20Cell%20Biol.&amp;doi=10.1016%2Fj.tcb.2015.12.004&amp;volume=26&amp;pages=379-388&amp;publication_year=2016&amp;author=Bard%2CF&amp;author=Chia%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. &amp; Clausen, H. Global view of human protein glycosylation pathways and functions. <i>Nat. Rev. Mol. Cell Biol.</i> <b>21</b>, 729749 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41580-020-00294-x" data-track-item_id="10.1038/s41580-020-00294-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41580-020-00294-x" aria-label="Article reference 42" data-doi="10.1038/s41580-020-00294-x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitFGmu73N" aria-label="CAS reference 42">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33087899" aria-label="PubMed reference 42">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Global%20view%20of%20human%20protein%20glycosylation%20pathways%20and%20functions&amp;journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;doi=10.1038%2Fs41580-020-00294-x&amp;volume=21&amp;pages=729-749&amp;publication_year=2020&amp;author=Schjoldager%2CKT&amp;author=Narimatsu%2CY&amp;author=Joshi%2CHJ&amp;author=Clausen%2CH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. <i>Proc. Natl Acad. Sci. USA</i> <b>102</b>, 1554515550 (2005).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.0506580102" data-track-item_id="10.1073/pnas.0506580102" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.0506580102" aria-label="Article reference 43" data-doi="10.1073/pnas.0506580102">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2005PNAS..10215545S" aria-label="ADS reference 43">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1ShtrnO" aria-label="CAS reference 43">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16199517" aria-label="PubMed reference 43">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1239896" aria-label="PubMed Central reference 43">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Gene%20set%20enrichment%20analysis%3A%20a%20knowledge-based%20approach%20for%20interpreting%20genome-wide%20expression%20profiles&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.0506580102&amp;volume=102&amp;pages=15545-15550&amp;publication_year=2005&amp;author=Subramanian%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. <i>Nat. Genet.</i> <b>34</b>, 267273 (2003).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ng1180" data-track-item_id="10.1038/ng1180" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fng1180" aria-label="Article reference 44" data-doi="10.1038/ng1180">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXkvFSrs7o%3D" aria-label="CAS reference 44">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12808457" aria-label="PubMed reference 44">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=PGC-1alpha-responsive%20genes%20involved%20in%20oxidative%20phosphorylation%20are%20coordinately%20downregulated%20in%20human%20diabetes&amp;journal=Nat.%20Genet.&amp;doi=10.1038%2Fng1180&amp;volume=34&amp;pages=267-273&amp;publication_year=2003&amp;author=Mootha%2CVK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45">Okayama, H. et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. <i>Cancer Res.</i> <b>72</b>, 100111 (2012).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-11-1403" data-track-item_id="10.1158/0008-5472.CAN-11-1403" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-11-1403" aria-label="Article reference 45" data-doi="10.1158/0008-5472.CAN-11-1403">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhvVCmtg%3D%3D" aria-label="CAS reference 45">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22080568" aria-label="PubMed reference 45">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20genes%20upregulated%20in%20ALK-positive%20and%20EGFR%2FKRAS%2FALK-negative%20lung%20adenocarcinomas&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-11-1403&amp;volume=72&amp;pages=100-111&amp;publication_year=2012&amp;author=Okayama%2CH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."><p class="c-article-references__text" id="ref-CR46">Lopez-Sambrooks, C. et al. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. <i>Nat. Chem. Biol.</i> <b>12</b>, 10231030 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nchembio.2194" data-track-item_id="10.1038/nchembio.2194" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnchembio.2194" aria-label="Article reference 46" data-doi="10.1038/nchembio.2194">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XhsFOmsLvE" aria-label="CAS reference 46">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27694802" aria-label="PubMed reference 46">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393272" aria-label="PubMed Central reference 46">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Oligosaccharyltransferase%20inhibition%20induces%20senescence%20in%20RTK-driven%20tumor%20cells&amp;journal=Nat.%20Chem.%20Biol.&amp;doi=10.1038%2Fnchembio.2194&amp;volume=12&amp;pages=1023-1030&amp;publication_year=2016&amp;author=Lopez-Sambrooks%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."><p class="c-article-references__text" id="ref-CR47">Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S. &amp; Brunak, S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. <i>Proteomics</i> <b>4</b>, 16331649 (2004).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/pmic.200300771" data-track-item_id="10.1002/pmic.200300771" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fpmic.200300771" aria-label="Article reference 47" data-doi="10.1002/pmic.200300771">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXkvFGitLg%3D" aria-label="CAS reference 47">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15174133" aria-label="PubMed reference 47">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Prediction%20of%20post-translational%20glycosylation%20and%20phosphorylation%20of%20proteins%20from%20the%20amino%20acid%20sequence&amp;journal=Proteomics&amp;doi=10.1002%2Fpmic.200300771&amp;volume=4&amp;pages=1633-1649&amp;publication_year=2004&amp;author=Blom%2CN&amp;author=Sicheritz-Ponten%2CT&amp;author=Gupta%2CR&amp;author=Gammeltoft%2CS&amp;author=Brunak%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."><p class="c-article-references__text" id="ref-CR48">Yamaguchi, K. et al. Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties. <i>J. Biol. Chem</i>. <b>266</b>, 2043420439 (1991).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0021-9258(18)54942-5" data-track-item_id="10.1016/S0021-9258(18)54942-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0021-9258%2818%2954942-5" aria-label="Article reference 48" data-doi="10.1016/S0021-9258(18)54942-5">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK3MXlvFykt70%3D" aria-label="CAS reference 48">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1657925" aria-label="PubMed reference 48">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=Effects%20of%20site-directed%20removal%20of%20N-glycosylation%20sites%20in%20human%20erythropoietin%20on%20its%20production%20and%20biological%20properties&amp;journal=J.%20Biol.%20Chem&amp;doi=10.1016%2FS0021-9258%2818%2954942-5&amp;volume=266&amp;pages=20434-20439&amp;publication_year=1991&amp;author=Yamaguchi%2CK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."><p class="c-article-references__text" id="ref-CR49">Bobby, R. et al. Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6. <i>FEBS J.</i> <b>281</b>, 24712483 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/febs.12800" data-track-item_id="10.1111/febs.12800" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Ffebs.12800" aria-label="Article reference 49" data-doi="10.1111/febs.12800">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXotFemtL0%3D" aria-label="CAS reference 49">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24712547" aria-label="PubMed reference 49">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Functional%20implications%20of%20large%20backbone%20amplitude%20motions%20of%20the%20glycoprotein%20130-binding%20epitope%20of%20interleukin-6&amp;journal=FEBS%20J.&amp;doi=10.1111%2Ffebs.12800&amp;volume=281&amp;pages=2471-2483&amp;publication_year=2014&amp;author=Bobby%2CR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."><p class="c-article-references__text" id="ref-CR50">Xiong, H. et al. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. <i>J. Biol. Chem.</i> <b>287</b>, 58195832 (2012).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M111.295964" data-track-item_id="10.1074/jbc.M111.295964" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M111.295964" aria-label="Article reference 50" data-doi="10.1074/jbc.M111.295964">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XisVyluro%3D" aria-label="CAS reference 50">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22205702" aria-label="PubMed reference 50">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=Roles%20of%20STAT3%20and%20ZEB1%20proteins%20in%20E-cadherin%20down-regulation%20and%20human%20colorectal%20cancer%20epithelial-mesenchymal%20transition&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1074%2Fjbc.M111.295964&amp;volume=287&amp;pages=5819-5832&amp;publication_year=2012&amp;author=Xiong%2CH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."><p class="c-article-references__text" id="ref-CR51">Wei, W. et al. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer. <i>Stem cells</i> <b>32</b>, 25712582 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/stem.1752" data-track-item_id="10.1002/stem.1752" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fstem.1752" aria-label="Article reference 51" data-doi="10.1002/stem.1752">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvFGjtLzE" aria-label="CAS reference 51">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24891218" aria-label="PubMed reference 51">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=STAT3%20signaling%20is%20activated%20preferentially%20in%20tumor-initiating%20cells%20in%20claudin-low%20models%20of%20human%20breast%20cancer&amp;journal=Stem%20cells&amp;doi=10.1002%2Fstem.1752&amp;volume=32&amp;pages=2571-2582&amp;publication_year=2014&amp;author=Wei%2CW">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."><p class="c-article-references__text" id="ref-CR52">Yao, C. et al. IGF/STAT3/NANOG/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer. <i>Stem Cells</i> <b>34</b>, 820831 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/stem.2320" data-track-item_id="10.1002/stem.2320" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fstem.2320" aria-label="Article reference 52" data-doi="10.1002/stem.2320">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26840943" aria-label="PubMed reference 52">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=IGF%2FSTAT3%2FNANOG%2FSlug%20signaling%20axis%20simultaneously%20controls%20epithelial-mesenchymal%20transition%20and%20stemness%20maintenance%20in%20colorectal%20cancer&amp;journal=Stem%20Cells&amp;doi=10.1002%2Fstem.2320&amp;volume=34&amp;pages=820-831&amp;publication_year=2016&amp;author=Yao%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."><p class="c-article-references__text" id="ref-CR53">Na, Y. R., Lee, J. S., Lee, S. J. &amp; Seok, S. H. Interleukin-6-induced twist and N-cadherin enhance melanoma cell metastasis. <i>Melanoma Res.</i> <b>23</b>, 434443 (2013).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/CMR.0000000000000021" data-track-item_id="10.1097/CMR.0000000000000021" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2FCMR.0000000000000021" aria-label="Article reference 53" data-doi="10.1097/CMR.0000000000000021">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhs12rtbbK" aria-label="CAS reference 53">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24051540" aria-label="PubMed reference 53">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Interleukin-6-induced%20twist%20and%20N-cadherin%20enhance%20melanoma%20cell%20metastasis&amp;journal=Melanoma%20Res.&amp;doi=10.1097%2FCMR.0000000000000021&amp;volume=23&amp;pages=434-443&amp;publication_year=2013&amp;author=Na%2CYR&amp;author=Lee%2CJS&amp;author=Lee%2CSJ&amp;author=Seok%2CSH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."><p class="c-article-references__text" id="ref-CR54">Gallucci, R. M., Lee, E. G. &amp; Tomasek, J. J. IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. <i>J. Invest. Dermatol</i>. <b>126</b>, 561568 (2006).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/sj.jid.5700109" data-track-item_id="10.1038/sj.jid.5700109" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fsj.jid.5700109" aria-label="Article reference 54" data-doi="10.1038/sj.jid.5700109">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XhsVSrsLc%3D" aria-label="CAS reference 54">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16397521" aria-label="PubMed reference 54">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6%20modulates%20alpha-smooth%20muscle%20actin%20expression%20in%20dermal%20fibroblasts%20from%20IL-6-deficient%20mice&amp;journal=J.%20Invest.%20Dermatol&amp;doi=10.1038%2Fsj.jid.5700109&amp;volume=126&amp;pages=561-568&amp;publication_year=2006&amp;author=Gallucci%2CRM&amp;author=Lee%2CEG&amp;author=Tomasek%2CJJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."><p class="c-article-references__text" id="ref-CR55">Romera-Hernandez, M. et al. Yap1-driven intestinal repair is controlled by group 3 innate lymphoid cells. <i>Cell Rep.</i> <b>30</b>, 3745.e33 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2019.11.115" data-track-item_id="10.1016/j.celrep.2019.11.115" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2019.11.115" aria-label="Article reference 55" data-doi="10.1016/j.celrep.2019.11.115">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXotFert70%3D" aria-label="CAS reference 55">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31914395" aria-label="PubMed reference 55">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=Yap1-driven%20intestinal%20repair%20is%20controlled%20by%20group%203%20innate%20lymphoid%20cells&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2019.11.115&amp;volume=30&amp;pages=37-45.e33&amp;publication_year=2020&amp;author=Romera-Hernandez%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."><p class="c-article-references__text" id="ref-CR56">Tsuji, T. et al. YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. <i>Nat. Commun.</i> <b>11</b>, 74 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-019-13771-5" data-track-item_id="10.1038/s41467-019-13771-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-019-13771-5" aria-label="Article reference 56" data-doi="10.1038/s41467-019-13771-5">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2020NatCo..11...74T" aria-label="ADS reference 56">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXlslWisg%3D%3D" aria-label="CAS reference 56">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31900393" aria-label="PubMed reference 56">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941996" aria-label="PubMed Central reference 56">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=YAP1%20mediates%20survival%20of%20ALK-rearranged%20lung%20cancer%20cells%20treated%20with%20alectinib%20via%20pro-apoptotic%20protein%20regulation&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-019-13771-5&amp;volume=11&amp;publication_year=2020&amp;author=Tsuji%2CT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."><p class="c-article-references__text" id="ref-CR57">Takahashi, A. et al. Ankyrin repeat domain 1 overexpression is associated with common resistance to afatinib and osimertinib in EGFR-mutant lung cancer. <i>Sci. Rep.</i> <b>8</b>, 14896 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41598-018-33190-8" data-track-item_id="10.1038/s41598-018-33190-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41598-018-33190-8" aria-label="Article reference 57" data-doi="10.1038/s41598-018-33190-8">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2018NatSR...814896T" aria-label="ADS reference 57">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30291293" aria-label="PubMed reference 57">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173712" aria-label="PubMed Central reference 57">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;title=Ankyrin%20repeat%20domain%201%20overexpression%20is%20associated%20with%20common%20resistance%20to%20afatinib%20and%20osimertinib%20in%20EGFR-mutant%20lung%20cancer&amp;journal=Sci.%20Rep.&amp;doi=10.1038%2Fs41598-018-33190-8&amp;volume=8&amp;publication_year=2018&amp;author=Takahashi%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."><p class="c-article-references__text" id="ref-CR58">Zheng, S. et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. <i>Genom. Proteom. Bioinform.</i> <b>20</b>, 587596 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.gpb.2022.01.004" data-track-item_id="10.1016/j.gpb.2022.01.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.gpb.2022.01.004" aria-label="Article reference 58" data-doi="10.1016/j.gpb.2022.01.004">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;title=SynergyFinder%20plus%3A%20toward%20better%20interpretation%20and%20annotation%20of%20drug%20combination%20screening%20datasets&amp;journal=Genom.%20Proteom.%20Bioinform.&amp;doi=10.1016%2Fj.gpb.2022.01.004&amp;volume=20&amp;pages=587-596&amp;publication_year=2022&amp;author=Zheng%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."><p class="c-article-references__text" id="ref-CR59">Roper, N. et al. Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer. <i>Cell Rep. Med.</i> <b>1</b>, 10007 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;title=Clonal%20evolution%20and%20heterogeneity%20of%20osimertinib%20acquired%20resistance%20mechanisms%20in%20EGFR%20mutant%20lung%20cancer&amp;journal=Cell%20Rep.%20Med.&amp;volume=1&amp;publication_year=2020&amp;author=Roper%2CN">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."><p class="c-article-references__text" id="ref-CR60">Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. <i>Nature</i> <b>462</b>, 108112 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature08460" data-track-item_id="10.1038/nature08460" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature08460" aria-label="Article reference 60" data-doi="10.1038/nature08460">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2009Natur.462..108B" aria-label="ADS reference 60">ADS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXht12gtrvL" aria-label="CAS reference 60">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19847166" aria-label="PubMed reference 60">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783335" aria-label="PubMed Central reference 60">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;title=Systematic%20RNA%20interference%20reveals%20that%20oncogenic%20KRAS-driven%20cancers%20require%20TBK1&amp;journal=Nature&amp;doi=10.1038%2Fnature08460&amp;volume=462&amp;pages=108-112&amp;publication_year=2009&amp;author=Barbie%2CDA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."><p class="c-article-references__text" id="ref-CR61">Heinz, M. C. et al. Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage. <i>Cancer Res.</i> <b>82</b>, 19531968 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-21-0933" data-track-item_id="10.1158/0008-5472.CAN-21-0933" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-21-0933" aria-label="Article reference 61" data-doi="10.1158/0008-5472.CAN-21-0933">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhsFehsbrE" aria-label="CAS reference 61">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35570706" aria-label="PubMed reference 61">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381095" aria-label="PubMed Central reference 61">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;title=Liver%20colonization%20by%20colorectal%20cancer%20metastases%20requires%20YAP-controlled%20plasticity%20at%20the%20micrometastatic%20stage&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-21-0933&amp;volume=82&amp;pages=1953-1968&amp;publication_year=2022&amp;author=Heinz%2CMC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."><p class="c-article-references__text" id="ref-CR62">Hamanaka, N. et al. YES1 is a targetable oncogene in cancers harboring YES1 gene amplification. <i>Cancer Res.</i> <b>79</b>, 57345745 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-18-3376" data-track-item_id="10.1158/0008-5472.CAN-18-3376" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-18-3376" aria-label="Article reference 62" data-doi="10.1158/0008-5472.CAN-18-3376">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXjslGjs70%3D" aria-label="CAS reference 62">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31391186" aria-label="PubMed reference 62">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;title=YES1%20is%20a%20targetable%20oncogene%20in%20cancers%20harboring%20YES1%20gene%20amplification&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-18-3376&amp;volume=79&amp;pages=5734-5745&amp;publication_year=2019&amp;author=Hamanaka%2CN">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."><p class="c-article-references__text" id="ref-CR63">Lopez Sambrooks, C. et al. Oligosaccharyltransferase inhibition overcomes therapeutic resistance to EGFR tyrosine kinase inhibitors. <i>Cancer Res.</i> <b>78</b>, 50945106 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-18-0505" data-track-item_id="10.1158/0008-5472.CAN-18-0505" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-18-0505" aria-label="Article reference 63" data-doi="10.1158/0008-5472.CAN-18-0505">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30026325" aria-label="PubMed reference 63">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 63" href="http://scholar.google.com/scholar_lookup?&amp;title=Oligosaccharyltransferase%20inhibition%20overcomes%20therapeutic%20resistance%20to%20EGFR%20tyrosine%20kinase%20inhibitors&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-18-0505&amp;volume=78&amp;pages=5094-5106&amp;publication_year=2018&amp;author=Lopez%20Sambrooks%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."><p class="c-article-references__text" id="ref-CR64">Chan, L. C. et al. IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. <i>J. Clin. Invest.</i> <b>129</b>, 33243338 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI126022" data-track-item_id="10.1172/JCI126022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI126022" aria-label="Article reference 64" data-doi="10.1172/JCI126022">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31305264" aria-label="PubMed reference 64">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668668" aria-label="PubMed Central reference 64">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6%2FJAK1%20pathway%20drives%20PD-L1%20Y112%20phosphorylation%20to%20promote%20cancer%20immune%20evasion&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI126022&amp;volume=129&amp;pages=3324-3338&amp;publication_year=2019&amp;author=Chan%2CLC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."><p class="c-article-references__text" id="ref-CR65">Miller, M. R. et al. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. <i>Mol. Cancer</i> <b>14</b>, 141 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s12943-015-0416-z" data-track-item_id="10.1186/s12943-015-0416-z" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12943-015-0416-z" aria-label="Article reference 65" data-doi="10.1186/s12943-015-0416-z">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26220087" aria-label="PubMed reference 65">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518861" aria-label="PubMed Central reference 65">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 65" href="http://scholar.google.com/scholar_lookup?&amp;title=Downregulation%20of%20dystroglycan%20glycosyltransferases%20LARGE2%20and%20ISPD%20associate%20with%20increased%20mortality%20in%20clear%20cell%20renal%20cell%20carcinoma&amp;journal=Mol.%20Cancer&amp;doi=10.1186%2Fs12943-015-0416-z&amp;volume=14&amp;publication_year=2015&amp;author=Miller%2CMR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="66."><p class="c-article-references__text" id="ref-CR66">Chugh, S., Meza, J., Sheinin, Y. M., Ponnusamy, M. P. &amp; Batra, S. K. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. <i>Br. J. Cancer</i> <b>114</b>, 13761386 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/bjc.2016.116" data-track-item_id="10.1038/bjc.2016.116" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fbjc.2016.116" aria-label="Article reference 66" data-doi="10.1038/bjc.2016.116">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XotFOhurw%3D" aria-label="CAS reference 66">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27187683" aria-label="PubMed reference 66">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984453" aria-label="PubMed Central reference 66">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 66" href="http://scholar.google.com/scholar_lookup?&amp;title=Loss%20of%20N-acetylgalactosaminyltransferase%203%20in%20poorly%20differentiated%20pancreatic%20cancer%3A%20augmented%20aggressiveness%20and%20aberrant%20ErbB%20family%20glycosylation&amp;journal=Br.%20J.%20Cancer&amp;doi=10.1038%2Fbjc.2016.116&amp;volume=114&amp;pages=1376-1386&amp;publication_year=2016&amp;author=Chugh%2CS&amp;author=Meza%2CJ&amp;author=Sheinin%2CYM&amp;author=Ponnusamy%2CMP&amp;author=Batra%2CSK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="67."><p class="c-article-references__text" id="ref-CR67">Peng, C. et al. Regulation of the Hippo-YAP pathway by glucose sensor O-GlcNAcylation. <i>Mol. Cell</i> <b>68</b>, 591604.e595 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molcel.2017.10.010" data-track-item_id="10.1016/j.molcel.2017.10.010" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molcel.2017.10.010" aria-label="Article reference 67" data-doi="10.1016/j.molcel.2017.10.010">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhslOju7rJ" aria-label="CAS reference 67">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29100056" aria-label="PubMed reference 67">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 67" href="http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20the%20Hippo-YAP%20pathway%20by%20glucose%20sensor%20O-GlcNAcylation&amp;journal=Mol.%20Cell&amp;doi=10.1016%2Fj.molcel.2017.10.010&amp;volume=68&amp;pages=591-604.e595&amp;publication_year=2017&amp;author=Peng%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="68."><p class="c-article-references__text" id="ref-CR68">Hung, T. L. et al. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis. <i>Clin. Cancer Res.</i> <b>9</b>, 26052612 (2003).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXlt1yrsrg%3D" aria-label="CAS reference 68">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12855637" aria-label="PubMed reference 68">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 68" href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20evaluation%20of%20HER-2%2Fneu%20protein%20in%20malignant%20pleural%20effusion-associated%20lung%20adenocarcinoma%20and%20as%20a%20tumor%20marker%20in%20pleural%20effusion%20diagnosis&amp;journal=Clin.%20Cancer%20Res.&amp;volume=9&amp;pages=2605-2612&amp;publication_year=2003&amp;author=Hung%2CTL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="69."><p class="c-article-references__text" id="ref-CR69">Chu, Y. W. et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. <i>Am. J. Respir. Cell Mol. Biol.</i> <b>17</b>, 353360 (1997).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1165/ajrcmb.17.3.2837" data-track-item_id="10.1165/ajrcmb.17.3.2837" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1165%2Fajrcmb.17.3.2837" aria-label="Article reference 69" data-doi="10.1165/ajrcmb.17.3.2837">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2sXmtVOrs7c%3D" aria-label="CAS reference 69">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9308922" aria-label="PubMed reference 69">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 69" href="http://scholar.google.com/scholar_lookup?&amp;title=Selection%20of%20invasive%20and%20metastatic%20subpopulations%20from%20a%20human%20lung%20adenocarcinoma%20cell%20line&amp;journal=Am.%20J.%20Respir.%20Cell%20Mol.%20Biol.&amp;doi=10.1165%2Fajrcmb.17.3.2837&amp;volume=17&amp;pages=353-360&amp;publication_year=1997&amp;author=Chu%2CYW">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="70."><p class="c-article-references__text" id="ref-CR70">Wisniewski, J. R., Zougman, A., Nagaraj, N. &amp; Mann, M. Universal sample preparation method for proteome analysis. <i>Nat. Methods</i> <b>6</b>, 359362 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nmeth.1322" data-track-item_id="10.1038/nmeth.1322" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnmeth.1322" aria-label="Article reference 70" data-doi="10.1038/nmeth.1322">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXks12ksb0%3D" aria-label="CAS reference 70">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19377485" aria-label="PubMed reference 70">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;title=Universal%20sample%20preparation%20method%20for%20proteome%20analysis&amp;journal=Nat.%20Methods&amp;doi=10.1038%2Fnmeth.1322&amp;volume=6&amp;pages=359-362&amp;publication_year=2009&amp;author=Wisniewski%2CJR&amp;author=Zougman%2CA&amp;author=Nagaraj%2CN&amp;author=Mann%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="71."><p class="c-article-references__text" id="ref-CR71">Bern, M., Kil, Y. J. &amp; Becker, C. Byonic: advanced peptide and protein identification software. <i>Curr. Protocol. Bioinform.</i> <b>13</b>, 13 20 1113 20 14 (2012).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 71" href="http://scholar.google.com/scholar_lookup?&amp;title=Byonic%3A%20advanced%20peptide%20and%20protein%20identification%20software&amp;journal=Curr.%20Protocol.%20Bioinform.&amp;volume=13&amp;pages=13%2020%2011-13%2020%2014&amp;publication_year=2012&amp;author=Bern%2CM&amp;author=Kil%2CYJ&amp;author=Becker%2CC">
                    Google Scholar</a>&nbsp;
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41467-024-51831-7?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>We acknowledge the Human BioBank (Research Center of Clinical Medicine), National Cheng Kung University Hospital (NCKUH), the Bioinformatics Center (National Cheng Kung University, NCKU), and the National Center for High Performance Computing for bioinformatics consulting, the Proteomics Core Laboratory of NCKU and the Mass Spectrometry Facility of National Yang Ming Chiao Tung University for protein identification, the Bioimaging Core Facility of the National Core Facility for Biopharmaceuticals (Ministry of Science and Technology, Taiwan) for assistance in analysis of confocal microscopic images and FACS-like tissue cytometric images, the Laboratory Animal Center, College of Medicine at National Cheng Kung University (NCKU), Taiwan, accredited by AAALAC International and Taiwan Animal Consortium for the technical support in Xenogen IVISR Spectrum Noninvasive Quantitative Molecular Imaging System, and the Biostatistics Consulting Center (NCKUH) for statistical consulting. We thank Dr. Chun-Hui Lee (Department of Oncology, NCKUH) for assistance in collecting MPE specimens, Dr. Wei-Pang Chung (Department of Oncology, NCKUH) for assistance in analyzing synergy of cytotoxicity, Prof. Chuan-Fa Chang (Department of Medical Laboratory Science and Biotechnology, NCKU) for providing primer sequences against N-OSTs, and Mr. Chein-Hung Chen (Academia Sinica Glycoscience Core Facility and the GRC Mass Core Facility) for glycopeptide analysis. This work was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-006-046-MY3, MOST 106-2314-B-006-040-MY2, MOST 107-2314-B-006-059-MY3), the Center of Applied Nanomedicine of National Cheng Kung University from Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE), Taiwan, the Yushan Fellow Program, Ministry of Education and NCKU, Taiwan, the Ministry of Health and Welfare (MOHW), Taiwan (MOHW112-TDU-B-221-124005), and Academia Sinica, Taiwan (AS-GC-110-04, AS-GC-110-MD-04).</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Authors and Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chun-Hua Hung,&nbsp;Shang-Yin Wu&nbsp;&amp;&nbsp;Wu-Chou Su</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chun-Hua Hung,&nbsp;Hsuan-Heng Yeh&nbsp;&amp;&nbsp;Wu-Chou Su</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chun-Hua Hung&nbsp;&amp;&nbsp;Wu-Chou Su</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Department of Biomedical Engineering, College of Engineering, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chun-Hua Hung</p></li><li id="Aff5"><p class="c-article-author-affiliation__address">Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Shang-Yin Wu,&nbsp;Chien-Chung Lin&nbsp;&amp;&nbsp;Wu-Chou Su</p></li><li id="Aff6"><p class="c-article-author-affiliation__address">Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan</p><p class="c-article-author-affiliation__authors-list">Cheng-I Daniel Yao&nbsp;&amp;&nbsp;Chun-Hung Lin</p></li><li id="Aff7"><p class="c-article-author-affiliation__address">Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chien-Chung Lin</p></li><li id="Aff8"><p class="c-article-author-affiliation__address">Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chien-Chung Lin</p></li><li id="Aff9"><p class="c-article-author-affiliation__address">Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chang-Yao Chu</p></li><li id="Aff10"><p class="c-article-author-affiliation__address">Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Tzu-Yu Huang&nbsp;&amp;&nbsp;Wu-Chou Su</p></li><li id="Aff11"><p class="c-article-author-affiliation__address">Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Meng-Ru Shen</p></li><li id="Aff12"><p class="c-article-author-affiliation__address">Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan</p><p class="c-article-author-affiliation__authors-list">Meng-Ru Shen</p></li><li id="Aff13"><p class="c-article-author-affiliation__address">Department of Chemistry and Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan</p><p class="c-article-author-affiliation__authors-list">Chun-Hung Lin</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Chun_Hua-Hung-Aff1-Aff2-Aff3-Aff4"><span class="c-article-authors-search__title u-h3 js-search-name">Chun-Hua Hung</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Chun-Hua%20Hung" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Chun-Hua%20Hung" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Chun-Hua%20Hung%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Shang_Yin-Wu-Aff1-Aff5"><span class="c-article-authors-search__title u-h3 js-search-name">Shang-Yin Wu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Shang-Yin%20Wu" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Shang-Yin%20Wu" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Shang-Yin%20Wu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Cheng_I_Daniel-Yao-Aff6"><span class="c-article-authors-search__title u-h3 js-search-name">Cheng-I Daniel Yao</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Cheng-I%20Daniel%20Yao" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Cheng-I%20Daniel%20Yao" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Cheng-I%20Daniel%20Yao%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Hsuan_Heng-Yeh-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Hsuan-Heng Yeh</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Hsuan-Heng%20Yeh" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Hsuan-Heng%20Yeh" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Hsuan-Heng%20Yeh%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Chien_Chung-Lin-Aff5-Aff7-Aff8"><span class="c-article-authors-search__title u-h3 js-search-name">Chien-Chung Lin</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Chien-Chung%20Lin" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Chien-Chung%20Lin" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Chien-Chung%20Lin%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Chang_Yao-Chu-Aff9"><span class="c-article-authors-search__title u-h3 js-search-name">Chang-Yao Chu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Chang-Yao%20Chu" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Chang-Yao%20Chu" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Chang-Yao%20Chu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Tzu_Yu-Huang-Aff10"><span class="c-article-authors-search__title u-h3 js-search-name">Tzu-Yu Huang</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Tzu-Yu%20Huang" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Tzu-Yu%20Huang" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Tzu-Yu%20Huang%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Meng_Ru-Shen-Aff11-Aff12"><span class="c-article-authors-search__title u-h3 js-search-name">Meng-Ru Shen</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Meng-Ru%20Shen" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Meng-Ru%20Shen" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Meng-Ru%20Shen%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Chun_Hung-Lin-Aff6-Aff13"><span class="c-article-authors-search__title u-h3 js-search-name">Chun-Hung Lin</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Chun-Hung%20Lin" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Chun-Hung%20Lin" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Chun-Hung%20Lin%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Wu_Chou-Su-Aff1-Aff2-Aff3-Aff5-Aff10"><span class="c-article-authors-search__title u-h3 js-search-name">Wu-Chou Su</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Wu-Chou%20Su" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Wu-Chou%20Su" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Wu-Chou%20Su%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="contributions">Contributions</h3><p>Chun-Hua Hung: Conceptualization, data curation, software, formal analysis, validation, investigation, visualization, methodology, writing-original draft. Shang-Yin Wu: Software, formal analysis, investigation. Cheng-I Daniel Yao: Formal analysis, methodology. Hsuan-Heng Yeh: Formal analysis, methodology. Chien-Chung Lin: Resources, formal analysis. Chang-Yao Chu: Formal analysis, methodology. Tzu-Yu Huang: Formal analysis, methodology. Meng-Ru Shen: Formal analysis, methodology, funding acquisition. Chun-Hung Lin: Formal analysis, methodology, funding acquisition. Wu-Chou Su*: Conceptualization, resources, supervision, funding acquisition, writing-original draft, project administration.</p><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:sunnysu@mail.ncku.edu.tw">Wu-Chou Su</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
                <h3 class="c-article__sub-heading" id="FPar4">Competing interests</h3>
                <p>The authors declare no competing interests.</p>
              
            </div></div></section><section data-title="Peer review"><div class="c-article-section" id="peer-review-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="peer-review">Peer review</h2><div class="c-article-section__content" id="peer-review-content">
              
              
                <h3 class="c-article__sub-heading" id="FPar3">Peer review information</h3>
                <p><i>Nature Communications</i> thanks Seiji Yano, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><p><b>Publishers note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Supplementary information"><div class="c-article-section" id="Sec46-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec46">Supplementary information</h2><div class="c-article-section__content" id="Sec46-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary information" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_MOESM1_ESM.pdf" data-supp-info-image="">Supplementary Information</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="peer review file" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_MOESM2_ESM.pdf" data-supp-info-image="">Peer Review File</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM3"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="reporting summary" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_MOESM3_ESM.pdf" data-supp-info-image="">Reporting Summary</a></h3></div></div></div></div></section><section data-title="Source data"><div class="c-article-section" id="Sec47-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec47">Source data</h2><div class="c-article-section__content" id="Sec47-content"><div data-test="supplementary-info"><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM4"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="source data" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_MOESM4_ESM.xlsx" data-supp-info-image="">Source data</a></h3></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articles Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articles Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="http://creativecommons.org/licenses/by-nc-nd/4.0/" rel="license">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Defective%20N-glycosylation%20of%20IL6%20induces%20metastasis%20and%20tyrosine%20kinase%20inhibitor%20resistance%20in%20lung%20cancer&amp;author=Chun-Hua%20Hung%20et%20al&amp;contentID=10.1038%2Fs41467-024-51831-7&amp;copyright=The%20Author%28s%29&amp;publication=2041-1723&amp;publicationDate=2024-09-09&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY-NC-ND">Reprints and permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1038/s41467-024-51831-7" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41467-024-51831-7" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img loading="lazy" width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Hung, CH., Wu, SY., Yao, CI.D. <i>et al.</i> Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer.
                    <i>Nat Commun</i> <b>15</b>, 7885 (2024). https://doi.org/10.1038/s41467-024-51831-7</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41467-024-51831-7?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-10-25">25 October 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2024-08-19">19 August 2024</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2024-09-09">09 September 2024</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1038/s41467-024-51831-7</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-block"><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><div data-component="article-info-list">
        <h3 class="c-article__sub-heading">Subjects</h3>
        <ul class="c-article-subject-list">
            <li class="c-article-subject-list__subject"><a href="/subjects/cancer-therapeutic-resistance" data-track="click" data-track-action="view subject" data-track-label="link">Cancer therapeutic resistance</a></li><li class="c-article-subject-list__subject"><a href="/subjects/glycobiology" data-track="click" data-track-action="view subject" data-track-label="link">Glycobiology</a></li><li class="c-article-subject-list__subject"><a href="/subjects/non-small-cell-lung-cancer" data-track="click" data-track-action="view subject" data-track-label="link">Non-small-cell lung cancer</a></li>
        </ul>
    </div></div></div></div></div></section>
            </div>

            
        <section>
            <div class="c-article-section js-article-section" id="further-reading-section" data-test="further-reading-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">This article is cited by</h2>
                <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
                    <ul class="c-article-further-reading__list" id="further-reading-list">
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Nordihydroguaiaretic acid inhibits bladder cancer metastasis through suppression of 1,3-mannosyltransferase expression and LRFN4 N-glycosylation" href="https://doi.org/10.1186/s12967-025-06571-7">
                                        Nordihydroguaiaretic acid inhibits bladder cancer metastasis through suppression of 1,3-mannosyltransferase expression and LRFN4 N-glycosylation
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Mulin Liu</li><li>Jingyang Zhang</li><li>Shijun Li</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Journal of Translational Medicine</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer" href="https://doi.org/10.1007/s00280-025-04772-x">
                                        Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Hayato Yokota</li><li>Kazuhiro Sato</li><li>Masatomo Miura</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Cancer Chemotherapy and Pharmacology</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Hotspots and frontiers of extracellular vesicles and lung cancer: a bibliometric and visualization analysis from 2002 to 2024" href="https://doi.org/10.1007/s12672-025-02830-7">
                                        Hotspots and frontiers of extracellular vesicles and lung cancer: a bibliometric and visualization analysis from 2002 to 2024
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Zelin Yang</li><li>Jie Tian</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Discover Oncology</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (19982024)" href="https://doi.org/10.1007/s12672-025-01782-2">
                                        Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (19982024)
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Cao Yu</li><li>Chong-Qi Fan</li><li>Huan-Wen Chen</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Discover Oncology</i> (2025)</p>
                            </li>
                        
                    </ul>
                </div>
            </div>
        </section>
    

        </div>
</article>
</main>

<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion="" data-container-type="reading-companion" data-track-component="reading companion">
    <div class="js-context-bar-sticky-point-desktop" data-track-context="reading companion">
        

        
            
                
                    
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41467-024-51831-7.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                
            
        
    </div>

    
        
    

    
    

    <div class="c-reading-companion">
        <div class="c-reading-companion__sticky c-reading-companion__sticky--stuck" data-component="reading-companion-sticky" data-test="reading-companion-sticky" style="top: -1282.56px; width: 389.367px;">
            <ul class="c-reading-companion__tabs" role="tablist"><li role="presentation"><button data-tab-target="sections" role="tab" id="tab-sections" aria-controls="tabpanel-sections" aria-selected="true" class="c-reading-companion__tab c-reading-companion__tab--active" data-track="click" data-track-action="sections tab" data-track-label="tab">Sections</button></li><li role="presentation"><button data-tab-target="figures" role="tab" id="tab-figures" aria-controls="tabpanel-figures" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="figures tab" data-track-label="tab">Figures</button></li><li role="presentation"><button data-tab-target="references" role="tab" id="tab-references" aria-controls="tabpanel-references" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="references tab" data-track-label="tab">References</button></li></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections" aria-labelledby="tab-sections" role="tabpanel"><div class="c-reading-companion__scroll-pane" style="max-height: none;"><ul class="c-reading-companion__sections-list"><li id="rc-sec-Abs1" class="c-reading-companion__section-item"><a href="#Abs1" data-track="click" data-track-action="section anchor" data-track-label="link:Abstract">Abstract</a></li><li id="rc-sec-Sec1" class="c-reading-companion__section-item"><a href="#Sec1" data-track="click" data-track-action="section anchor" data-track-label="link:Introduction">Introduction</a></li><li id="rc-sec-Sec2" class="c-reading-companion__section-item"><a href="#Sec2" data-track="click" data-track-action="section anchor" data-track-label="link:Results">Results</a></li><li id="rc-sec-Sec10" class="c-reading-companion__section-item"><a href="#Sec10" data-track="click" data-track-action="section anchor" data-track-label="link:Discussion">Discussion</a></li><li id="rc-sec-Sec11" class="c-reading-companion__section-item"><a href="#Sec11" data-track="click" data-track-action="section anchor" data-track-label="link:Methods">Methods</a></li><li id="rc-sec-data-availability" class="c-reading-companion__section-item"><a href="#data-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Data availability">Data availability</a></li><li id="rc-sec-Bib1" class="c-reading-companion__section-item"><a href="#Bib1" data-track="click" data-track-action="section anchor" data-track-label="link:References">References</a></li><li id="rc-sec-Ack1" class="c-reading-companion__section-item"><a href="#Ack1" data-track="click" data-track-action="section anchor" data-track-label="link:Acknowledgements">Acknowledgements</a></li><li id="rc-sec-author-information" class="c-reading-companion__section-item"><a href="#author-information" data-track="click" data-track-action="section anchor" data-track-label="link:Author information">Author information</a></li><li id="rc-sec-ethics" class="c-reading-companion__section-item"><a href="#ethics" data-track="click" data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a></li><li id="rc-sec-peer-review" class="c-reading-companion__section-item"><a href="#peer-review" data-track="click" data-track-action="section anchor" data-track-label="link:Peer review">Peer review</a></li><li id="rc-sec-additional-information" class="c-reading-companion__section-item"><a href="#additional-information" data-track="click" data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a></li><li id="rc-sec-Sec46" class="c-reading-companion__section-item"><a href="#Sec46" data-track="click" data-track-action="section anchor" data-track-label="link:Supplementary information">Supplementary information</a></li><li id="rc-sec-Sec47" class="c-reading-companion__section-item"><a href="#Sec47" data-track="click" data-track-action="section anchor" data-track-label="link:Source data">Source data</a></li><li id="rc-sec-rightslink" class="c-reading-companion__section-item"><a href="#rightslink" data-track="click" data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a></li><li id="rc-sec-article-info" class="c-reading-companion__section-item"><a href="#article-info" data-track="click" data-track-action="section anchor" data-track-label="link:About this article">About this article</a></li><li id="rc-sec-further-reading" class="c-reading-companion__section-item c-reading-companion__section-item--active"><a href="#further-reading" data-track="click" data-track-action="section anchor" data-track-label="link:This article is cited by">This article is cited by</a></li></ul></div>
                <div class="u-lazy-ad-wrapper u-mt-16 u-show" data-component-mpu="">
                    <div class="c-ad c-ad--300x250">
                        <div class="c-ad__inner">
                            <p class="c-ad__label">Advertisement</p>
                            
    <div id="div-gpt-ad-right-2" class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide" data-ad-type="right" data-test="right-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/nature_communications/article" data-gpt-sizes="300x250" data-gpt-targeting="type=article;pos=right;artid=s41467-024-51831-7;doi=10.1038/s41467-024-51831-7;techmeta=1,13,14,19,21,34,38,42,49,5,51,58,59,60,61,64,70,77,82,83,88,89,95,96;subjmeta=1059,1350,1612,221,2326,631,67,80;kwrd=Cancer+therapeutic+resistance,Glycobiology,Non-small-cell+lung+cancer" data-google-query-id="CPHh7aDQq44DFXbEZQMdrCsRpg">
        
        
        
    <div id="google_ads_iframe_/270604982/nature/ncomms/articles_1__container__" style="border: 0pt;"><iframe id="google_ads_iframe_/270604982/nature/ncomms/articles_1" name="google_ads_iframe_/270604982/nature/ncomms/articles_1" title="3rd party ad content" width="300" height="250" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" style="border: 0px; vertical-align: bottom;" aria-label="Advertisement" tabindex="0" sandbox="allow-forms allow-pointer-lock allow-popups allow-popups-to-escape-sandbox allow-same-origin allow-scripts allow-top-navigation-by-user-activation" data-google-container-id="2" data-load-complete="true"></iframe></div></div>

                        </div>
                    </div>
                </div>
            </div>
            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures" aria-labelledby="tab-figures" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ul class="c-reading-companion__figures-list"><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig1">Fig. 1: IL6 Is Modified by N-Glycosylation in NSCLC.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig1_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig1_HTML.png" alt="figure 1" aria-describedby="rc-Fig1"></picture><p class="c-reading-companion__figure-links"><a href="#Fig1" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/1" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig2">Fig. 2: N-glycosylated IL6 promotes the tyrosine phosphorylation and nuclear retention of STAT3.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig2_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig2_HTML.png" alt="figure 2" aria-describedby="rc-Fig2"></picture><p class="c-reading-companion__figure-links"><a href="#Fig2" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/2" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig3">Fig. 3: deNG-IL6 Induces EMT, Migration, and Metastasis in NSCLC.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig3_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig3_HTML.png" alt="figure 3" aria-describedby="rc-Fig3"></picture><p class="c-reading-companion__figure-links"><a href="#Fig3" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/3" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig4">Fig. 4: deNG-IL6 Switches the GP130 Signaling Preference from the JAK-STAT3 Axis to the SRC-YAP Axis.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig4_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig4_HTML.png" alt="figure 4" aria-describedby="rc-Fig4"></picture><p class="c-reading-companion__figure-links"><a href="#Fig4" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/4" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig5">Fig. 5: SOX2 Contributes to deNG-IL6-Induced SRC-YAP Axis-Promoted Migration and Metastasis.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig5_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig5_HTML.png" alt="figure 5" aria-describedby="rc-Fig5"></picture><p class="c-reading-companion__figure-links"><a href="#Fig5" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/5" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig6">Fig. 6: Inhibition of osimertinib-induced deNG-IL6 restores TKI sensitivity in TKI-resistant NSCLC.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig6_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig6_HTML.png" alt="figure 6" aria-describedby="rc-Fig6"></picture><p class="c-reading-companion__figure-links"><a href="#Fig6" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/6" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig7">Fig. 7: Osimertinib-induced deNG-IL6 activates the SRC-YAP-SOX2 axis and migration in TKI-resistant NSCLC.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig7_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig7_HTML.png" alt="figure 7" aria-describedby="rc-Fig7"></picture><p class="c-reading-companion__figure-links"><a href="#Fig7" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/7" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig8">Fig. 8: EGFR TKI-resistant NSCLC patients show high deNG-IL6 expression and a shift signaling preference from JAK-STAT3 to the SRC-YAP axis.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig8_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig8_HTML.png" alt="figure 8" aria-describedby="rc-Fig8"></picture><p class="c-reading-companion__figure-links"><a href="#Fig8" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/8" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig9">Fig. 9: Long-Term EGFR TKI Treatment Induces deNG-IL6 to Drive Resistance.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig9_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-024-51831-7/MediaObjects/41467_2024_51831_Fig9_HTML.png" alt="figure 9" aria-describedby="rc-Fig9"></picture><p class="c-reading-companion__figure-links"><a href="#Fig9" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41467-024-51831-7/figures/9" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li></ul></div></div>
            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references" aria-labelledby="tab-references" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ol class="c-reading-companion__references-list c-reading-companion__references-list--numeric" data-track-context="article references sidebar"><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR1">Yu, H., Lee, H., Herrmann, A., Buettner, R. &amp; Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. <i>Nat. Rev. Cancer</i> <b>14</b>, 736746 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnrc3818" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nrc3818" data-track-item_id="10.1038/nrc3818">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvVSmtLnF" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25342631" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Revisiting%20STAT3%20signalling%20in%20cancer%3A%20new%20and%20unexpected%20biological%20functions&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fnrc3818&amp;volume=14&amp;pages=736-746&amp;publication_year=2014&amp;author=Yu%2CH&amp;author=Lee%2CH&amp;author=Herrmann%2CA&amp;author=Buettner%2CR&amp;author=Jove%2CR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR2">Jones, S. A. &amp; Jenkins, B. J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. <i>Nat. Rev. Immunol.</i> <b>18</b>, 773789 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41577-018-0066-7" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41577-018-0066-7" data-track-item_id="10.1038/s41577-018-0066-7">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXhslymur7N" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30254251" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Recent%20insights%20into%20targeting%20the%20IL-6%20cytokine%20family%20in%20inflammatory%20diseases%20and%20cancer&amp;journal=Nat.%20Rev.%20Immunol.&amp;doi=10.1038%2Fs41577-018-0066-7&amp;volume=18&amp;pages=773-789&amp;publication_year=2018&amp;author=Jones%2CSA&amp;author=Jenkins%2CBJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR3">Rose-John, S. The soluble interleukin 6 receptor: advanced therapeutic options in inflammation. <i>Clin. Pharmacol. Therapeut.</i> <b>102</b>, 591598 (2017).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fcpt.782" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/cpt.782" data-track-item_id="10.1002/cpt.782">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsFWjt77I" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20soluble%20interleukin%206%20receptor%3A%20advanced%20therapeutic%20options%20in%20inflammation&amp;journal=Clin.%20Pharmacol.%20Therapeut.&amp;doi=10.1002%2Fcpt.782&amp;volume=102&amp;pages=591-598&amp;publication_year=2017&amp;author=Rose-John%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR4">Trikha, M., Corringham, R., Klein, B. &amp; Rossi, J. F. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. <i>Clin. Cancer Res.</i> <b>9</b>, 46534665 (2003).</p><p class="c-reading-companion__reference-links"><a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3sXosVGjsrw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14581334" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929399" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Targeted%20anti-interleukin-6%20monoclonal%20antibody%20therapy%20for%20cancer%3A%20a%20review%20of%20the%20rationale%20and%20clinical%20evidence&amp;journal=Clin.%20Cancer%20Res.&amp;volume=9&amp;pages=4653-4665&amp;publication_year=2003&amp;author=Trikha%2CM&amp;author=Corringham%2CR&amp;author=Klein%2CB&amp;author=Rossi%2CJF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR5">Hunter, C. A. &amp; Jones, S. A. IL-6 as a keystone cytokine in health and disease. <i>Nat. Immunol</i>. <b>16</b>, 448457 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fni.3153" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/ni.3153" data-track-item_id="10.1038/ni.3153">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtF2murbF" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25898198" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6%20as%20a%20keystone%20cytokine%20in%20health%20and%20disease&amp;journal=Nat.%20Immunol&amp;doi=10.1038%2Fni.3153&amp;volume=16&amp;pages=448-457&amp;publication_year=2015&amp;author=Hunter%2CCA&amp;author=Jones%2CSA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR6">Garbers, C., Heink, S., Korn, T. &amp; Rose-John, S. Interleukin-6: designing specific therapeutics for a complex cytokine. <i>Nat. Rev. Drug Discov.</i> <b>17</b>, 395412 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnrd.2018.45" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nrd.2018.45" data-track-item_id="10.1038/nrd.2018.45">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXovVagtbw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29725131" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Interleukin-6%3A%20designing%20specific%20therapeutics%20for%20a%20complex%20cytokine&amp;journal=Nat.%20Rev.%20Drug%20Discov.&amp;doi=10.1038%2Fnrd.2018.45&amp;volume=17&amp;pages=395-412&amp;publication_year=2018&amp;author=Garbers%2CC&amp;author=Heink%2CS&amp;author=Korn%2CT&amp;author=Rose-John%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR7">Murakami, M., Kamimura, D. &amp; Hirano, T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. <i>Immunity</i> <b>50</b>, 812831 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.immuni.2019.03.027" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.immuni.2019.03.027" data-track-item_id="10.1016/j.immuni.2019.03.027">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXnsFGksLY%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30995501" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Pleiotropy%20and%20specificity%3A%20insights%20from%20the%20interleukin%206%20family%20of%20cytokines&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2019.03.027&amp;volume=50&amp;pages=812-831&amp;publication_year=2019&amp;author=Murakami%2CM&amp;author=Kamimura%2CD&amp;author=Hirano%2CT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR8">Duan, Z. et al. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. <i>Clin. Cancer Res.</i> <b>12</b>, 50555063 (2006).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F1078-0432.CCR-06-0861" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/1078-0432.CCR-06-0861" data-track-item_id="10.1158/1078-0432.CCR-06-0861">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD28XovF2hu7s%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16951221" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Signal%20transducers%20and%20activators%20of%20transcription%203%20pathway%20activation%20in%20drug-resistant%20ovarian%20cancer&amp;journal=Clin.%20Cancer%20Res.&amp;doi=10.1158%2F1078-0432.CCR-06-0861&amp;volume=12&amp;pages=5055-5063&amp;publication_year=2006&amp;author=Duan%2CZ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR9">Huang, W. L. et al. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells. <i>Mol. Cancer</i> <b>9</b>, 309 (2010).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/1476-4598-9-309" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/1476-4598-9-309" data-track-item_id="10.1186/1476-4598-9-309">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsF2hs7rK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21122157" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027602" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Signal%20transducer%20and%20activator%20of%20transcription%203%20activation%20up-regulates%20interleukin-6%20autocrine%20production%3A%20a%20biochemical%20and%20genetic%20study%20of%20established%20cancer%20cell%20lines%20and%20clinical%20isolated%20human%20cancer%20cells&amp;journal=Mol.%20Cancer&amp;doi=10.1186%2F1476-4598-9-309&amp;volume=9&amp;publication_year=2010&amp;author=Huang%2CWL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR10">Lee, H. J. et al. Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. <i>Cancer Cell</i> <b>26</b>, 207221 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ccr.2014.05.019" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ccr.2014.05.019" data-track-item_id="10.1016/j.ccr.2014.05.019">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXht1agsL7I" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25065853" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Drug%20resistance%20via%20feedback%20activation%20of%20Stat3%20in%20oncogene-addicted%20cancer%20cells&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccr.2014.05.019&amp;volume=26&amp;pages=207-221&amp;publication_year=2014&amp;author=Lee%2CHJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR11">Rokavec, M. et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. <i>J. Clin. Invest.</i> <b>124</b>, 18531867 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2FJCI73531" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/JCI73531" data-track-item_id="10.1172/JCI73531">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXmtVGgur4%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24642471" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973098" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6R%2FSTAT3%2FmiR-34a%20feedback%20loop%20promotes%20EMT-mediated%20colorectal%20cancer%20invasion%20and%20metastasis&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI73531&amp;volume=124&amp;pages=1853-1867&amp;publication_year=2014&amp;author=Rokavec%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR12">Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. <i>Nature</i> <b>519</b>, 5762 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnature14228" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nature14228" data-track-item_id="10.1038/nature14228">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2015Natur.519...57T" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXjvVGjsrk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25731159" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=A%20gp130-Src-YAP%20module%20links%20inflammation%20to%20epithelial%20regeneration&amp;journal=Nature&amp;doi=10.1038%2Fnature14228&amp;volume=519&amp;pages=57-62&amp;publication_year=2015&amp;author=Taniguchi%2CK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR13">Quintanal-Villalonga, A. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. <i>Nat. Rev. Clin. Oncol.</i> <b>17</b>, 360371 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41571-020-0340-z" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41571-020-0340-z" data-track-item_id="10.1038/s41571-020-0340-z">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32152485" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397755" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Lineage%20plasticity%20in%20cancer%3A%20a%20shared%20pathway%20of%20therapeutic%20resistance&amp;journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;doi=10.1038%2Fs41571-020-0340-z&amp;volume=17&amp;pages=360-371&amp;publication_year=2020&amp;author=Quintanal-Villalonga%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR14">Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. <i>Science</i> <b>304</b>, 14971500 (2004).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscience.1099314" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/science.1099314" data-track-item_id="10.1126/science.1099314">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2004Sci...304.1497P" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXksVGmsbs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15118125" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=EGFR%20mutations%20in%20lung%20cancer%3A%20correlation%20with%20clinical%20response%20to%20gefitinib%20therapy&amp;journal=Science&amp;doi=10.1126%2Fscience.1099314&amp;volume=304&amp;pages=1497-1500&amp;publication_year=2004&amp;author=Paez%2CJG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR15">Ramalingam, S. S. et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. <i>N. Engl. J. Med.</i> <b>382</b>, 4150 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa1913662" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa1913662" data-track-item_id="10.1056/NEJMoa1913662">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXnsFGgtL4%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31751012" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Overall%20survival%20with%20osimertinib%20in%20untreated%2C%20EGFR-mutated%20advanced%20NSCLC&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa1913662&amp;volume=382&amp;pages=41-50&amp;publication_year=2020&amp;author=Ramalingam%2CSS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR16">Oxnard, G. R. et al. Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib. <i>JAMA Oncol.</i> <b>4</b>, 15271534 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1001%2Fjamaoncol.2018.2969" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1001/jamaoncol.2018.2969" data-track-item_id="10.1001/jamaoncol.2018.2969">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30073261" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20resistance%20mechanisms%20and%20clinical%20implications%20in%20patients%20with%20EGFR%20T790M-positive%20lung%20cancer%20and%20acquired%20resistance%20to%20osimertinib&amp;journal=JAMA%20Oncol.&amp;doi=10.1001%2Fjamaoncol.2018.2969&amp;volume=4&amp;pages=1527-1534&amp;publication_year=2018&amp;author=Oxnard%2CGR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR17">Yang, Z. et al. Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients. <i>Clin. Cancer Res.</i> <b>24</b>, 30973107 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F1078-0432.CCR-17-2310" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/1078-0432.CCR-17-2310" data-track-item_id="10.1158/1078-0432.CCR-17-2310">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXht1alurvK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29506987" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Investigating%20novel%20resistance%20mechanisms%20to%20third-generation%20EGFR%20tyrosine%20kinase%20inhibitor%20osimertinib%20in%20non-small%20cell%20lung%20cancer%20patients&amp;journal=Clin.%20Cancer%20Res.&amp;doi=10.1158%2F1078-0432.CCR-17-2310&amp;volume=24&amp;pages=3097-3107&amp;publication_year=2018&amp;author=Yang%2CZ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR18">Sequist, L. V. et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. <i>Sci. Transl. Med.</i> <b>3</b>, 75ra26 (2011).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscitranslmed.3002003" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/scitranslmed.3002003" data-track-item_id="10.1126/scitranslmed.3002003">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21430269" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132801" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Genotypic%20and%20histological%20evolution%20of%20lung%20cancers%20acquiring%20resistance%20to%20EGFR%20inhibitors&amp;journal=Sci.%20Transl.%20Med.&amp;doi=10.1126%2Fscitranslmed.3002003&amp;volume=3&amp;publication_year=2011&amp;author=Sequist%2CLV" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR19">Lambert, A. W. &amp; Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. <i>Nat. Rev. Cancer</i> <b>21</b>, 325338 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41568-021-00332-6" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41568-021-00332-6" data-track-item_id="10.1038/s41568-021-00332-6">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXjsVCquro%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33547455" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Linking%20EMT%20programmes%20to%20normal%20and%20neoplastic%20epithelial%20stem%20cells&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fs41568-021-00332-6&amp;volume=21&amp;pages=325-338&amp;publication_year=2021&amp;author=Lambert%2CAW&amp;author=Weinberg%2CRA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR20">Williams, E. D., Gao, D., Redfern, A. &amp; Thompson, E. W. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. <i>Nat. Rev. Cancer</i> <b>19</b>, 716732 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41568-019-0213-x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41568-019-0213-x" data-track-item_id="10.1038/s41568-019-0213-x">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXitV2hsb7J" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31666716" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055151" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Controversies%20around%20epithelial-mesenchymal%20plasticity%20in%20cancer%20metastasis&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fs41568-019-0213-x&amp;volume=19&amp;pages=716-732&amp;publication_year=2019&amp;author=Williams%2CED&amp;author=Gao%2CD&amp;author=Redfern%2CA&amp;author=Thompson%2CEW" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR21">Yao, Z. et al. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. <i>Proc. Natl Acad. Sci. USA</i> <b>107</b>, 1553515540 (2010).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1073%2Fpnas.1009472107" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1073/pnas.1009472107" data-track-item_id="10.1073/pnas.1009472107">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2010PNAS..10715535Y" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtFaqu7%2FN" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20713723" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932568" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20IL-6%20axis%20mediates%20selective%20and%20adaptive%20mechanisms%20of%20resistance%20to%20molecular%20targeted%20therapy%20in%20lung%20cancer&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.1009472107&amp;volume=107&amp;pages=15535-15540&amp;publication_year=2010&amp;author=Yao%2CZ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR22">Kim, S. M. et al. Activation of IL-6R/JAK1/STAT signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation. <i>Mol. Cancer Ther.</i> <b>11</b>, 22542264 (2012).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F1535-7163.MCT-12-0311" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/1535-7163.MCT-12-0311" data-track-item_id="10.1158/1535-7163.MCT-12-0311">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhsVyksrvI" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22891040" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Activation%20of%20IL-6R%2FJAK1%2FSTAT%20signaling%20induces%20de%20novo%20resistance%20to%20irreversible%20EGFR%20inhibitors%20in%20non-small%20cell%20lung%20cancer%20with%20T790M%20resistance%20mutation&amp;journal=Mol.%20Cancer%20Ther.&amp;doi=10.1158%2F1535-7163.MCT-12-0311&amp;volume=11&amp;pages=2254-2264&amp;publication_year=2012&amp;author=Kim%2CSM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR23">Korkaya, H., Liu, S. &amp; Wicha, M. S. Regulation of cancer stem cells by cytokine networks: attacking cancers inflammatory roots. <i>Clin. Cancer Res.</i> <b>17</b>, 61256129 (2011).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F1078-0432.CCR-10-2743" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/1078-0432.CCR-10-2743" data-track-item_id="10.1158/1078-0432.CCR-10-2743">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXht1Ggs7jP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21685479" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312242" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20cancer%20stem%20cells%20by%20cytokine%20networks%3A%20attacking%20cancer%E2%80%99s%20inflammatory%20roots&amp;journal=Clin.%20Cancer%20Res.&amp;doi=10.1158%2F1078-0432.CCR-10-2743&amp;volume=17&amp;pages=6125-6129&amp;publication_year=2011&amp;author=Korkaya%2CH&amp;author=Liu%2CS&amp;author=Wicha%2CMS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR24">Senescence-Associated Pro-inflammatory Cytokines, VernotJ. P. and tumor cell plasticity. <i>Front. Mol. Biosci.</i> <b>7</b>, 63 (2020).</p><p class="c-reading-companion__reference-links"><a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2020FrMat...7...63S" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=and%20tumor%20cell%20plasticity&amp;journal=Front.%20Mol.%20Biosci.&amp;volume=7&amp;publication_year=2020&amp;author=Senescence-Associated%20Pro-inflammatory%20Cytokines%2CVernotJP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR25">Kurppa, K. J. et al. Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. <i>Cancer Cell</i> <b>37</b>, 104122.e112 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ccell.2019.12.006" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ccell.2019.12.006" data-track-item_id="10.1016/j.ccell.2019.12.006">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXotVent78%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31935369" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146079" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Treatment-induced%20tumor%20dormancy%20through%20YAP-mediated%20transcriptional%20reprogramming%20of%20the%20apoptotic%20pathway&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2019.12.006&amp;volume=37&amp;pages=104-122.e112&amp;publication_year=2020&amp;author=Kurppa%2CKJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR26">Ferone, G. et al. SOX2 is the determining oncogenic switch in promoting lung squamous cell carcinoma from different cells of origin. <i>Cancer Cell</i> <b>30</b>, 519532 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ccell.2016.09.001" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ccell.2016.09.001" data-track-item_id="10.1016/j.ccell.2016.09.001">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28Xhs1GqtLbP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27728803" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065004" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=SOX2%20is%20the%20determining%20oncogenic%20switch%20in%20promoting%20lung%20squamous%20cell%20carcinoma%20from%20different%20cells%20of%20origin&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2016.09.001&amp;volume=30&amp;pages=519-532&amp;publication_year=2016&amp;author=Ferone%2CG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR27">Boumahdi, S. &amp; de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. <i>Nat. Rev. Drug Discov.</i> <b>19</b>, 3956 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41573-019-0044-1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41573-019-0044-1" data-track-item_id="10.1038/s41573-019-0044-1">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvFCktL%2FM" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31601994" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20great%20escape%3A%20tumour%20cell%20plasticity%20in%20resistance%20to%20targeted%20therapy&amp;journal=Nat.%20Rev.%20Drug%20Discov.&amp;doi=10.1038%2Fs41573-019-0044-1&amp;volume=19&amp;pages=39-56&amp;publication_year=2020&amp;author=Boumahdi%2CS&amp;author=Sauvage%2CFJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR28">Mosteiro, L. et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. <i>Science</i> <b>354</b>, 6315 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscience.aaf4445" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/science.aaf4445" data-track-item_id="10.1126/science.aaf4445">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Tissue%20damage%20and%20senescence%20provide%20critical%20signals%20for%20cellular%20reprogramming%20in%20vivo&amp;journal=Science&amp;doi=10.1126%2Fscience.aaf4445&amp;volume=354&amp;publication_year=2016&amp;author=Mosteiro%2CL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR29">Bora-Singhal, N. et al. YAP1 regulates OCT4 activity and SOX2 expression to facilitate self-renewal and vascular mimicry of stem-like cells. <i>Stem cells</i> <b>33</b>, 17051718 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fstem.1993" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/stem.1993" data-track-item_id="10.1002/stem.1993">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtleqsLvK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25754111" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=YAP1%20regulates%20OCT4%20activity%20and%20SOX2%20expression%20to%20facilitate%20self-renewal%20and%20vascular%20mimicry%20of%20stem-like%20cells&amp;journal=Stem%20cells&amp;doi=10.1002%2Fstem.1993&amp;volume=33&amp;pages=1705-1718&amp;publication_year=2015&amp;author=Bora-Singhal%2CN" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR30">Poupart, P. et al. B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). <i>EMBO J</i> <b>6</b>, 12191224 (1987).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fj.1460-2075.1987.tb02357.x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/j.1460-2075.1987.tb02357.x" data-track-item_id="10.1002/j.1460-2075.1987.tb02357.x">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaL2sXkt1Wktr0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3497029" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC553922" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=B%20cell%20growth%20modulating%20and%20differentiating%20activity%20of%20recombinant%20human%2026-kd%20protein%20%28BSF-2%2C%20HuIFN-beta%202%2C%20HPGF%29&amp;journal=EMBO%20J&amp;doi=10.1002%2Fj.1460-2075.1987.tb02357.x&amp;volume=6&amp;pages=1219-1224&amp;publication_year=1987&amp;author=Poupart%2CP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR31">May, L. T. et al. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. <i>Biochem. Biophys. Res. Commun.</i> <b>152</b>, 11441150 (1988).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0006-291X%2888%2980404-2" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0006-291X(88)80404-2" data-track-item_id="10.1016/S0006-291X(88)80404-2">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaL1cXktVGjt70%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3259872" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Phosphorylation%20of%20secreted%20forms%20of%20human%20beta%202-interferon%2Fhepatocyte%20stimulating%20factor%2Finterleukin-6&amp;journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;doi=10.1016%2FS0006-291X%2888%2980404-2&amp;volume=152&amp;pages=1144-1150&amp;publication_year=1988&amp;author=May%2CLT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR32">Hirano, T. et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). <i>Proc. Natl Acad. Sci. USA</i> <b>82</b>, 54905494 (1985).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1073%2Fpnas.82.16.5490" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1073/pnas.82.16.5490" data-track-item_id="10.1073/pnas.82.16.5490">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=1985PNAS...82.5490H" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaL2MXlt1Wnt7s%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2410927" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC391148" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Purification%20to%20homogeneity%20and%20characterization%20of%20human%20B-cell%20differentiation%20factor%20%28BCDF%20or%20BSFp-2%29&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.82.16.5490&amp;volume=82&amp;pages=5490-5494&amp;publication_year=1985&amp;author=Hirano%2CT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR33">May, L. T., Santhanam, U. &amp; Sehgal, P. B. On the multimeric nature of natural human interleukin-6. <i>J. Biol. Chem.</i> <b>266</b>, 99509955 (1991).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0021-9258%2818%2992911-X" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0021-9258(18)92911-X" data-track-item_id="10.1016/S0021-9258(18)92911-X">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK3MXkt1Onsbw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2033081" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=On%20the%20multimeric%20nature%20of%20natural%20human%20interleukin-6&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1016%2FS0021-9258%2818%2992911-X&amp;volume=266&amp;pages=9950-9955&amp;publication_year=1991&amp;author=May%2CLT&amp;author=Santhanam%2CU&amp;author=Sehgal%2CPB" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR34">Mereiter, S., Balmana, M., Campos, D., Gomes, J. &amp; Reis, C. A. Glycosylation in the era of cancer-targeted therapy: where are we heading? <i>Cancer Cell</i> <b>36</b>, 616 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ccell.2019.06.006" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ccell.2019.06.006" data-track-item_id="10.1016/j.ccell.2019.06.006">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtlersb%2FJ" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31287993" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Glycosylation%20in%20the%20era%20of%20cancer-targeted%20therapy%3A%20where%20are%20we%20heading%3F&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2019.06.006&amp;volume=36&amp;pages=6-16&amp;publication_year=2019&amp;author=Mereiter%2CS&amp;author=Balmana%2CM&amp;author=Campos%2CD&amp;author=Gomes%2CJ&amp;author=Reis%2CCA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR35">Parekh, R. B., Dwek, R. A., Rademacher, T. W., Opdenakker, G. &amp; Van Damme, J. Glycosylation of interleukin-6 purified from normal human blood mononuclear cells. <i>Eur. J. Biochem.</i> <b>203</b>, 135141 (1992).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Fj.1432-1033.1992.tb19838.x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/j.1432-1033.1992.tb19838.x" data-track-item_id="10.1111/j.1432-1033.1992.tb19838.x">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK38Xht1KmtL8%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1730219" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Glycosylation%20of%20interleukin-6%20purified%20from%20normal%20human%20blood%20mononuclear%20cells&amp;journal=Eur.%20J.%20Biochem.&amp;doi=10.1111%2Fj.1432-1033.1992.tb19838.x&amp;volume=203&amp;pages=135-141&amp;publication_year=1992&amp;author=Parekh%2CRB&amp;author=Dwek%2CRA&amp;author=Rademacher%2CTW&amp;author=Opdenakker%2CG&amp;author=Damme%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR36">Dela Cruz, C. S. et al. N-linked glycosylation is required for optimal function of Kaposis sarcoma herpesvirus-encoded, but not cellular, interleukin 6. <i>J. Exp. Med.</i> <b>199</b>, 503514 (2004).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1084%2Fjem.20031205" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1084/jem.20031205" data-track-item_id="10.1084/jem.20031205">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=N-linked%20glycosylation%20is%20required%20for%20optimal%20function%20of%20Kaposi%E2%80%99s%20sarcoma%20herpesvirus-encoded%2C%20but%20not%20cellular%2C%20interleukin%206&amp;journal=J.%20Exp.%20Med.&amp;doi=10.1084%2Fjem.20031205&amp;volume=199&amp;pages=503-514&amp;publication_year=2004&amp;author=Cruz%2CCS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR37">Thomas, D., Rathinavel, A. K. &amp; Radhakrishnan, P. Altered glycosylation in cancer: a promising target for biomarkers and therapeutics. <i>Biochimica. et biophysica. Acta Rev. Cancer</i> <b>1875</b>, 188464 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.bbcan.2020.188464" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.bbcan.2020.188464" data-track-item_id="10.1016/j.bbcan.2020.188464">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitl2msr%2FP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Altered%20glycosylation%20in%20cancer%3A%20a%20promising%20target%20for%20biomarkers%20and%20therapeutics&amp;journal=Biochimica.%20et%20biophysica.%20Acta%20Rev.%20Cancer&amp;doi=10.1016%2Fj.bbcan.2020.188464&amp;volume=1875&amp;publication_year=2021&amp;author=Thomas%2CD&amp;author=Rathinavel%2CAK&amp;author=Radhakrishnan%2CP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR38">Pinho, S. S. &amp; Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. <i>Nat. Rev. Cancer</i> <b>15</b>, 540555 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnrc3982" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nrc3982" data-track-item_id="10.1038/nrc3982">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtlKkt7fK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26289314" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Glycosylation%20in%20cancer%3A%20mechanisms%20and%20clinical%20implications&amp;journal=Nat.%20Rev.%20Cancer&amp;doi=10.1038%2Fnrc3982&amp;volume=15&amp;pages=540-555&amp;publication_year=2015&amp;author=Pinho%2CSS&amp;author=Reis%2CCA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR39">Yeh, H. H., Lai, W. W., Chen, H. H., Liu, H. S. &amp; Su, W. C. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. <i>Oncogene</i> <b>25</b>, 43004309 (2006).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fsj.onc.1209464" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/sj.onc.1209464" data-track-item_id="10.1038/sj.onc.1209464">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD28XntVWks7o%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16518408" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Autocrine%20IL-6-induced%20Stat3%20activation%20contributes%20to%20the%20pathogenesis%20of%20lung%20adenocarcinoma%20and%20malignant%20pleural%20effusion&amp;journal=Oncogene&amp;doi=10.1038%2Fsj.onc.1209464&amp;volume=25&amp;pages=4300-4309&amp;publication_year=2006&amp;author=Yeh%2CHH&amp;author=Lai%2CWW&amp;author=Chen%2CHH&amp;author=Liu%2CHS&amp;author=Su%2CWC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR40">Roth, J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. <i>Chem. Rev.</i> <b>102</b>, 285303 (2002).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1021%2Fcr000423j" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1021/cr000423j" data-track-item_id="10.1021/cr000423j">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD38XntlGrug%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11841244" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Protein%20N-glycosylation%20along%20the%20secretory%20pathway%3A%20relationship%20to%20organelle%20topography%20and%20function%2C%20protein%20quality%20control%2C%20and%20cell%20interactions&amp;journal=Chem.%20Rev.&amp;doi=10.1021%2Fcr000423j&amp;volume=102&amp;pages=285-303&amp;publication_year=2002&amp;author=Roth%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR41">Bard, F. &amp; Chia, J. Cracking the glycome encoder: signaling, trafficking, and glycosylation. <i>Trends Cell Biol.</i> <b>26</b>, 379388 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.tcb.2015.12.004" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.tcb.2015.12.004" data-track-item_id="10.1016/j.tcb.2015.12.004">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XjslKrtA%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26832820" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Cracking%20the%20glycome%20encoder%3A%20signaling%2C%20trafficking%2C%20and%20glycosylation&amp;journal=Trends%20Cell%20Biol.&amp;doi=10.1016%2Fj.tcb.2015.12.004&amp;volume=26&amp;pages=379-388&amp;publication_year=2016&amp;author=Bard%2CF&amp;author=Chia%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR42">Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. &amp; Clausen, H. Global view of human protein glycosylation pathways and functions. <i>Nat. Rev. Mol. Cell Biol.</i> <b>21</b>, 729749 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41580-020-00294-x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41580-020-00294-x" data-track-item_id="10.1038/s41580-020-00294-x">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitFGmu73N" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33087899" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Global%20view%20of%20human%20protein%20glycosylation%20pathways%20and%20functions&amp;journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;doi=10.1038%2Fs41580-020-00294-x&amp;volume=21&amp;pages=729-749&amp;publication_year=2020&amp;author=Schjoldager%2CKT&amp;author=Narimatsu%2CY&amp;author=Joshi%2CHJ&amp;author=Clausen%2CH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR43">Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. <i>Proc. Natl Acad. Sci. USA</i> <b>102</b>, 1554515550 (2005).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1073%2Fpnas.0506580102" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1073/pnas.0506580102" data-track-item_id="10.1073/pnas.0506580102">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2005PNAS..10215545S" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1ShtrnO" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16199517" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1239896" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Gene%20set%20enrichment%20analysis%3A%20a%20knowledge-based%20approach%20for%20interpreting%20genome-wide%20expression%20profiles&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.0506580102&amp;volume=102&amp;pages=15545-15550&amp;publication_year=2005&amp;author=Subramanian%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR44">Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. <i>Nat. Genet.</i> <b>34</b>, 267273 (2003).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fng1180" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/ng1180" data-track-item_id="10.1038/ng1180">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3sXkvFSrs7o%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12808457" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=PGC-1alpha-responsive%20genes%20involved%20in%20oxidative%20phosphorylation%20are%20coordinately%20downregulated%20in%20human%20diabetes&amp;journal=Nat.%20Genet.&amp;doi=10.1038%2Fng1180&amp;volume=34&amp;pages=267-273&amp;publication_year=2003&amp;author=Mootha%2CVK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR45">Okayama, H. et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. <i>Cancer Res.</i> <b>72</b>, 100111 (2012).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F0008-5472.CAN-11-1403" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/0008-5472.CAN-11-1403" data-track-item_id="10.1158/0008-5472.CAN-11-1403">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhvVCmtg%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22080568" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20genes%20upregulated%20in%20ALK-positive%20and%20EGFR%2FKRAS%2FALK-negative%20lung%20adenocarcinomas&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-11-1403&amp;volume=72&amp;pages=100-111&amp;publication_year=2012&amp;author=Okayama%2CH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR46">Lopez-Sambrooks, C. et al. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. <i>Nat. Chem. Biol.</i> <b>12</b>, 10231030 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnchembio.2194" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nchembio.2194" data-track-item_id="10.1038/nchembio.2194">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhsFOmsLvE" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27694802" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393272" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Oligosaccharyltransferase%20inhibition%20induces%20senescence%20in%20RTK-driven%20tumor%20cells&amp;journal=Nat.%20Chem.%20Biol.&amp;doi=10.1038%2Fnchembio.2194&amp;volume=12&amp;pages=1023-1030&amp;publication_year=2016&amp;author=Lopez-Sambrooks%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR47">Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S. &amp; Brunak, S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. <i>Proteomics</i> <b>4</b>, 16331649 (2004).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fpmic.200300771" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/pmic.200300771" data-track-item_id="10.1002/pmic.200300771">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXkvFGitLg%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15174133" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Prediction%20of%20post-translational%20glycosylation%20and%20phosphorylation%20of%20proteins%20from%20the%20amino%20acid%20sequence&amp;journal=Proteomics&amp;doi=10.1002%2Fpmic.200300771&amp;volume=4&amp;pages=1633-1649&amp;publication_year=2004&amp;author=Blom%2CN&amp;author=Sicheritz-Ponten%2CT&amp;author=Gupta%2CR&amp;author=Gammeltoft%2CS&amp;author=Brunak%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR48">Yamaguchi, K. et al. Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties. <i>J. Biol. Chem</i>. <b>266</b>, 2043420439 (1991).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0021-9258%2818%2954942-5" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0021-9258(18)54942-5" data-track-item_id="10.1016/S0021-9258(18)54942-5">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK3MXlvFykt70%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1657925" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Effects%20of%20site-directed%20removal%20of%20N-glycosylation%20sites%20in%20human%20erythropoietin%20on%20its%20production%20and%20biological%20properties&amp;journal=J.%20Biol.%20Chem&amp;doi=10.1016%2FS0021-9258%2818%2954942-5&amp;volume=266&amp;pages=20434-20439&amp;publication_year=1991&amp;author=Yamaguchi%2CK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR49">Bobby, R. et al. Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6. <i>FEBS J.</i> <b>281</b>, 24712483 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Ffebs.12800" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/febs.12800" data-track-item_id="10.1111/febs.12800">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXotFemtL0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24712547" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Functional%20implications%20of%20large%20backbone%20amplitude%20motions%20of%20the%20glycoprotein%20130-binding%20epitope%20of%20interleukin-6&amp;journal=FEBS%20J.&amp;doi=10.1111%2Ffebs.12800&amp;volume=281&amp;pages=2471-2483&amp;publication_year=2014&amp;author=Bobby%2CR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR50">Xiong, H. et al. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. <i>J. Biol. Chem.</i> <b>287</b>, 58195832 (2012).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1074%2Fjbc.M111.295964" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1074/jbc.M111.295964" data-track-item_id="10.1074/jbc.M111.295964">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XisVyluro%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22205702" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Roles%20of%20STAT3%20and%20ZEB1%20proteins%20in%20E-cadherin%20down-regulation%20and%20human%20colorectal%20cancer%20epithelial-mesenchymal%20transition&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1074%2Fjbc.M111.295964&amp;volume=287&amp;pages=5819-5832&amp;publication_year=2012&amp;author=Xiong%2CH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR51">Wei, W. et al. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer. <i>Stem cells</i> <b>32</b>, 25712582 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fstem.1752" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/stem.1752" data-track-item_id="10.1002/stem.1752">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvFGjtLzE" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24891218" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=STAT3%20signaling%20is%20activated%20preferentially%20in%20tumor-initiating%20cells%20in%20claudin-low%20models%20of%20human%20breast%20cancer&amp;journal=Stem%20cells&amp;doi=10.1002%2Fstem.1752&amp;volume=32&amp;pages=2571-2582&amp;publication_year=2014&amp;author=Wei%2CW" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR52">Yao, C. et al. IGF/STAT3/NANOG/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer. <i>Stem Cells</i> <b>34</b>, 820831 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fstem.2320" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/stem.2320" data-track-item_id="10.1002/stem.2320">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26840943" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=IGF%2FSTAT3%2FNANOG%2FSlug%20signaling%20axis%20simultaneously%20controls%20epithelial-mesenchymal%20transition%20and%20stemness%20maintenance%20in%20colorectal%20cancer&amp;journal=Stem%20Cells&amp;doi=10.1002%2Fstem.2320&amp;volume=34&amp;pages=820-831&amp;publication_year=2016&amp;author=Yao%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR53">Na, Y. R., Lee, J. S., Lee, S. J. &amp; Seok, S. H. Interleukin-6-induced twist and N-cadherin enhance melanoma cell metastasis. <i>Melanoma Res.</i> <b>23</b>, 434443 (2013).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1097%2FCMR.0000000000000021" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1097/CMR.0000000000000021" data-track-item_id="10.1097/CMR.0000000000000021">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXhs12rtbbK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24051540" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Interleukin-6-induced%20twist%20and%20N-cadherin%20enhance%20melanoma%20cell%20metastasis&amp;journal=Melanoma%20Res.&amp;doi=10.1097%2FCMR.0000000000000021&amp;volume=23&amp;pages=434-443&amp;publication_year=2013&amp;author=Na%2CYR&amp;author=Lee%2CJS&amp;author=Lee%2CSJ&amp;author=Seok%2CSH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR54">Gallucci, R. M., Lee, E. G. &amp; Tomasek, J. J. IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. <i>J. Invest. Dermatol</i>. <b>126</b>, 561568 (2006).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fsj.jid.5700109" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/sj.jid.5700109" data-track-item_id="10.1038/sj.jid.5700109">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD28XhsVSrsLc%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16397521" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6%20modulates%20alpha-smooth%20muscle%20actin%20expression%20in%20dermal%20fibroblasts%20from%20IL-6-deficient%20mice&amp;journal=J.%20Invest.%20Dermatol&amp;doi=10.1038%2Fsj.jid.5700109&amp;volume=126&amp;pages=561-568&amp;publication_year=2006&amp;author=Gallucci%2CRM&amp;author=Lee%2CEG&amp;author=Tomasek%2CJJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR55">Romera-Hernandez, M. et al. Yap1-driven intestinal repair is controlled by group 3 innate lymphoid cells. <i>Cell Rep.</i> <b>30</b>, 3745.e33 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.celrep.2019.11.115" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.celrep.2019.11.115" data-track-item_id="10.1016/j.celrep.2019.11.115">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXotFert70%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31914395" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Yap1-driven%20intestinal%20repair%20is%20controlled%20by%20group%203%20innate%20lymphoid%20cells&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2019.11.115&amp;volume=30&amp;pages=37-45.e33&amp;publication_year=2020&amp;author=Romera-Hernandez%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR56">Tsuji, T. et al. YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. <i>Nat. Commun.</i> <b>11</b>, 74 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-019-13771-5" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-019-13771-5" data-track-item_id="10.1038/s41467-019-13771-5">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2020NatCo..11...74T" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXlslWisg%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31900393" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941996" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=YAP1%20mediates%20survival%20of%20ALK-rearranged%20lung%20cancer%20cells%20treated%20with%20alectinib%20via%20pro-apoptotic%20protein%20regulation&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-019-13771-5&amp;volume=11&amp;publication_year=2020&amp;author=Tsuji%2CT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR57">Takahashi, A. et al. Ankyrin repeat domain 1 overexpression is associated with common resistance to afatinib and osimertinib in EGFR-mutant lung cancer. <i>Sci. Rep.</i> <b>8</b>, 14896 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41598-018-33190-8" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41598-018-33190-8" data-track-item_id="10.1038/s41598-018-33190-8">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2018NatSR...814896T" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30291293" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173712" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Ankyrin%20repeat%20domain%201%20overexpression%20is%20associated%20with%20common%20resistance%20to%20afatinib%20and%20osimertinib%20in%20EGFR-mutant%20lung%20cancer&amp;journal=Sci.%20Rep.&amp;doi=10.1038%2Fs41598-018-33190-8&amp;volume=8&amp;publication_year=2018&amp;author=Takahashi%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR58">Zheng, S. et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. <i>Genom. Proteom. Bioinform.</i> <b>20</b>, 587596 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.gpb.2022.01.004" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.gpb.2022.01.004" data-track-item_id="10.1016/j.gpb.2022.01.004">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=SynergyFinder%20plus%3A%20toward%20better%20interpretation%20and%20annotation%20of%20drug%20combination%20screening%20datasets&amp;journal=Genom.%20Proteom.%20Bioinform.&amp;doi=10.1016%2Fj.gpb.2022.01.004&amp;volume=20&amp;pages=587-596&amp;publication_year=2022&amp;author=Zheng%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR59">Roper, N. et al. Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer. <i>Cell Rep. Med.</i> <b>1</b>, 10007 (2020).</p><p class="c-reading-companion__reference-links"><a href="http://scholar.google.com/scholar_lookup?&amp;title=Clonal%20evolution%20and%20heterogeneity%20of%20osimertinib%20acquired%20resistance%20mechanisms%20in%20EGFR%20mutant%20lung%20cancer&amp;journal=Cell%20Rep.%20Med.&amp;volume=1&amp;publication_year=2020&amp;author=Roper%2CN" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR60">Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. <i>Nature</i> <b>462</b>, 108112 (2009).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnature08460" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nature08460" data-track-item_id="10.1038/nature08460">Article</a>&nbsp;<a href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2009Natur.462..108B" data-track="click_references" data-track-action="ads reference" data-track-value="ads reference" data-track-label="link" data-track-item_id="link">ADS</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXht12gtrvL" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19847166" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783335" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Systematic%20RNA%20interference%20reveals%20that%20oncogenic%20KRAS-driven%20cancers%20require%20TBK1&amp;journal=Nature&amp;doi=10.1038%2Fnature08460&amp;volume=462&amp;pages=108-112&amp;publication_year=2009&amp;author=Barbie%2CDA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR61">Heinz, M. C. et al. Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage. <i>Cancer Res.</i> <b>82</b>, 19531968 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F0008-5472.CAN-21-0933" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/0008-5472.CAN-21-0933" data-track-item_id="10.1158/0008-5472.CAN-21-0933">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhsFehsbrE" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35570706" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381095" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Liver%20colonization%20by%20colorectal%20cancer%20metastases%20requires%20YAP-controlled%20plasticity%20at%20the%20micrometastatic%20stage&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-21-0933&amp;volume=82&amp;pages=1953-1968&amp;publication_year=2022&amp;author=Heinz%2CMC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR62">Hamanaka, N. et al. YES1 is a targetable oncogene in cancers harboring YES1 gene amplification. <i>Cancer Res.</i> <b>79</b>, 57345745 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F0008-5472.CAN-18-3376" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/0008-5472.CAN-18-3376" data-track-item_id="10.1158/0008-5472.CAN-18-3376">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXjslGjs70%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31391186" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=YES1%20is%20a%20targetable%20oncogene%20in%20cancers%20harboring%20YES1%20gene%20amplification&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-18-3376&amp;volume=79&amp;pages=5734-5745&amp;publication_year=2019&amp;author=Hamanaka%2CN" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR63">Lopez Sambrooks, C. et al. Oligosaccharyltransferase inhibition overcomes therapeutic resistance to EGFR tyrosine kinase inhibitors. <i>Cancer Res.</i> <b>78</b>, 50945106 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1158%2F0008-5472.CAN-18-0505" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1158/0008-5472.CAN-18-0505" data-track-item_id="10.1158/0008-5472.CAN-18-0505">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30026325" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Oligosaccharyltransferase%20inhibition%20overcomes%20therapeutic%20resistance%20to%20EGFR%20tyrosine%20kinase%20inhibitors&amp;journal=Cancer%20Res.&amp;doi=10.1158%2F0008-5472.CAN-18-0505&amp;volume=78&amp;pages=5094-5106&amp;publication_year=2018&amp;author=Lopez%20Sambrooks%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR64">Chan, L. C. et al. IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. <i>J. Clin. Invest.</i> <b>129</b>, 33243338 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2FJCI126022" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/JCI126022" data-track-item_id="10.1172/JCI126022">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31305264" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668668" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=IL-6%2FJAK1%20pathway%20drives%20PD-L1%20Y112%20phosphorylation%20to%20promote%20cancer%20immune%20evasion&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI126022&amp;volume=129&amp;pages=3324-3338&amp;publication_year=2019&amp;author=Chan%2CLC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR65">Miller, M. R. et al. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. <i>Mol. Cancer</i> <b>14</b>, 141 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s12943-015-0416-z" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s12943-015-0416-z" data-track-item_id="10.1186/s12943-015-0416-z">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26220087" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518861" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Downregulation%20of%20dystroglycan%20glycosyltransferases%20LARGE2%20and%20ISPD%20associate%20with%20increased%20mortality%20in%20clear%20cell%20renal%20cell%20carcinoma&amp;journal=Mol.%20Cancer&amp;doi=10.1186%2Fs12943-015-0416-z&amp;volume=14&amp;publication_year=2015&amp;author=Miller%2CMR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR66">Chugh, S., Meza, J., Sheinin, Y. M., Ponnusamy, M. P. &amp; Batra, S. K. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. <i>Br. J. Cancer</i> <b>114</b>, 13761386 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fbjc.2016.116" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/bjc.2016.116" data-track-item_id="10.1038/bjc.2016.116">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XotFOhurw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27187683" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984453" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Loss%20of%20N-acetylgalactosaminyltransferase%203%20in%20poorly%20differentiated%20pancreatic%20cancer%3A%20augmented%20aggressiveness%20and%20aberrant%20ErbB%20family%20glycosylation&amp;journal=Br.%20J.%20Cancer&amp;doi=10.1038%2Fbjc.2016.116&amp;volume=114&amp;pages=1376-1386&amp;publication_year=2016&amp;author=Chugh%2CS&amp;author=Meza%2CJ&amp;author=Sheinin%2CYM&amp;author=Ponnusamy%2CMP&amp;author=Batra%2CSK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR67">Peng, C. et al. Regulation of the Hippo-YAP pathway by glucose sensor O-GlcNAcylation. <i>Mol. Cell</i> <b>68</b>, 591604.e595 (2017).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.molcel.2017.10.010" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.molcel.2017.10.010" data-track-item_id="10.1016/j.molcel.2017.10.010">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhslOju7rJ" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29100056" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20the%20Hippo-YAP%20pathway%20by%20glucose%20sensor%20O-GlcNAcylation&amp;journal=Mol.%20Cell&amp;doi=10.1016%2Fj.molcel.2017.10.010&amp;volume=68&amp;pages=591-604.e595&amp;publication_year=2017&amp;author=Peng%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR68">Hung, T. L. et al. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis. <i>Clin. Cancer Res.</i> <b>9</b>, 26052612 (2003).</p><p class="c-reading-companion__reference-links"><a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3sXlt1yrsrg%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12855637" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20evaluation%20of%20HER-2%2Fneu%20protein%20in%20malignant%20pleural%20effusion-associated%20lung%20adenocarcinoma%20and%20as%20a%20tumor%20marker%20in%20pleural%20effusion%20diagnosis&amp;journal=Clin.%20Cancer%20Res.&amp;volume=9&amp;pages=2605-2612&amp;publication_year=2003&amp;author=Hung%2CTL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR69">Chu, Y. W. et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. <i>Am. J. Respir. Cell Mol. Biol.</i> <b>17</b>, 353360 (1997).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1165%2Fajrcmb.17.3.2837" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1165/ajrcmb.17.3.2837" data-track-item_id="10.1165/ajrcmb.17.3.2837">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK2sXmtVOrs7c%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9308922" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Selection%20of%20invasive%20and%20metastatic%20subpopulations%20from%20a%20human%20lung%20adenocarcinoma%20cell%20line&amp;journal=Am.%20J.%20Respir.%20Cell%20Mol.%20Biol.&amp;doi=10.1165%2Fajrcmb.17.3.2837&amp;volume=17&amp;pages=353-360&amp;publication_year=1997&amp;author=Chu%2CYW" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR70">Wisniewski, J. R., Zougman, A., Nagaraj, N. &amp; Mann, M. Universal sample preparation method for proteome analysis. <i>Nat. Methods</i> <b>6</b>, 359362 (2009).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnmeth.1322" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nmeth.1322" data-track-item_id="10.1038/nmeth.1322">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXks12ksb0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19377485" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Universal%20sample%20preparation%20method%20for%20proteome%20analysis&amp;journal=Nat.%20Methods&amp;doi=10.1038%2Fnmeth.1322&amp;volume=6&amp;pages=359-362&amp;publication_year=2009&amp;author=Wisniewski%2CJR&amp;author=Zougman%2CA&amp;author=Nagaraj%2CN&amp;author=Mann%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR71">Bern, M., Kil, Y. J. &amp; Becker, C. Byonic: advanced peptide and protein identification software. <i>Curr. Protocol. Bioinform.</i> <b>13</b>, 13 20 1113 20 14 (2012).</p><p class="c-reading-companion__reference-links"><a href="http://scholar.google.com/scholar_lookup?&amp;title=Byonic%3A%20advanced%20peptide%20and%20protein%20identification%20software&amp;journal=Curr.%20Protocol.%20Bioinform.&amp;volume=13&amp;pages=13%2020%2011-13%2020%2014&amp;publication_year=2012&amp;author=Bern%2CM&amp;author=Kil%2CYJ&amp;author=Becker%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li></ol></div></div>
        </div>
    </div>
</aside>
</div>


    
        
    
    
        
            
        

        
            
        
    
    <script>
        window.dataLayer = window.dataLayer || [];
        window.dataLayer.push({
            page: {
                content: {
                    fundingWidget: "true",
                        }
                    }
                });
    </script>




<footer class="composite-layer" itemscope="" itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        

        <div class="u-mt-16 u-mb-16">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
            

            <div class="c-meta u-ma-0 u-flex-shrink">
                <p class="c-meta__item c-meta__type u-mt-0">
                    <span itemprop="name">
                        Nature Communications
                    </span>
                    (<i itemprop="alternateName">Nat Commun</i>)
                </p>
                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">2041-1723</span> (online)
        </p>
    

                
    

            </div>
        </div>
    </div>
</div>

    <div class="c-footer">
        <div class="u-hide-print" data-track-component="footer">
    <h2 class="u-visually-hidden">nature.com sitemap</h2>
    <div class="c-footer__container">
        <div class="c-footer__grid c-footer__group--separator">
            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">About Nature Portfolio</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" data-track-label="link">About us</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link">Press releases</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link">Press office</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" data-track-label="link">Contact us</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Discover content</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/siteindex" data-track="click" data-track-action="journals a-z" data-track-label="link">Journals A-Z</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/subjects" data-track="click" data-track-action="article by subject" data-track-label="link">Articles by subject</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.protocols.io/" data-track="click" data-track-action="protocols.io" data-track-label="link">protocols.io</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link">Nature Index</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Publishing policies</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/authors/editorial_policies" data-track="click" data-track-action="Nature portfolio policies" data-track-label="link">Nature portfolio policies</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nature-research/open-access" data-track="click" data-track-action="open access" data-track-label="link">Open access</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Author &amp; Researcher services</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/reprints" data-track="click" data-track-action="reprints and permissions" data-track-label="link">Reprints &amp; permissions</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link">Research data</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/language-editing/" data-track="click" data-track-action="language editing" data-track-label="link">Language editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link">Scientific editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link">Nature Masterclasses</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://solutions.springernature.com/" data-track="click" data-track-action="research solutions" data-track-label="link">Research Solutions</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Libraries &amp; institutions</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link">Librarian service &amp; tools</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link">Librarian portal</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/openresearch/about-open-access/information-for-institutions" data-track="click" data-track-action="open research" data-track-label="link">Open research</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/recommend-to-your-library" data-track="click" data-track-action="Recommend to library" data-track-label="link">Recommend to library</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Advertising &amp; partnerships</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/digital-advertising/" data-track="click" data-track-action="advertising" data-track-label="link">Advertising</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/" data-track="click" data-track-action="partnerships and services" data-track-label="link">Partnerships &amp; Services</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/media-kits/" data-track="click" data-track-action="media kits" data-track-label="link">Media kits</a>
                    </li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link">Branded
                        content</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Professional development</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/naturecareers/" data-track="click" data-track-action="nature careers" data-track-label="link">Nature Careers</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://conferences.nature.com" data-track="click" data-track-action="nature conferences" data-track-label="link">Nature<span class="u-visually-hidden"> </span>
                        Conferences</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Regional websites</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natafrica" data-track="click" data-track-action="nature africa" data-track-label="link">Nature Africa</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link">Nature China</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link">Nature India</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natitaly" data-track="click" data-track-action="nature Italy" data-track-label="link">Nature Italy</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureasia.com/ja-jp" data-track="click" data-track-action="nature japan" data-track-label="link">Nature Japan</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nmiddleeast" data-track="click" data-track-action="nature middle east" data-track-label="link">Nature Middle East</a></li>
                </ul>
            </div>

        </div>
    </div>
    <div class="c-footer__container">
        <ul class="c-footer__links">
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/privacy" data-track="click" data-track-action="privacy policy" data-track-label="link">Privacy
                Policy</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/cookies" data-track="click" data-track-action="use of cookies" data-track-label="link">Use
                of cookies</a></li>
            <li class="c-footer__item">
                <button class="optanon-toggle-display c-footer__link" onclick="javascript:;" data-cc-action="preferences" data-track="click" data-track-action="manage cookies" data-track-label="link">Your privacy choices/Manage cookies
                </button>
            </li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/legal-notice" data-track="click" data-track-action="legal notice" data-track-label="link">Legal
                notice</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/accessibility-statement" data-track="click" data-track-action="accessibility statement" data-track-label="link">Accessibility
                statement</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/terms-and-conditions" data-track="click" data-track-action="terms and conditions" data-track-label="link">Terms &amp; Conditions</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/ccpa" data-track="click" data-track-action="california privacy statement" data-track-label="link">Your US state privacy rights</a></li>
            
        </ul>
    </div>
</div>


        <div class="c-footer__container">
    <a href="https://www.springernature.com/" class="c-footer__link">
        <img src="/static/images/logos/sn-logo-white-ea63208b81.svg" alt="Springer Nature" loading="lazy" width="200" height="20">
    </a>
    <p class="c-footer__legal" data-test="copyright"> 2025 Springer Nature Limited</p>
</div>

    </div>
    <div class="u-visually-hidden" aria-hidden="true">
    
    <!--?xml version="1.0" encoding="UTF-8"?--><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><defs><path id="a" d="M0 .74h56.72v55.24H0z"></path></defs><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"></path></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"></path></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"></path></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"></path></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"></path></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"></path></symbol><symbol id="icon-cart" viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"></path></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"></path></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"></path></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"></path></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"></path></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand"><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"></path></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"></path></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"></path></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"></path></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"></path></symbol><symbol id="icon-minus" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"></path></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"></path></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"></path></symbol><symbol id="icon-search" viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"></path></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"></path></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"></path></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"></path></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"></path></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"></path></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"><path style="fill:none" d="M0 0h56.69v56.69H0z"></path><clipPath id="b"><use xlink:href="#a" style="overflow:visible"></use></clipPath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"></path><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"></path></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-eds-i-arrow-right-medium" viewBox="0 0 24 24"><path d="m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z"></path></symbol><symbol id="icon-eds-i-check-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z"></path></symbol><symbol id="icon-eds-i-chevron-down-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-chevron-down-small" viewBox="0 0 16 16"><path d="M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z"></path></symbol><symbol id="icon-eds-i-chevron-right-medium" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-right-small" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-up-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-close-medium" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-copy-link" viewBox="0 0 24 24"><path fill-rule="evenodd" clip-rule="evenodd" d="M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z"></path><path d="M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z"></path><path d="M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z"></path><path d="M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z"></path></symbol><symbol id="icon-eds-i-download-medium" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-info-filled-medium" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-institution-medium" viewBox="0 0 24 24"><g><path fill-rule="evenodd" clip-rule="evenodd" d="M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z"></path></g></symbol><symbol id="icon-eds-i-mail-medium" viewBox="0 0 22 18"><path d="m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z"></path></symbol><symbol id="icon-eds-i-menu-medium" viewBox="0 0 24 24"><path d="M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z"></path></symbol><symbol id="icon-eds-i-search-medium" viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z"></path></symbol><symbol id="icon-eds-i-user-single-medium" viewBox="0 0 24 24"><path d="M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z"></path></symbol><symbol id="icon-eds-i-warning-filled-medium" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand-image" viewBox="0 0 18 18"><path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule="evenodd"></path></symbol><symbol id="icon-github" viewBox="0 0 100 100"><path fill-rule="evenodd" clip-rule="evenodd" d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"></path></symbol><symbol id="icon-orcid-logo" viewBox="0 0 40 40"><path fill-rule="evenodd" d="M12.281 10.453c.875 0 1.578-.719 1.578-1.578 0-.86-.703-1.578-1.578-1.578-.875 0-1.578.703-1.578 1.578 0 .86.703 1.578 1.578 1.578Zm-1.203 18.641h2.406V12.359h-2.406v16.735Z"></path><path fill-rule="evenodd" d="M17.016 12.36h6.5c6.187 0 8.906 4.421 8.906 8.374 0 4.297-3.36 8.375-8.875 8.375h-6.531V12.36Zm6.234 14.578h-3.828V14.53h3.703c4.688 0 6.828 2.844 6.828 6.203 0 2.063-1.25 6.203-6.703 6.203Z" clip-rule="evenodd"></path></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id="icon-submit-open" viewBox="0 0 16 17"><path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule="nonzero"></path></symbol></svg>
</div>
</footer>




    

    

<div class="c-site-messages message u-hide-print c-site-messages--nature-briefing c-site-messages--nature-briefing-email-variant c-site-messages--nature-briefing-redesign-2020 sans-serif" data-component-id="nature-briefing-banner" data-component-expirydays="30" data-component-trigger-scroll-percentage="15" data-track="in-view" data-track-action="in-view" data-track-category="nature briefing" data-track-label="Briefing banner visible: Flagship">

    
    <div class="c-site-messages__banner-large">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__form-container">

            <div class="grid grid-12 last">
                <div class="grid grid-4">
                    <img alt="Nature Briefing" src="/static/images/logos/nature-briefing-logo-n150-white-d81c9da3ec.svg" width="250" height="40">
                    <p class="c-site-messages--nature-briefing__strapline extra-tight-line-height">Sign up for the <em>Nature Briefing</em> newsletter  what matters in science, free to your inbox daily.</p>
                </div>
                <div class="grid grid-8 last">
                    <form action="https://www.nature.com/briefing/briefing" method="post" data-location="banner" data-track="signup_nature_briefing_banner" data-track-action="transmit-form" data-track-category="nature briefing" data-track-label="Briefing banner submit: Flagship">
                        <input id="briefing-banner-signup-form-input-track-originReferralPoint" type="hidden" name="track_originReferralPoint" value="MainBriefingBanner">
                        <input id="briefing-banner-signup-form-input-track-formType" type="hidden" name="track_formType" value="DirectEmailBanner">

                        <input type="hidden" value="false" name="gdpr_tick" id="gdpr_tick_banner">
                        <input type="hidden" value="false" name="marketing" id="marketing_input_banner">
                        <input type="hidden" value="false" name="marketing_tick" id="marketing_tick_banner">
                        <input type="hidden" value="MainBriefingBanner" name="brieferEntryPoint" id="brieferEntryPoint_banner">

                        <label class="nature-briefing-banner__email-label" for="emailAddress">Email address</label>

                        <div class="nature-briefing-banner__email-wrapper">
                            <input class="nature-briefing-banner__email-input box-sizing text14" type="email" id="emailAddress" name="emailAddress" value="" placeholder="e.g. jo.smith@university.ac.uk" required="" data-test-element="briefing-emailbanner-email-input">
                            
                            <input type="hidden" value="true" name="N:nature_briefing_daily" id="defaultNewsletter_banner">
                            <button type="submit" class="nature-briefing-banner__submit-button box-sizing text14" data-test-element="briefing-emailbanner-signup-button">Sign up</button>
                        </div>

                        <div class="nature-briefing-banner__checkbox-wrapper grid grid-12 last">
                            <input class="nature-briefing-banner__checkbox-checkbox" id="gdpr-briefing-banner-checkbox" type="checkbox" name="gdpr" value="true" data-test-element="briefing-emailbanner-gdpr-checkbox" required="">
                            <label class="nature-briefing-banner__checkbox-label box-sizing text13 sans-serif block tighten-line-height" for="gdpr-briefing-banner-checkbox">I agree my information will be processed in accordance with the <em>Nature</em> and Springer Nature Limited <a href="https://www.nature.com/info/privacy">Privacy Policy</a>.</label>
                        </div>
                    </form>
                </div>
            </div>

        </div>

    </div>

    
    <div class="c-site-messages__banner-small">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__content text14">
            <span class="c-site-messages--nature-briefing__strapline strong">Get the most important science stories of the day, free in your inbox.</span>
            <a class="nature-briefing__link text14 sans-serif" data-track="click" data-track-category="nature briefing" data-track-label="Small-screen banner CTA to site" data-test-element="briefing-banner-link" target="_blank" rel="noreferrer noopener" href="https://www.nature.com/briefing/signup/?brieferEntryPoint=MainBriefingBanner">Sign up for Nature Briefing
            </a>
        </div>

    </div>

</div>






<noscript>
    <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
</noscript>




<script src="//content.readcube.com/ping?doi=10.1038/s41467-024-51831-7&amp;format=js&amp;last_modified=2024-09-09" async=""></script>

<div data-cc-ghost="" style="height: 381px;"></div><script src="https://verify.nature.com/verify/nature.min.js"></script><script type="text/javascript" id="fetch-contextual-ads-campaign-data" charset="">(function(){var g=function(a){a=new CustomEvent("campaignDataLoaded",{detail:a});document.dispatchEvent(a)},b=google_tag_manager["rm"]["50443292"](21);if(b){var k=1500;b=google_tag_manager["rm"]["50443292"](22);b="link"===b?google_tag_manager["rm"]["50443292"](23):google_tag_manager["rm"]["50443292"](24);var m=function(a,c){var h=!1,l=setTimeout(function(){h=!0;c(null)},k),d=new XMLHttpRequest;d.onload=function(){var e=null,f=[];if(200===d.status){try{e=JSON.parse(d.responseText)}catch(p){e={}}f=e.campaigns||[]}h||(clearTimeout(l),c(f.length?f.join(","):null))};d.open("GET",
"/platform/contextual?doi\x3d"+a);d.send()},n=function(a,c){a&&-1===a.indexOf("not set")?m(a,c):setTimeout(c,1)};n(b,function(a){window.campaignsForContextualAds=a;g(a);window.dataLayer.push({content:{article:{campaignID:a}}})})}else window.campaignsForContextualAds="",g(null)})();</script>
<script type="text/javascript" id="gtm-setup-accessdetailsloaded-handler" charset="">document.addEventListener("accessdetailsloaded",function(a){a=a.detail||{};var b={event:"update-access-details"};a.institutional_business_partner_ids&&a.resolved_by||console.log("BPID data could not be retrieved from /exposed-details");a.logged_in_to_sn_profile||console.log("logged_in_to_sn_profile could not be retrieved from /exposed-details");var c=a.institutional_business_partner_ids&&a.institutional_business_partner_ids.join?a.institutional_business_partner_ids.join(";"):"",d=a.resolved_by&&a.resolved_by.join?
a.resolved_by.join(";"):"",e=a.personal_business_partner_id_found,f=a.logged_in_to_sn_profile,g=a.snid;b.user={};b.user.profile={};b.user.profile.profileInfo={resolvedBy:d||null,bpid:c||null,personal:e||null,logged_in_to_sn_profile:f,snid:g||null};b.session={};b.session.authentication={};b.session.authentication.token=a.token||null;b.session.authentication.legacy={};window.dataLayer.push(b);window.idpUserDataLoaded=!0},!1);window.dataLayer.push({event:"accessdetailsloaded-handler-added"});
window.accessDetailsLoadedHandlerAdded=!0;</script><script type="text/javascript" id="gtm-mediatrust" charset="">var s=document.getElementsByTagName("script")[0],p=document.createElement("script");p.async="async";p.src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2";s.parentNode.insertBefore(p,s);</script><script id="crossmark-script" text="" charset="" type="text/javascript" src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script><script type="text/javascript" id="polyfill-matches" charset="">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script><script type="text/javascript" id="fetch-idp-user-data" charset="">(function(a){if("function"===typeof window.CustomEvent)return!1;var c=function(d,b){b=b||{};var e=document.createEvent("CustomEvent");e.initCustomEvent(d,b.bubbles||!1,b.cancelable||!1,b.detail||a);return e};c.prototype=window.Event.prototype;window.CustomEvent=c})();var parse=function(a,c){try{return 200===a?JSON.parse(c):null}catch(d){return null}},dispatch=function(a){a=new CustomEvent("accessdetailsloaded",{detail:a});document.dispatchEvent(a)},site=google_tag_manager["rm"]["50443292"](58),idpUrl;
switch(site){case "nature":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?"https://staging-idp.nature.com/exposed-details":"https://idp.nature.com/exposed-details";break;case "link":idpUrl=-1<window.location.hostname.indexOf("link-qa")?"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details";break;case "springer":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?
"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details"}if(void 0!==idpUrl){var transport=new XMLHttpRequest;transport.open("GET",idpUrl,!0);transport.withCredentials=!0;transport.onreadystatechange=function(){4===transport.readyState&&dispatch(parse(transport.status,transport.responseText))};transport.send()}else dispatch(null);</script><script type="text/javascript" id="create-ad-slots" charset="">function createAndLoadAds(){function h(b){"nature"===a&&google_tag_manager["rm"]["50443292"](206)(b);"bmc"!==a&&"springeropen"!==a||google_tag_manager["rm"]["50443292"](221)(b);("link"===a&&"oscar"===google_tag_manager["rm"]["50443292"](222)||"springer"===a||"link"===a&&!0===google_tag_manager["rm"]["50443292"](223))&&google_tag_manager["rm"]["50443292"](248)(b);"link"===a&&"bunsen"===google_tag_manager["rm"]["50443292"](249)&&google_tag_manager["rm"]["50443292"](274)(b);"link"===a&&"Core"===google_tag_manager["rm"]["50443292"](275)&&google_tag_manager["rm"]["50443292"](287)(b)}window.googletag=window.googletag||{cmd:[]};var a=google_tag_manager["rm"]["50443292"](288),e=google_tag_manager["rm"]["50443292"](290);
if(-1===window.location.search.indexOf("hide_ads\x3dtrue"))if(window.adSlots&&0!==Object.keys(window.adSlots).length)console.log("Ads previously loaded. Will not update ad slots until next page load.");else{window.adSlots||(window.adSlots={});window.getAd=function(b,f){for(var c in window.adSlots)if(-1<c.indexOf(b)){if("object"===f)return adSlots[c];if("slot"===f)return adSlots[c].slot}};googletag.cmd.push(function(){googletag.pubads().setPrivacySettings({limitedAds:e});console.log("limitedAds is ",
e);googletag.pubads().setRequestNonPersonalizedAds(google_tag_manager["rm"]["50443292"](292));googletag.pubads().enableSingleRequest();googletag.pubads().disableInitialLoad()});for(var g=document.querySelectorAll("[data-gpt]"),d=0;g[d];++d)h(g[d]);googletag.cmd.push(function(){googletag.enableServices()})}}createAndLoadAds();</script>
<iframe name="google_ads_top_frame" id="google_ads_top_frame" style="display: none; position: fixed; left: -999px; top: -999px; width: 0px; height: 0px;"></iframe></body></html>